WHO (2021), World Health Statistics 2021
WHO (2021), World Health Statistics 2021
WHO (2021), World Health Statistics 2021
2021
World Health Statistics 2021
The World health statistics report is the World Health Organization’s (WHO) annual compilation of
the most recent available data on health and health-related indicators for its 194 Member States.
The 2021 edition features the latest data for 50+ health-related indicators from the Sustainable
Development Goals (SDG) and WHO Triple Billion targets. The 2021 report additionally focuses on
the human toll and impact of the coronavirus disease 2019 (COVID-19) pandemic, highlighting the
importance of tracking inequalities and the urgency to accelerate progress to get back on track and
recover equitably with the support of robust data and health information systems.
World health statistics 2021: monitoring health for the SDGs, sustainable development goals
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO;
https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as
indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the
WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a
translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health
Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic
edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property
Organization (http://www.wipo.int/amc/en/mediation/rules/).
Suggested citation. World health statistics 2021: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2021.
Licence: CC BY-NC-SA 3.0 IGO.
Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on
rights and licensing, see http://www.who.int/about/licensing.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your respon-
sibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from
infringement of any third-party-owned component in the work rests solely with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion
whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference
to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital
letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distrib-
uted without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no
event shall WHO be liable for damages arising from its use.
CONTENTS
Foreword. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
3. Risks to health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
W
hen the World Health Statistics was released last year, we were still in the early stages of the COVID-19
pandemic. Countries were responding rapidly under uncertain conditions, frontline health workers
were making heroic efforts to contain the spread of the virus, and governments and partners were
scrambling to assist those in need.
One year on, the world has made great strides. But the race against this coronavirus and its variants is still
on, and there is still much work to be done. At the time of writing, more than 160 million confirmed COVID-19
cases and 3.3 million deaths had been reported to WHO. Yet these numbers are only a partial picture, as many
countries have not been able to accurately measure and report on deaths that are either directly or indirectly
attributable to COVID-19.
One of the greatest lessons from the pandemic is the importance of timely, reliable, actionable and disaggregated
data. This requires strong country data and health information systems through collaboration between
governments, ministries of health, national statistical offices, and registrar generals. It also requires engagement
with the private sector, academia, nonprofit organizations, and the scientific community to ensure data is
accessible as a public good
WHO’s World Health Statistics report 2021 presents the latest data for more than 50 health-related indicators
for the Sustainable Development Goals and WHO’s “triple billion” targets.
It finds an overall increase in global life expectancy and healthy life expectancy at birth as a result of improvements
in several communicable diseases, maternal, perinatal and nutritional conditions, noncommunicable diseases,
injuries and their underlying determinants. Persisting inequalities also continue to impact population health
in most, if not all, aspects. Despite the overall improvement in service coverage, between and within countries
disadvantaged populations still have lower access to care and are at greater risk of facing catastrophic costs.
While premature deaths from noncommunicable diseases – the world’s leading cause of death – continue to
fall, progress has slowed in recent years and key risk factors including tobacco use and alcohol consumption,
hypertension, obesity, and physical inactivity will require urgent and targeted intervention.
Deaths from communicable diseases have also declined but continue to claim millions of lives each year, particularly
in lower-resource settings where many people cannot access quality health services. There has also been a steady
decrease in mortality from suicide, homicide, unintentional poisoning and road traffic injuries, but many more of
these deaths can still be prevented and men are at higher risk of dying from these causes than women.
To close these gaps and meet the global goals, we must continue to focus on the
equitable distribution of services and access to quality, affordable healthcare and
effective interventions in all countries and for all populations. We must also be on
alert that COVID-19 has disrupted many essential services and that the distribution
of health and care workers varies widely, with the lowest density of medical doctors,
nurses and midwives in the areas where they are needed most. Out-of-pocket
spending on healthcare is also on the rise, with the most vulnerable populations at
greatest risk of being pushed into poverty, thus further widening inequalities.
Real-time, quality data to track population health is critical for every country to
improve health outcomes and eliminate health inequalities. WHO is committed to
work with countries and partners to strengthen health information systems and Dr Tedros Adhanom Ghebreyesus
support data-driven policies and interventions. COVID-19 is not the first pandemic Director-General
World Health Organization
and likely will not be the last. In order to be better prepared we must have better data.
T
he World health statistics report is the World Health Organization (WHO) annual compilation of the latest
available data on health and health-related indicators for its 194 Member States. The report is produced by
the WHO Division of Data, Analytics and Delivery for Impact, in collaboration with WHO technical departments
and regional offices. The 2021 edition features the latest data for more than 50 health-related indicators from
the Sustainable Development Goals (SDG) and the WHO Triple Billion targets. In the WHO Thirteenth General
Programme of Work (GPW 13), all Member States are committed to deliver on the Triple Billion targets and to
accelerate progress towards the 2030 Agenda for Sustainable Development as informed by national data and
health information systems.
As the COVID-19 pandemic is unfolding and countries are responding, critical inequalities have surfaced,
demanding global cooperation and concerted action to be better prepared to respond to this and other global
health threats. With newly-confirmed COVID-19 cases at an all-time high globally, the scale of transmission
elevates the risk of potentially more contagious, lethal and/or immune-evasive variants. The pandemic is entering
a new phase characterized by a dramatic shift of its epicentre to the developing world, jeopardizing the world’s
collective goal to end it and risking further setbacks to the entire sustainable development agenda.
The commitment to “leave no one behind” is a cornerstone of the 2030 Agenda for Sustainable Development.
But within and between countries, high and rising inequalities act as both visible and concealed impediments to
progress in population health and human, social and economic development. Reducing inequality is a discrete
SDG (SDG 10) and is vital to achieving all SDGs including ending poverty (SDG 1), ending hunger (SDG 2), ensuring
healthy lives (SDG 3), ensuring inclusive and equitable quality education (SDG 4) and achieving gender equality
(SDG 5).
Using both between country and within country inequality lenses, this report presents in Section 1 the latest
available data on COVID-19: including cases, deaths, vaccination, disruptions to health services, impact on health
workers, migrants and refugees and related data gaps. Section 2 summarizes the recent trends and levels in life
expectancy, healthy life expectancy, and global and regional burden of disease and injuries. Section 3 addresses
various behavioural, environmental and metabolic risk factors that comprise the underlying drivers of existing
disease burden. Section 4 centres around universal health coverage (UHC), describing the trends in both service
coverage and financial protection, with a closer look at different types of tracer interventions, including services
for reproductive, maternal, newborn and child health (RMNCH), services for communicable diseases, health
workforce (HWF) and health security. Section 5 concludes the report with a summary of recent progress towards
and projections for achieving the Triple Billion targets and opportunities for accelerating progress towards the
health-related SDGs by reducing health inequalities and strengthening data and health information systems.
COVID-19 poses major challenges to population health and well-being globally and thwarts the
progress in meeting SDGs and the WHO Triple Billion targets.
Emerging only at the end of 2019, the COVID-19 pandemic has quickly become a global threat to population health,
infecting over 153 million people, devastatingly costing more than 3.2 million lives by 1 May 2021 globally. COVID-19
has become a leading cause of death, caused a considerable number of additional deaths indirectly at global,
regional and national levels and has inevitably shortened life expectancy in many countries, with still unknown
long-term impact on morbidity. Preliminary WHO estimates suggest the total global excess deaths attributable
to COVID-19, both directly and indirectly, amounts to at least 3 million in the year 2020. This is 1.2 million deaths
more than the reported 1.8 million global COVID-19 deaths.
Acceleration of development, production and distribution of COVID-19 vaccines is underway in countries and
through international cooperation including the COVAX initiative. However, fair and equitable access to the vaccines
is far from being achieved, and the inequality across income groups is pronounced with only 1% of doses going
to low Income countries as compared to the 19% administered in lower -middle-income countries, 33% in upper
-middle-income countries and 47% in high-income countries as of 1 May 2021. Pre-pandemic inequalities have
driven the unequal global distribution of vaccines and run the risk of perpetuating the pandemic, which in turn
has amplified existing inequality and risks throwing the entire 2030 sustainable development agenda off-track.
Achieving equal global vaccination is imperative, or the risk of a more virulent or transmissible variant remains
high: no one is safe until everyone is safe.
Disruptions of essential health services due to COVID-19 have been widespread due to the shortage of medicines,
staff, diagnostics and public transport services. The second WHO “pulse survey” highlights persistent disruptions
at a considerable scale over one year into the COVID-19 pandemic, with 89% of 135 countries and territories
reporting one or more disruptions to essential health services. Improvements were seen within countries,
however, with average reported disruptions in essential health services decreasing from about half in 2020 to
just over one third in the first quarter of 2021. In response to service disruptions, the majority of countries are
implementing mitigation strategies and approaches including community communications, triaging to identify
priorities, recruitment of additional staff, and provision of home-based care.
COVID-19 is disproportionately impacting vulnerable populations, including the economically disadvantaged, older
adults and those who live in congregate residential settings or with existing underlying health conditions. This
draws further attention to persistent inequalities in both health outcomes and health determinants, including
risk factors, social determinants and access to health services, within and across countries. The pandemic
poses critical challenges to the health systems in low-resource settings and is jeopardizing the hard-won health
and development gains towards achieving the WHO Triple Billion targets and UN Sustainable Development
Goals (SDGs). However, the lack of disaggregated COVID-19 data and strong data infrastructure with good vital
registration systems limits the development of more effective and better targeted policies and the allocation of
resources that are data-driven for mitigating the pandemic situation and restoring progress towards the Triple
Billion targets and SDGs.
Prior to the COVID-19 pandemic, improvements in health were made. However, the progress is
inadequate for attaining the Triple Billion targets and health-related SDGs, calling for more effective
disease and injury prevention and control programmes.
The global population continues to live longer and live more years in good health. Between 2000 and 2019, global
life expectancy (LE) at birth increased from 66.8 years in 2000 to 73.3 years in 2019, and healthy life expectancy
(HALE) increased from 58.3 years to 63.7 years. Sharing similar increasing trends but starting with different
These patterns were driven by the rapid transitions and associated inequalities in the evolution of mortality
and morbidity profiles since 2000. The dramatic decline in premature mortality due to communicable diseases,
particularly in low-resource settings, has shifted the disease burden to noncommunicable diseases (NCD),
increasing the global share of NCD deaths among all deaths from 60.8% in 2000 to 73.6% in 2019.
While NCDs accounted for up to over 85% of deaths in HICs – with heart disease, dementia and stroke being the
leading causes – communicable diseases along with maternal, perinatal and nutritional conditions were still
responsible for nearly half of all deaths in LICs with lower respiratory infections, diarrhoeal diseases, malaria,
tuberculosis and HIV/AIDS remaining in the top 10 causes of death. LICs and lower middle-income countries
(LMICs) bore the vast majority of the burden of communicable diseases, including that attributable to tuberculosis
(TB), HIV, malaria, neglected tropical diseases (NTDs) and hepatitis B.
Despite the progress already made, the current pace of improvements is not rapid enough for many indicators to meet
the SDG targets by 2030, including premature mortality from NCDs, the incidence of TB and malaria, and new HIV
infections. These challenges underscore the need for strong disease and injury prevention and control programmes
to adequately accelerate the current progress for meeting various national and international health targets.
Indicators for health-related SDGs and the WHO Triple Billion targets have seen overall improvements,
but progress is not fast enough and risks being set back by COVID-19. Further acceleration is needed
for addressing risk factors, scaling up universal health coverage (UHC), and strengthening capacities
to detect, assess, report on and respond to public health emergencies.
To prevent diseases and injuries and keep the population healthy in the first place, the WHO Triple Billion
targets and SDGs both dedicate several indicators to addressing risk factors through the impact of multisectoral
interventions. Progress in reducing exposure to risk factors is mixed and also manifests inequalities. While there
has been a success in reducing tobacco use globally, the prevalence of adult obesity was on the rise with up to
a quarter of the population in HICs being obese. The prevalence of hypertension also showed a mixed picture
where the prevalence declined worldwide between 2000 and 2015, except for LICs where a slightly upward trend
was seen. A notable decline for harmful use of alcohol was only seen recently after a plateau in 2010–2015.
In addition, lower-resource countries continue to be exposed to ambient and household air pollution at higher
rates than more developed countries. Children and women in low and lower-middle-income countries are also
at higher risk of malnutrition , including stunting, wasting, and anaemia during pregnancy. Upper-middle income
countries are more susceptible to overweight.
Many countries are already making progress towards UHC, although everywhere the COVID-19 pandemic impacted
the ability of health systems to provide undisrupted health services. Improvements in coverage of essential
health services have been recorded in all income groups and across different types of services, despite persistent
inequalities. The UHC service coverage index (SCI) increased from a global average of 45 (of 100) in 2000 to 66
in 2017. The greatest progress has been in LICs, driven mainly by interventions for infectious diseases and, to a
smaller extent, for reproductive, maternal, newborn, and child health (RMNCH) services. Globally and for many
countries, however, the pace of progress has slowed since 2010, and the poorest countries and those affected by
conflict generally lag furthest behind. Continued progress requires considerable strengthening of health systems,
particularly in lower income settings. Unfortunately, the gains in service coverage have come at a major cost to
individuals and their families. Overall, financial protection prior to COVID-19 has been deteriorating. The proportion
of the population with out-of-pocket health spending exceeding 10% of their household budget rose from 9% to
13%, and those exceeding 25% rose from 1.7% to 2.9%, over the period 2000–2015. The impact of COVID-19 on
the number of households spending a large share of their budgets on health care remains uncertain, as there is
evidence of income shrinking, poverty increasing and households forgoing health care.
In terms of global health security, trends in State Party self-assessment and reporting tool (SPAR) show stability
and steady progress since 2018 in almost every core capacity except for a very small reduction observed in 2020,
compared to 2019, in the capacities related to zoonotic events and human–animal health interface and chemical
events. The COVID-19 experience shows the critical need for a coordinated multisectoral health emergency surge
capacity and preparedness at all levels within countries. In addition, continuing efforts are needed to improve
and maintain early warning systems to mitigate and manage public health risks within the national context and
to consider worldwide pandemic context for national health emergency operational preparedness planning.
The Triple Billion targets are critical for helping countries to accelerate the delivery of the SDGs,
and require swift and enhanced political commitment and investment for achieving them by 2023.
Inequalities continue to impede the achievement of optimal and equitable health gains. Strong
health information systems with high-quality, timely and reliable disaggregated data are urgently
needed to identify the health gaps and inequalities and to inform targeted, effective and cost-
effective decision-making.
Before the COVID-19 pandemic, none of the Triple Billion targets was projected to be met; with UHC, Healthier
Populations and Health Emergencies falling short of the one billion GPW 13 goals by 710, 100 and 80 million
respectively. These projections have not taken the full impacts of COVID-19 into account, which is expected to
further impede the attainment of many of the targets. COVID-19 has revealed that no country is prepared to deal
with a pandemic of such magnitude, scale and impact. Getting back on track and accelerating progress towards
meeting the Triple Billion targets requires multilateralism and equitable, rights-based and inclusive multisectoral
responses to global health challenges.
A strong health information system is crucial for monitoring and accelerating progress towards the SDGs,
GPW 13 Triple Billion targets, and national and subnational health priorities. It is critical that such a system can
generate timely, reliable, disaggregated comparable and actionable data, to measure and track population health
determinants and outcomes along with health inequality therein, and to ultimately drive strategic policy changes.
The WHO SCORE assessment showed that about 40% of the world’s deaths remain unregistered, and 50% of
countries have limited or less capacity for systematic monitoring health care quality, and only 59% of countries
have good capacity to use data to drive policy and planning. The COVID-19 pandemic further highlighted the
importance of closing existing data gaps with high-quality health data and strong health information systems for
guiding all stages of policy to respond to daily needs for improving population health and unpredictable health
emergencies.
Irrespective of the COVID-19 pandemic, existing inequalities, both within countries and between countries, impede
appropriately targeted interventions and the accrual of equitable health gains. As evidenced throughout this
report, populations in low-resource settings, those who are less educated, women, rural populations, racial and
ethnic minorities, and migrants continue to have higher exposures to many health risks, lower access to health
services and lower health literacy and consequently face poorer health outcomes.
Identifying health inequalities and their determinants is essential for achieving health equity and improving
programme delivery. Knowing who is being left behind relies on equity-oriented national health information
systems to produce and use inequality data for a fairer, healthier world. Yet, high-quality disaggregated data for
monitoring health inequalities and for ensuring equitable health service access and uptake are lacking worldwide.
In addition, even the available disaggregated data are often not made accessible to decision-makers as needed.
Only 51% of 133 studied countries include data disaggregation in published national health statistical reports,
ranging from 63% in HICs to only 46–50% for other income groups. Investment and political commitment are
vital to enhancing country health information systems that generate disaggregated data by multiple inequality
dimensions through various data sources including civil registration and vital statistics, population-based surveys,
routine health facility data and administrative data.
1
That said, a recent shift in distribution of cases and This is in contrast to the rise of the share of global
deaths from higher- to lower-resource settings is monthly new cases contributed by LMICs from 8% in
evident. For example, while HICs accounted for about January 2021 to 37% in April 2021, and the share for
64% and 59% of the global monthly new cases and new deaths from 8% to 22% between January and April
deaths, respectively, in January 2021, the shares 2021.
dropped to 31% and 27%, respectively, in April 2021.
a) Cumulative confirmed cases (in thousands) b) Cumulative confirmed cases, per 100,000
population
Americas 62 248
Americas 6 114
Europe 51 891
Europe 5 562
Un
n
ite
(Is
Af ric
d
la
St
a
m
te
In
ic
s
d
of
on
Re
Am
es
pu
er
ia
b…
ic
a
ia
AFRO
Ind
EM
RO
SE
AR
O
AMRO
Brazil
EURO
Arg
en
Co tin
a
s lom
nd bia
la M
er chia e
h
t e e Pe xico
Ne Cz ain ru
kr
d
m
n
Russian Federation
U
y
la
Kingdo
an
Po
rm
Fra
ain
T urk
Ge
nc
Sp
Ital
e
ited
ey
T he U n
Fig. 1.1. Cumulative confirmed COVID-19 cases as of 1 May 2021, by region: a) in thousands; b) per 100 000 population; and c) by location
Americas 1 520
Americas 149
Europe 1 084
Europe 116
Africa 83 Africa 7
0 250 500 750 1000 1250 1500 1… 0 25 50 75 100 125 150 175
Un
n
ite
(Is
d
Africa
St
la
a te
mi
so
In
fA
cR
d
on
m
er
ep
e
ica
si
ub
a
In
…
d ia
AFRO
EM
SE
RO
AR
O
Brazil
AMRO
Hungary
Romania
ia
Czech EURO
ey
T urk e
ain
U kr
d
lan
Po Me
xic
ain o
Sp y
an
ion
rm
Co
The United Kingdom
e
lo
Ar
G
ce
rat
m
ge
an
bi
de
Fr
a
nt
Pe
e
in
ru
nF
Italy
a
sia
s
Ru
Fig. 1.2. Cumulative confirmed COVID-19 deaths as of 1 May 2021, by region: a) in thousands; b) per 100 000 population; and c) by location
80+ 80+
75-79 75-79
70-74 70-74
65-69 65-69
60-64 60-64
50-59 50-59
Age-group
40-49 40-49
30-39 30-39
20-29 20-29
15-19 15-19
10-14 10-14
5-9 5-9
<5 <5
5 4 3 2 1 0 1 2 3 4 5
Number of cases (millions)
Fig. 1.3. Total number of COVID-19 cases (probable and confirmed), by age and sex, January 2020 to April 2021
5
Number of cases (millions)
0
Jan 2020 Feb 2020 Mar 2020 Apr 2020 May 2020 Jun 2020 Jul 2020 Aug 2020 Sep 2020 Oct 2020 Nov 2020 Dec 2020 Jan 2021 Feb 2021 Mar 2021 Apr 2021
period
Female Male
Note: The illustrated April cases are only up to 12 April and not the complete month.
Source: WHO Coronavirus (COVID-19) surveillance dashboard (6).
Fig. 1.4. Change over time in number of COVID-19 cases (probable and confirmed), by sex, January 2020 to April 2021
80+ 80+
75-79 75-79
70-74 70-74
65-69 65-69
60-64 60-64
50-59 50-59
Age-group
40-49 40-49
30-39 30-39
20-29 20-29
15-19 15-19
10-14 10-14
5-9 5-9
<5 <5
Fig. 1.5. Total number of COVID-19 deaths (probable and confirmed), by age and sex, January 2020 to April 2021
5
Number of cases (millions)
0
Jan 2020 Feb 2020 Mar 2020 Apr 2020 May 2020 Jun 2020 Jul 2020 Aug 2020 Sep 2020 Oct 2020 Nov 2020 Dec 2020 Jan 2021 Feb 2021 Mar 2021 Apr 2021
period
Female Male
Note: The illustrated April deaths are only up to 12 April and not the complete month.
Source: WHO Coronavirus (COVID-19) surveillance dashboard (6).
Fig. 1.6. Change over time in number of COVID-19 deaths (probable and confirmed), by sex, January 2020 to April 2021
COVID-19 vaccines and vaccination Note: Comparing total deaths estimated for leading causes in 2019 Global Health Estimates to the reported
COVID-19 deaths for the year 2020. Comparing quantities from two different periods and so does not account
for population growth or any epidemiological changes. However, gives an order of magnitude picture and
expected relative ranking of causes for 2020 assuming mortality risks and levels for other causes have not
In light of the still unfolding pandemic, global equitable changed significantly.
access to vaccines – with a focus on protecting priority Source: WHO Global Health Estimates 2019 (11) and WHO Covid-19 surveillance dashboard (6).
Regional distributions of COVID-19 cases, deaths and Income group distributions of COVID-19 cases, deaths and
vaccine doses vaccine doses
50 50
47
48 48 45
41
40
40 40
34 34
33 33
32
30 30
Percent
Percent
23
22
20
20 20 19
17
15
14
10 9 10
6 6
4
3
2 2
1 1 1 1 1
0 0
AFRO AMRO EMRO EURO SEARO WPRO LIC LMIC UMIC HIC
WHO region WB income group
% global cases % global deaths % global doses % global cases % global deaths % global doses
Fig. 1.7. Distribution of COVID-19 vaccine doses by WHO regions and World Bank income groups
8M
New vaccinations
6M
4M
2M
0
7. Dec 21. Dec 4. Jan 18. Jan 1. Feb 15. Feb 1. Mar 15. Mar 29. Mar 12. Apr 26. Apr
Date
Notes: Timeline
Source: Ourshown is frominDecember
World data as2020
ofuntil
1 MayApril 2021.
2021 M = million; WB = World Bank.
Source: Our world in data (14).
Fig. 1.8. Distribution of new COVID-19 vaccinations doses by World Bank income group and date
Unequal roll-out of vaccines amidst the spread of Disruption of essential health services
new variants puts lower-resourced settings at greater
risk and partly explains the recent shift of mortality The second round of the WHO “pulse survey” of
distribution from higher to lower-resource settings. 135 countries and territories (April 2021) highlights
Pre-pandemic inequalities have driven the unequal persistent disruptions to health services at considerable
global distribution of vaccines and run the risk of scale over one year into the COVID-19 pandemic, with
perpetuating the pandemic, which in turn has amplified 89% of countries reporting one or more disruptions
existing inequality and risks throwing the entire 2030 to essential health services. Improvements, however,
sustainable development agenda off-track. Global were seen within countries, with average reported
solidarity to boost the manufacturing of vaccines and disruptions falling from about half of essential
to guarantee their equitable access is critical to prevent health services in 2020 to just over one third in the
potentially more transmissible, lethal or immune- first quarter of 2021 (15,16). Health workforce-related
evasive variants from spreading and to eventually keep reasons, including reassignment within the health
the global community safe from the virus. system, remain the most common causes of service
disruption, affecting two thirds of the surveyed
However, vaccines alone will not be sufficient to end the countries. Disrupted supply chains persist in nearly one
pandemic. Sustained downturns in weekly cases and third of surveyed countries, limiting the availability of
deaths at global level are still yet to be seen: we need essential medicines, diagnostics and the PPE required
to do everything possible – including social distancing, to safeguard health workers to effectively provide care.
wearing masks and frequently cleaning hands – to stop Other most frequently cited reasons for discontinuing
the spread of the virus and prevent mutations that may or reducing services were cancellations of planned
compromise the efficacy of existing vaccines. prevention and treatment services and a decrease in
public transport services.
Fig. 1.10. Reasons for refugees and migrants not seeking medical care in case of (suspected)
COVID‑19 symptoms
An ongoing survey conducted in a partnership between Facebook and the University of Maryland in 35 HICs shows that in the past 10 months (between May 2020 and
February 2021), the more deprived people are, the less they apply protective behaviours against COVID-19. Household overcrowding is an indicator of socioeconomic status,
with extremely overcrowded defined as more than five people per room used for sleeping, moderately overcrowded defined as more than two but less than or equal to five,
and uncrowded defined as two or less. Survey respondents constituted between 1% and 21% of the adult population living in moderately overcrowded conditions, and 0.01%
to 3.1% living in extremely overcrowded conditions across the 35 countries.
People living in overcrowded households are overall less likely to intentionally avoid contact with others, practice regular handwashing each day, and wear masks in public
when compared to people living in uncrowded households. Preventive behaviours decrease as the amount of overcrowding increases (Fig. 1.11).
Overall, 79% of people living in uncrowded households1 reported trying to physically distance themselves from others, compared to 71% in moderately overcrowded and
65% in extremely overcrowded households. Regular daily handwashing practices were also more common among people who lived in uncrowded households (93%) than in
moderately overcrowded (89%) and extremely overcrowded households (82%). In terms of mask wearing in public, overall, 87% of people living in uncrowded households
wore a mask all or most of the time when in public in the last seven days, compared to 80% of people living in moderately overcrowded conditions and 74% of people living in
extremely overcrowded conditions.
60
Median (%)
50
40
30
20
10
0
Extremely Moderately Uncrowded Extremely Moderately Uncrowded Extremely Moderately Uncrowded
overcrowded overcrowded (≤ 2 people per room) overcrowded overcrowded (≤ 2 people per room) overcrowded overcrowded (≤ 2 people per room)
(>5 people per room) (>2-5 people per room) (>5 people per room) (>2-5 people per room) (>5 people per room) (>2-5 people per room)
Note: Overcrowding is measured by the number of persons per room used for sleeping. The number of people per room considers rooms used for sleeping. Physical distancing is defined as intentionally avoiding
contact with other people all the time or most of the time. Handwashing is defined as washing hands with soap and water or using hand sanitizing three or more times in the last 24 hours. Mask-wearing refers to
wearing a mask all the time or most of the time when in public in the last 7 days.
Source: WHO calculations using COVID-19 World Symptoms Survey data.
Fig. 1.11. Combined data for preventive indicators: physical distancing, handwashing and wearing masks, by ‘household crowding’ in 35 HICs
Data gaps From the onset of the pandemic, completed WHO case
report forms have provided an important source of
The main challenge to determining the factors that information for real-time monitoring and tracking of
are primarily associated with elevated COVID-19 the impact of the pandemic. These data are submitted
infection and related mortality risk is the paucity of to WHO by Member States in line with the Global
available data, particularly the absence of identifiers surveillance system for COVID-19 set up in January
such as sex and age in a significant proportion of the 2020 under the framework of the International Health
data that have been reported. Importantly, analysis Regulations (2005) (21). An interim case reporting form
of COVID-19 cases and deaths by sex and age relies for severe acute respiratory syndrome coronavirus
on the availability of high-quality, timely and reliable 2 (SARS-CoV-2) confirmed and probable cases was
disaggregated data. Active COVID-19 surveillance posted on the WHO website and Member States were
represents a substantial additional burden for public requested to submit completed forms within 48 hours
health surveillance systems, especially in low- and of case identification. On 27 February 2020, a revised
middle-income countries. Countries have prioritized form was posted with the request to resubmit forms
reporting in different ways, and opportunities for sex when patient outcomes were known or 30 days after the
and age disaggregation have been limited for some first submission. Countries were requested to submit
countries, and at different stages of the pandemic. case report forms as feasible and data submitted up to
70
60
50
Percentage
40
30
20
13.7
10
5.8 5.2
0 0.1
0
AFRO AMRO EMRO EURO SEARO WPRO
WHO region
99.6 99.3
100
80
Percentage
60
50.5
44.2
40
20
8
6.3 5.4
2.5
0.3 0.2 0.2 0 0.3 0.4
0
AFRO AMRO EMRO EURO SEARO WPRO Global
WHO region
Fig. 1.13. SARS-CoV-2 case report forms with missing attributes, by region (%)
Table 1.2. Health workforce data in SARS-CoV-2 case report forms, by region
WHO region Number of countries Total cases reported Number of countries Proportion of countries Number of HWF cases
reporting cases reporting HWF data reporting HWF data
AMR 40 56 189 932 30 75% 1 118 000
EUR 54 45 551 551 40 74% 692 408
AFR 47 3 089 961 46 98% 104 625
EMR 21 5 807 616 17 81% 39 327
WPR 10 1 842 207 9 90% 23 244
SEAR 10 15 330 286 5 50% 660
Total 182 127 811 553 147 81% 1 978 264
Note: HWF = health workforce; AMR = Region of the Americas; EUR = European Region; AFR = African Region; EMR = Eastern Mediterranean Region; WPR = Western Pacific Region; SEAR = South-East Asia Region.
Source: WHO Coronavirus (COVID-19) surveillance dashboard (6).
2. Aburto JM, Kashyap R, Schöley J, Angus C, Ermisch J, Mills MC, Beam Dowd J. Estimating the burden of the COVID-19
pandemic on mortality, life expectancy and lifespan inequality in England and Wales: a population-level analysis. J Epidemiol
Community Health. 2021 (published online). doi: 10.1136/jech-2020-215505.
3. Life expectancy by age and sex [online database]. Brussels: Eurostat; 2021 (https://ec.europa.eu/eurostat/databrowser/view/
DEMO_MLEXPEC/bookmark/table, accessed 1 May 2021).
5. Post-COVID conditions. Atlanta: US Centers for Disease Control and Prevention; 2021 (https://www.cdc.gov/coronavirus/2019-
ncov/long-term-effects.html, accessed 1 May 2021).
6. WHO Coronavirus (COVID-19) dashboard [online database]. Geneva: World Health Organization; 2021 (https://covid19.who.int,
accessed 1 May 2021).
7. Tracking covid-19 excess deaths across countries [online database]. The Economist. 16 April 2021 (https://www.economist.
com/graphic-detail/coronavirus-excess-deaths-tracker, accessed 1 May 2021).
8. Excess mortality across countries in 2020. Oxford: The Centre for Evidence-Based Medicine; 2021 (https://www.cebm.net/
covid-19/excess-mortality-across-countries-in-2020/, accessed 1 May 2021).
9. Excess mortality during the Coronavirus pandemic (COVID-19) [online database]. Oxford: Our World in Data; 2021 (https://
ourworldindata.org/excess-mortality-covid, accessed 1 May 2021).
10. Technical Advisory Group on COVID-19 Mortality Assessment. Geneva: World Health Organization; 2020 (https://www.who.int/
data/technical-advisory-group/covid-19--mortality-assessment/membership, accessed 1 May 2021).
11. Global health estimates 2019: Disease burden by Cause, Age, Sex, by Country and by Region, 2000-2019. Geneva, World
Health Organization; 2020. (https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates, accessed 1
May 2021).
12. Just how do deaths due to COVID-19 stack up? ThinkGlobalHealth [website]. New York: Council on Foreign Relations; 2021
(https://www.thinkglobalhealth.org/article/just-how-do-deaths-due-covid-19-stack, accessed 1 May 2021).
13. COVAX vaccine roll-out. Geneva: GAVI; 2021 (https://www.gavi.org/covax-vaccine-roll-out, accessed 1 May 2021).
14. Coronavirus (COVID-19) vaccinations [online database]. Oxford: Our World in Data; 2021 (https://ourworldindata.org/covid-
vaccinations, accessed 1 May 2021).
15. Second round of the national pulse survey on continuity of essential health services during the COVID-19 pandemic. Geneva:
World Health Organization; 2021 (https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS-continuity-survey-2021.1,
accessed 1 May 2021).
16. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020.
Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-
survey-2020.1, accessed 1 May 2021).
17. World Health Worker Week video message from Dr Tedros Adhanom Ghebreyesus, WHO Director-General [website]. Geneva:
World Health Organization; 2021 (https://www.who.int/campaigns/annual-theme/year-of-health-and-care-workers-2021#,
accessed 1 May 2021).
18. Weekly epidemiological update - 2 February 2021. Geneva: World Health Organization; 2021 (https://www.who.int/
publications/m/item/weekly-epidemiological-update---2-february-2021, accessed 1 May 2021).
19. Apart Together survey. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240017924,
accessed 1 May 2021).
20. A UN framework for the immediate socio-economic response to COVID-19. New York: United Nations Sustainable
Development Group; 2020 (https://unsdg.un.org/resources/un-framework-immediate-socio-economic-response-covid-19,
accessed 1 May 2021).
21. International Health Regulations (2005) Third Edition. Geneva: World Health Organization; 2005 (https://www.who.int/
publications/i/item/9789241580496, accessed 1 May 2021).
22. Lang T. Plug COVID-19 research gaps in detection, prevention and care. Nature;583:333 (https://www.nature.com/articles/
d41586-020-02004-1, accessed 1 May 2021).
23. The need for data innovations in the time of COVID-19. In: The Sustainable Development Goals Report 2020. New York: United
Nations Department of Economic and Social Affairs; 2020 (https://unstats.un.org/sdgs/report/2020/the-need-for-data-
innovations-in-the-time-of-COVID-19/, accessed 1 May 2021).
Prior to the COVID-19 pandemic, population health A metric to assess the health of older adults, LE at
was improving globally, increasing the global average 60 years of age, has also improved globally from 18.8
life expectancy at birth from 66.8 years in 2000 to 73.3 in 2000 to 21.1 in 2019. However, HALE at 60 years has
years in 2019, and healthy life expectancy at birth from only risen from 14.1 to 15.8 in the same period.
15
Life expectancy and healthy life expectancy at birth
Afr Amr Emr Eur Sear Wpr Global
80
Male
40
80
11 11.3 10.4 10.6
12.1 12.3 10.8 10
11.4 11.7 11.8 10.3 10.4 9.5 9.7 11
11.2 10.3 10.7
10.3 10.6 10.7 10.9 9.7 10
9.6 9.7 9.9 10.2 10.3
60 9.2 9.8
8.7
8
7.7
Female
40
2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019
Year
Fig. 2.1. Life expectancy and healthy life expectancy, by sex, global and WHO region, 2000–2019
Inequalities in healthy life expectancy and life Despite the remarkable gains in LE and HALE in the
expectancy past 20 years, LICs remain behind the global average
with 65.1 and 56.7, respectively (Fig. 2.2). LICs have
Globally, LE and HALE for males were consistently been improving the fastest, gaining over 11 years
around 5 years and 2.4 years lower than females, and (21.0%) in LE and nearly 10 years (20.8%) in HALE since
there has been very little change in the gaps between 2000. However, in the latest 2015–2019 period, the pace
women and men in the past 20 years. of change in LICs has slowed down.
Across country income groups, however, there are In HICs, increases were only 3.2 (4.2%) years in LE and
different patterns of sex-related inequality in HALE. 2.1 years (3.1%) in HALE since 2000, reaching 80.9 and
HALE is lowest in LICs for both men and women and 69.8 years respectively in 2019.
has been improving the fastest of all income groups.
However, the situation has been improving slightly The marked gains in LE and HALE at birth in LICs and
faster for women than men, and the gap in HALE has LMICs, relative to UMICs and HICs, predominantly
consequently widened. Conversely, in HICs the gap reflect the significant progress made in the past 20
between women and men is narrowing, as HALE among years in reducing mortality among children under
men has improved at a faster pace. 5 years of age in these settings (2). The reduction is up
to 53% in LICs, down from 143.6 deaths per 1000 live
When examined according to WHO regions, the births in 2000 to 67.6 in 2019 (2).
European Region and Western Pacific Region observed
the widest male–female gaps in LE and HALE in 2019, at Examining LE and HALE at age 60 years, the income
6.2 and 6.1 years for LE and 3.4 and 3.2 years for HALE, gradient associated with improvements reversed, with
respectively. In contrast, the Eastern Mediterranean UMICs and HICs gaining more years than LMICs and
and South-East Asia regions had the narrowest gaps LICs between 2000 and 2019. For example, LE and
at 3.0 and 3.2 years for LE and 0.5 and 0.8 years for HALE at 60 years in LICs increased by 2.2 years (from
HALE, respectively. Compared to 2000, the gaps were 15.2 to 17.4 years) and 1.6 years (from 11.4 to 13.0
widening in the African, South-East Asia and Western years), respectively; whereas in UMICs the increase
Pacific regions, but closing in the Americas, European was 2.7 years (from 18.5 to 21.2 years) and 2.0 years
and Eastern Mediterranean regions. (from 14.0 to 16.0 years), respectively. This is in line with
80
Male
40
80
11.5 11.9 12 12.4
10.5 10.8 11.3
10.1 11
9.6 9.8 10.7
10.3
10.4 10.7 9.7 10
9.5 10.2
60 9.1 9.8
8.6 9.5
8.2
7.7
Female
40
2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019
Year
Fig. 2.2. Life expectancy and healthy life expectancy by sex, globally and by World Bank income group, 2000–2019
the greater mortality reduction at older ages in higher for a female infant, reaching 11.0 years. From 2000
resource settings since the beginning of the century, to 2019, the increases in the same figure at 60 years
mainly driven by a rapid decline in noncommunicable were 0.6 and 0.7 years, and reaching 4.7 and 6.0 years,
disease (NCD) mortality, partly because of the success respectively, for men and women. This shows that
in curbing cardiovascular diseases (CVDs) in many females, irrespective of age, on average live more
parts of the world. years in disability and that the sex gap is widening as
LE continues to grow overall.
Improvements in longevity, health and the These gains in LE and HALE reflect rapid transitions in the
changing disease burden mortality and morbidity profiles in the past two decades.
Globally, across WHO regions, age-standardized rates
In relative terms, HALE as a proportion of overall LE at (ASR) of deaths and disability-adjusted life years (DALYs)
birth – at global, regional and income levels – remained dropped between 2000 and 2019 across all three broad
largely constant with a slight downward trend at categories of causes of death: communicable, maternal,
approximately 87–90% for men and 84–87% for women. perinatal and nutritional conditions (communicable
The trends for the HALE/LE ratio at age 60 years are diseases hereafter); noncommunicable diseases (NCDs);
similar but with lower levels, at approximately 73–78% and injuries. This trend is underpinned by a dramatic
for men and 70–75% for women. The corresponding decline in communicable diseases, most significantly
downward trends in UMICs and HICs were greater than in LICs and LMICs with reductions in ASRs of over 50%,
other income groups, with up to a 1% decline between at least doubling the decline seen in NCDs and injuries
2000 and 2019. Similarly, the Region of the Americas, over the same period (1).
the European Region and the Western Pacific Region
also had a relatively higher rate of decline compared to The rapid decline in communicable diseases and
other regions, signalling the rising levels of disability attributable deaths – relative to NCDs and injuries –
partly due to extended longevity in higher-resourced has led to overall population ageing as more individuals
settings. survive to older ages at which NCDs become the
predominant health risks. Seven of the 10 leading
With improvements in longevity, the average number causes of deaths in 2019 were NCDs. Globally, NCDs
of years a male infant is expected to live in less than accounted for 60.8 % of all deaths in 2000, rising to
full health has risen by about one year since 2000, to 73.6% in 2019, with nearly all increase shifted from the
8.3 years in 2019 at the global level, and by 1.3 years percentage decline in communicable diseases, while
100
75
Percentage
50
25
2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019
100
75
Percentage
50
25
0
2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019
Year
Fig. 2.3. Composition of causes of death, by World Bank income group and region, 2000–2019
7500
YLD per 100,000 population
5000
2500
2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019 2000 2005 2010 2015 2019
Year
Fig. 2.4. Age-standardized rates of years lived with disability, by cause and World Bank income group, 2000–2019
1
Communicable, maternal, perinatal and nutritional conditions.
2
All uncertainty intervals are presented using 95% limits, unless otherwise stated.
Source: Levels and trends in child mortality: Report 2020. Estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation (2).
Fig. 2.6. Estimates of under-five and neonatal mortality rate (deaths per 1000 live births) by Sustainable Development Goal regions and World Bank
income groups, 2019
Sources: Maternal mortality: Levels and trends 2000 to 2017 (5); WHO Global Health Observatory (6).
Fig. 2.7. Estimates of maternal mortality ratio by Sustainable Development Goal regions and World Bank income group, 2000 and 2017
Fig. 2.8. Countries with the highest TB burden (at least 100 000 incident cases), 2019
Progress required to reach key 2025 and 2030 global HIV targets
2 500 000
Epidemiological progress until the end of 2019 Projected impact of scaling up and achieving 90% reduction by 2030
the 2025 targets (using 2010 as a baseline)
2 000 000
1 500 000
1 000 000
500 000
0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Annual number of people newly infected with HIV Annual number of people dying from HIV-related causes
Sources: AIDSinfo. Joint United Nations Programme on HIV/AIDS (UNAIDS) (16); and WHO Global Health Observatory (GHO) data (17).
Fig. 2.9. Global trends in HIV incidence and mortality, and progress required to reach key 2025 and 2030 global targets, 2010–2030
a) Others
5%
Burundi, Chad, South Sudan, Kenya, Zambia,
a) Sierra Leone, Ethiopia, Sudan, Madagascar, Togo,
Liberia, Central African Republic: 1% each
Guinea
2%
Malawi
2%
Rwanda
2% Nigeria
Benin 27%
2%
Ghana
2%
India
2%
Cameroon
3%
Mali
3%
Angola
3%
Fig. 2.10. Global distribution of a) malaria cases and b) deaths, by country, 2019
Malawi
b) 2%
Sierra Leone
2%
Benin
2% Nigeria
23%
India
2%
Zambia
2%
Guinea
2%
Chad
2%
Côte d’Ivoire
2%
Ghana
3%
Cameroon
3%
Kenya
3%
Uganda
3% United Republic of Tanzania
Angola 5%
3% Niger
Burkina Faso
Mozambique 4%
4%
4%
Fig. 2.10. Global distribution of a) malaria cases and b) deaths, by country, 2019
Only one in 10 people with hepatitis B are aware of Antimicrobial resistance is a global health and
their infection development threat
WHO estimates that in 2019, 295.8 million people Antimicrobial resistance (AMR) threatens the effective
were living with chronic hepatitis B infection (defined prevention and treatment of an ever-increasing range
as hepatitis B surface antigen positive); among them, of infections caused by bacteria, parasites, viruses
30.4 million people living with hepatitis B knew their and fungi. WHO launched the Global Antimicrobial
hepatitis B status and 6.6 million people diagnosed with Resistance and Use Surveillance System (GLASS) (23) in
hepatitis B received treatment (20). In 2019, hepatitis 2015 to continue filling knowledge gaps and to inform
B resulted in an estimated 820 000 (UI 450 000 to 950 strategies at all levels.
000) deaths, mostly from cirrhosis and hepatocellular
carcinoma (i.e. primary liver cancer). It is estimated In 2020, two pathogens responsible for bloodstream
that 1.5 million people were newly infected with chronic infections were added to the SDG indicators. The first
hepatitis B infection in 2019. measure included in the indicator is the proportion
of bloodstream infections due to Escherichia coli
Hepatitis B prevalence is highest in the African Region that is resistant to third generation cephalosporins,
and the Western Pacific Region, where 7.5% and 5.9% reported by 60 countries for the year 2019 (global
of the adult population, respectively, are estimated to median, 37% with resistance, interquartile range (IQR)
be infected. In the South-East Asia Region, the Eastern 17–58%). The second measure is the proportion of
Mediterranean Region and the European Region, methicillin-resistant Staphylococcus aureus, reported
an estimated 3.0%, 2.5% and 1.46% of the general by 54 countries for 2019 (global median 25% with
population are thought to be infected, respectively. In the resistance, IQR 11-40%). Resistance rates for the
Region of the Americas, prevalence is lower at 0.53%. two pathogens do not show interpretable time trends
but lower values are observed in HICs. National
Hepatitis B can be prevented by vaccines that are representativeness of the reported data remains
safe, available and effective. The global proportion of problematic particularly in low-resourced countries
children under 5 years of age chronically infected with generally still at an early stage of antimicrobial
hepatitis B virus dropped to 0.94% in 2019, down from resistance surveillance (23).
around 5% in the pre-vaccine era ranging from the
1980s to the early 2000s.
Noncommunicable diseases
25
25
Probability of dying 30−70 years (%)
20 2000
2019
20
15
15
Afr Amr Emr Eur Sear Wpr LICs LMICs UMICs HICs Global
WHO Regions World Bank income groups
Fig. 2.11. Probability of premature mortality from major noncommunicable diseases, by WHO regions and World Bank income group, 2000–2019
The global ARR in premature NCD mortality has Trends in deaths due to the four major NCDs in all
decreased by 30% since 2015, to just below 1% (from ages (i.e. not only premature mortality) were driven by
the 1.4% ARR observed between 2000–2015). Without diverse changes across regions in 2000–2019. Globally,
effective acceleration strategies to bring the ARR back the greatest decline in mortality was seen for CRD,
in line with the required 2.7% annual decrease from with a 37% decline in age-standardized rates (ASR)
2015, the world is destined to fall short of the SDG for all ages, followed by CVD and cancer at 27% and
target with few countries on track to meet it. 16% respectively. However, the ASR for diabetes has
shown an unfavourable trend with a 3% increase in
But regional trends belie mixed underlying situations: ASR. The greatest success in lowering mortality from
WHO regions that had already achieved relatively low CRD occurred in the Western Pacific Region, showing
premature NCD mortality by 2019 tended to show the a decline of about 55%. In the Region of the Americas
most marked declines in ARR since 2015. In the Region and the European Region, CVD declines led to the
of the Americas and the Western Pacific Region, for greatest reduction in mortality by up to 43%, followed
example, the ARR declines were up to 40%, and 30% by cancer with a decline of around 20%. The mortality
in the European Region. In contrast, those with the from diabetes, however, has worsened in some parts of
persistently highest premature NCD mortalities by the world, ranging from an increase in ASR of less than
2019 saw more rapid decreases in mortality during 5% in the Region of the Americas and the South-East
2015–2019, as demonstrated by increases in ARR Asia Region, to over 20% in the Eastern Mediterranean
ranging from 14% in the South-East Asia Region to Region. Similar increases were seen when diabetes
86% in the Eastern Mediterranean Region (Fig 2.12). mortality was assessed according to income groups,
increasing ASR by approximately 5% in UMICs and by
When examined according to World Bank income 13% in LMICs.
groups, the underlying variations were less distinct, with
the ARRs in LICs, UMICs and HICs slowing at similar Although the overall trends in mortality for the four
rates (24%, 26% and 30%, respectively). Acceleration major NCDs are heading downwards, as indicated by
was seen in LMICs, however, with ARRs rising by 22% the ASRs for all age groups, the total number of deaths
in 2015–2019 compared to 2000–2015. Despite the generally attributed to these causes have gone up
acceleration in a handful of regions, if the current rates because of population growth and ageing. Those four
of decline continue, meeting the SDG target in these diseases alone killed a total of 33.2 million people in
regions would remain a remote possibility. 2019, a 28% increase compared to 2000. The greatest
2.3
2.1
1.9
Annulized rate of reduction 2015−2019 (%)
1.7
1.5
Eur (16.3%)
Afr (20.8%) UMICs (17.2%)
1.3
HICs (11.8%)
Emr (24.5%)
1.1
Wpr (15.6%)
Global (17.8%)
0.9
LMICs (22.3%)
Amr (14.0%)
Sear (21.6%)
0.7
LICs (23.8%)
0.5
0.5 0.7 0.9 1.1 1.3 1.5 1.7 1.9 2.1 2.3
Annulized rate of reduction 2000−2015 (%)
0.12 0.15 0.18 0.21 0.24 a Global a WHO regions a World Bank income groups
Fig. 2.12. Annualized rate of reduction in noncommunicable disease mortality, by WHO regions and World Bank income group, 2000–2015 and 2015–2019
burden was borne by the Western Pacific Region with sufficiently to lead to an over 10% reduction in the total
14.6 million deaths, and by UMICs (10.0 million) and number of deaths (Fig. 2.13).
LMICs (10.5 million).
In summary, notwithstanding some reductions in
By disease, the total global CVD deaths grew by one the premature mortality risk from NCDs, progress is
quarter since 2000, reaching 17.9 million in 2019; insufficient to attain the corresponding SDG target. The
cancer deaths grew 37% to 9.3 million; CRD grew 10% COVID-19 pandemic is an additional wake-up call for
to 4.1 million; and diabetes by 72% to 2.0 million. The intensified NCD intervention, as patients with existing
greatest increase in absolute number of deaths was NCD conditions and comorbidities suffer from increased
from CVD with a rise of 1.8 million in the Western risk of severe illness and death from COVID-19.
Pacific Region (and 1.9 million in UMICs) compared to Populations that are already affected by NCDs now
2000. Increases in cancer were also highest from these become additionally vulnerable to a life-threatening
parts of the world, at 1.2 and 1.0 million respectively. condition that could cost their lives in a matter of
Although deaths from diabetes and its increase between days, potentially shortening the population level LE
2000 and 2019 were lower, the greatest percentage and erasing the hard-won progress made worldwide in
increases were seen for this disease in the South-East the past 20 years. Accelerated progress calls for more
Asia Region and the Eastern Mediterranean Region effective and cost-effective policies and actions for NCD
(and LMICs) with a doubling of deaths in 2019 relative prevention and control, through investments in health
to 2000. In contrast, the only observed declines were promotion, reducing the prevalence of risk factors and
CVD in the European Region (and HICs), and CRD in improving diagnosis, treatment, rehabilitation and
the Western Pacific Region (and UMICs) and for which palliation with strengthened health systems.
the mortality rates across the age span have dropped
3.4 3.3
0
−2.9
−5.1
Change in ASR (%)
−13.5
−15.4 −16.4 −15.8
−17.2
−20 −18.9 −18.9
−23.4
−26.1 −26
−27.7 −27.4
−36.5
−40
−43.4
−54.1
100 97.2
78.9
75 72.3
67.2
Change in deaths (%)
60.1
48.5
50 45.6 44.7
40.1
36.8 35.9
30.9 31.7
25.1 23.5 25.3
25
17.4
10
0
−9
−15
Fig. 2.13. Changes in age-standardized mortality rate and deaths for major noncommunicable diseases, by World Bank income group, 2000–2019
Nearly 475 000 (UI 337 000 to 668 000) people were
killed by others in 2019: 80% of them were men.
40
30
28.3
27.5
Both Sexes
21
20 19.1
17.9
17.3 16.8 16.7
14 13.6 14
12.6 13.3 13
10.6
10.1
10 8.6 9.2 9.2
8 7.9 8.4 8 8.1
6.7
6.2 6.1
5.4
3.5
2.9
2.4 2.3 1.7 1.5
1.4 0.9 1.3 0.5 1.1
0.4
0
40
Deaths per 100,000 population
30
Female
20
17.9
17
11.1
9.7 10.4 10.1 10
10 8.9 8.5 9.2
7.9 7.7
6.7 6.9 6.8
5.7
4.6 4.9 4.7
4 3.9 4.4
3.4 2.6 3.4 3.4
2.5 1.6 2.5 2.4 1.7
1.1 1 0.7 1.2 1 1.1 0.8
0.3 0.3
0
39.8
40
37.3
30.7
30
27.6
25.7 25.7
25.5 24.8
20.5 21.2
19.9
Male
20
17.2 17.2 16.7
15.7
15
13.2 13.4 12.6
12.3 12.4 11.7
11.1 11.3
9.9 9.9
10 8.8
8.1
4.6
4.4 3.7
3
1.7 2.3 1.6 2
1.1 0.7 0.5 1.4
0
LICs LMICs UMICs HICs Global LICs LMICs UMICs HICs Global LICs LMICs UMICs HICs Global LICs LMICs UMICs HICs Global
2000 2019
Fig. 2.14. Crude death rate for all ages combined by injury type, by sex, 2000 and 2019
Unintentional poisoning in LICs at 2.3 (UI 0.9 to 5.1) per 100 000 population. The
CDR in the WHO African Region was even higher at 2.5
A total of over 84 000 (UI 48 000 to 137 000) people, (UI 1.2 to 5.0). This, however, represents significant
equivalent to 1.1 (UI 0.6 to 1.7) per 100 000 population progress compared to 2000, decreasing by one third
died from unintentional poisoning in 2019. Men were and one quarter, respectively. Countries of the South-
dying from poisoning at a rate that was 66% higher than East Asia Region and European Region showed the
women, and the population at both ends of the age span largest decline, dropping by approximately half and two
succumb to the highest mortality rates. Among World thirds, respectively.
Bank income groups, the highest CDRs were observed
2. Levels and trends in child mortality: Report 2020. Estimates developed by the United Nations Inter-agency Group for Child
Mortality Estimation. New York: United Nations Children’s Fund; 2020 (https://www.unicef.org/reports/levels-and-trends-
child-mortality-report-2020, accessed 1 May 2021).
3. Every Woman Every Child. Protect the progress: rise, refocus, recover. New York: United Nations Children’s Fund; 2020
(https://www.unicef.org/reports/protect-progress-rise-refocus-recover-every-woman-every-child-2020, accessed 1 May
2021).
4. UNICEF Regional Office for South Asia. Direct and indirect effects of the COVID-19 pandemic and response in South Asia.
Kathmandu: United Nations Children’s Fund; 2021 (https://www.unicef.org/rosa/reports/direct-and-indirect-effects-covid-19-
pandemic-and-response-south-asia, accessed 1 May 2021).
5. Trends in maternal mortality: 2000 to 2017: Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations
Population Division. Geneva: World Health Organization; 2019 (https://www.who.int/reproductivehealth/publications/
maternal-mortality-2000-2017/en/, accessed 1 May 2021).
6. Maternal mortality (Global Health Observatory) [online database]. Geneva: World Health Organization; 2019 (https://www.who.
int/data/gho/data/themes/topics/topic-details/GHO/maternal-mortality, accessed 1 May 2021).
7. Strategies towards ending preventable maternal mortality (EPMM). Geneva: World Health Organization; 2015 (https://www.
who.int/reproductivehealth/topics/maternal_perinatal/epmm/en/, accessed 1 May 2021).
9. Global health sector strategy on HIV: 2016–2021. Geneva: World Health Organization; 2016 (https://www.who.int/
publications/i/item/WHO-HIV-2016.05, accessed 1 May 2021).
10. End Inequalities. End AIDS. Global AIDS Strategy 2021–2026. Geneva: Joint United Nations AIDS Programme; 2021 (https://
www.unaids.org/en/resources/documents/2021/2021-2026-global-AIDS-strategy, accessed 1 May 2021).
11. Global Technical Strategy for Malaria 2016–2030. Geneva: World Health Organization; 2015 (https://www.who.int/malaria/
publications/atoz/9789241564991/en/, accessed 1 May 2021).
12. Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030.
Geneva: World Health Organization; 2021 (https://apps.who.int/iris/rest/bitstreams/1326801/retrieve, accessed 1 May 2021).
13. The Polio Endgame Strategy 2019–2023: Eradication, Integration, Containment and Certification. Geneva: World Health
Organization; 2019 (https://polioeradication.org/who-we-are/polio-endgame-strategy-2019-2023/, accessed 1 May 2021).
14. Global tuberculosis report 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/hand
le/10665/336069/9789240013131-eng.pdf, accessed 1 May 2021).
15. Global HIV & AIDS statistics — 2020 fact sheet. Geneva: Joint United Nations AIDS Programme; 2020 (https://www.unaids.org/
en/resources/fact-sheet#, accessed 1 May 2021).
16. AIDSinfo [online database]. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) (http://aidsinfo.unaids.org/,
accessed 1 May 2021).
17. HIV/AIDS (Global Health Observatory) [online database]. Geneva: World Health Organization; 2019 (https://www.who.int/data/
gho/data/themes/hiv-aids, accessed 1 May 2021).
18. World malaria report 2020. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/
item/9789240015791, accessed 1 May 2021).
19. Accelerating work to overcome the global impact of neglected tropical diseases – A roadmap for implementation. Geneva:
World Health Organization; 2012 (https://apps.who.int/iris/bitstream/handle/10665/70809/WHO_HTM_NTD_2012.1_eng.pdf,
accessed 1 May 2021).
20. WHO (2021) Progress report on HIV, viral hepatitis and sexually transmitted infections. Geneva: World Health Organization;
2019 (https://www.who.int/hiv/strategy2016-2021/progress-report-2019/en/, accessed 1 May 2021).
21. Two out of three wild poliovirus strains eradicated. Geneva: World Health Organization; 2019 (https://www.who.int/news-
room/feature-stories/detail/two-out-of-three-wild-poliovirus-strains-eradicated, accessed 1 May 2021).
22. Global Polio Eradication Initiative [website]. (https://polioeradication.org/, accessed 1 May 2021).
23. Global Antimicrobial Resistance Surveillance System (GLASS) [website]. (https://www.who.int/glass/en/, accessed 1 May
2021).
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Notes: Share is relative to the total number affected across the four country-income groups; this varies from the global totals because the populations are based on the FY2021 World Bank income classification. The differences are
as follows: Stunting official global estimate of 149.2 million; sum of four country-income groups = 148.8 million. Wasting official global estimate of 45.4 million; sum of four country-income groups = 41.9 million. Overweight
official global estimate of 38.9 million; sum of four country-income groups = 38.7 million.
Source: UNICEF–WHO–The World Bank: Joint child malnutrition estimates –levels and trends – 2021 edition (1).
Fig. 3.1. Proportion of stunted, wasted and overweight children under 5 years of age, by World Bank income group, 2020
Fig. 3.2. Prevalence of anaemia among reproductive age women (15–49 years), 2019
Fig. 3.3. Prevalence estimates of lifetime physical and/or sexual intimate partner violence among ever-married/-partnered women aged 15–49 years,
2018
The sex of an individual carries a range of biological, The age-standardized prevalence of insufficient
behavioural, social and economic consequences for physical activity (hereafter physical inactivity, defined
health that results in marked differences in exposure as not meeting the 2010 Global recommendations on
to risk factors between sexes. As such, sex-related physical activity for health) among adults aged 18 and
inequalities in hypertension, overweight and obesity, older (6) was 27.5% (UI 25.0 to 32.2) in 2016, with over
and physical inactivity are explored using comparable 8% difference between sexes, males: 23.4% (UI 21.1
data from WHO STEPS surveys conducted between to 30.7), females 31.7% (UI 28.6 to 39.0) (7). Over the
2015 and 2019 in 32 countries (4). past 15 years, levels of physical inactivity have only
marginally and insignificantly decreased from the
Adult obesity and physical inactivity global prevalence at 28.5% (UI 23.9 to 33.9) in 2001.
The age-standardized prevalence of obesity among HICs showed levels of physical inactivity increasing over
adults aged 18 and older (defined as body mass index time in both males and females, reaching a level in 2016
(BMI) >30 kg/m2) has been rising globally over the that was more than double the prevalence seen in LICs:
past few decades with 650 million obese adults in from 31.6% (UI 27.1 to 37.2) in 2001 to 36.8% (UI 35.0 to
2016. The prevalence of obesity has increased 50% 38.0) in 2016 in HICs vs 16.0% (UI 12.0 to 19.6) in 2001
from 8.7% in 2000 to 13.1% (UI 12.4 to 13.9) in 2016 to 16.2% (UI 14.2 to 17.9) in 2016 in LICs.
90
80
Percentage of men aged 18-69 years (%)
70
Nauru
Tonga
60
Lebanon
50 Tuvalu
40
Micronesia (Federated States of)
Percentage of women aged 18-69 years (%) Percentage of women aged 18-69 years (%)
Note: The further from the diagonal line, the more sex-related inequality.
Source: WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) 2015–2019 (4).
Fig. 3.4. Sex-related inequality in prevalence of obesity and the proportion of people who do not meet thresholds for recommended physical activity in 32
countries, 2015–2019
90
80
Age-standardized prevalence (%)
70
60
50.8
50
40 36.7
33.4
30 27.7
24.5
20 19.1
11.7
10
5.5
Notes: sbp= systolic blood pressure; dbp= diastolic blood pressure. Circles indicate countries – each country is represented by multiple circles (one for each subgroup). Horizontal black lines indicate the median value (middle
point of estimates).
Source: WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) 2015–2019 (4).
Fig. 3.5. Sex-related inequality in the diagnosis and treatment cascade for hypertension in 32 countries, 2015–2019
14.0
11.9
12.0
10.1
(litres of pure alcohol per capita)
10.0
Alcohol Consumption
7.9
8.0 7.1
6.0
4.3
4.0 3.5
2.9
1.9 1.5
2.0 0.8
0.1
0.0
African Region Region of the Americas Eastern Mediterranean European Region South-East Asia Region Western Pacific Region
Region
Male Female
Fig. 3.6. Annual alcohol consumption (litres pure alcohol per capita), by sex and WHO region, 2019
47.3 48.8
50
40
Prevalence of tobacco use
33.6 34.3
30
24.3
21.3
19
20
12.8
10.9
10
4.1 4.3 3.7
0
African Region Region of the Americas Eastern Mediterranean European Region South-East Asia Region Western Pacific Region
Region
Male Female
Sources: WHO Global Health Observatory (GHO) data (13); WHO global report on trends in prevalence of tobacco use 2000–2025, third edition (14).
Fig. 3.7. Prevalence of tobacco use, by sex and WHO region, 2018
50
40
30
20
10
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Fig. 3.8. Trends in the percentage of the population with primary reliance on clean fuels and technologies, by WHO region, 2000–2019
Water, sanitation and hygiene In 2019, a quarter of health care facilities lacked basic
water services, exposing 1.8 billion people – including
Clean water, sanitation and hygiene (WASH) are health care workers and patients – to greater risk of
essential to human health and well-being and are infections. One in three health care facilities did not
especially important in the context of infectious disease have hand hygiene facilities at the point of care, and
outbreaks, such as the current COVID-19 pandemic. 10% of facilities had no sanitation service at all. One
Unsafe drinking water, unsafe sanitation and lack of third did not segregate waste safely.
hygiene also remain important causes of death, with an
estimated 870 000 associated deaths occurring in 2016.1 Ensuring water and sanitation for all requires financial
The African Region suffered a disproportionate burden resources and technical capacity to support and sustain
from such deaths, with a mortality rate four times investments in infrastructure. From 2015 to 2019, official
higher than the global average. Available data from development assistance (ODA) disbursements to the
98 countries indicate that safely managed drinking- water sector increased slightly by 3% from US$ 9.0 to
water services – that is, located on premises, available US$ 9.2 billion. In the same period, ODA commitments
when needed and free from contamination – were to the water sector rose 11%. A 2018 survey found
enjoyed by only 71% of the global population (5.3 billion that more than 80% of countries reported insufficient
people) in 2017. Safely managed sanitation services – financing to meet national WASH targets (21).
with excreta safely disposed of in situ or treated off-site
– were available to only 45% of the global population Inequitable access to WASH impedes progress
(3.4 billion people). towards equitable recovery and building back better
Access to WASH services varies substantially across
In the same year, two in five households globally (40%) countries (21). Data for 98 countries from surveys over
lacked basic handwashing facilities with soap and the period of 2008–2017 show that while globally more
water in their home. Untreated household wastewater than nine out of 10 people use safely managed drinking-
contaminates drinking-water sources, posing risks water services (median of 92% across 98 countries),
to public health and the environment. Preliminary in two countries less than one out of 10 people have
estimates from 74 countries (excluding much of Africa access (Sierra Leone and Uganda). Similarly, while
and Asia) show that, in about a third of countries, less globally almost 80% of the population have access to
than 50% of all household wastewater flows are safely safely managed sanitation services (median of 78%
treated. across 88 countries), coverage is below 20% in seven
countries. Access to basic hygiene services varies
Data compiled in 2020 highlighted the inadequate from 1% to 100% across 77 countries with available
WASH status within many health care facilities, a data, with less than half of the population using these
potentially critical factor in the control of COVID-19 (20). services overall (median of 46% across 78 countries).
1
Deaths associated with diarrhoeal disease, soil-transmitted helminth infections and
malnutrition.
Population using safely managed drinking water services (%) Population using safely managed sanitation services (%)
100
90
80
70
60
Coverage (%)
50
40
30
20
10
0
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Rural Urban
Source: WHO/UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP) (23).
Fig. 3.9. Drinking-water and sanitation services by rural/urban place of residence: change over time
100
90
86.3
81.8
80
72.9
70
64.9
Coverage (%)
60 57.8 56.8
50
40
30
20
10
Note: Circles indicate countries – each country is represented by multiple circles (one for each subgroup). Horizontal black lines indicate the median value (middle point of estimates).
Source: WHO/UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP) (22).
Fig. 3.10. Health care facilities with basic water services by multiple dimensions of inequality: latest situation
2. Prevalence of anaemia in women of reproductive age (Global Health Observatory) [online database]. Geneva: World Health
Organization; 2019 (https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-anaemia-in-women-
of-reproductive-age-(-), accessed 1 May 2021).
3. Violence Against Women Prevalence Estimates, 2018. Geneva: World Health Organization, on behalf of the United Nations
Inter-Agency Working Group on Violence Against Women Estimation and Data (UNICEF, UNFPA, UNODC, UNSD, UNWomen);
2021 (https://cdn.who.int/media/docs/default-source/documents/violence-prevention/vaw_report_web_09032021_oleksandr.
pdf, accessed 1 May 2021).
4. STEPwise Approach to NCD Risk Factor Surveillance (STEPS) [website]. Geneva: World Health Organization; 2021 (https://
www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps, accessed 1 May 2021).
5. Prevalence of obesity among adults (Global Health Observatory) [online database]. Geneva: World Health Organization; 2019
(https://www.who.int/data/gho/indicator-metadata-registry/imr-details/2389, accessed 1 May 2021).
6. Global recommendations on physical activity for health. Geneva: World Health Organization; 2010 (https://www.who.int/
publications/i/item/9789241599979, accessed 1 May 2021).
7. Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled
analysis of 358 population-based surveys with 1.9 million participants. Lancet Glob Health. 2018;6(10):e1077–e86.
8. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L et al. Global burden of hypertension and systolic blood pressure
of at least 110 to 115 mmHg, 1990–2015. JAMA. 2017;317(2):165–182. doi:10.1001/jama.2016.19043.
9. Raised blood pressure (Global Health Observatory) [online database]. Geneva: World Health Organization; 2019 (https://www.
who.int/data/gho/data/indicators/indicator-details/GHO/raised-blood-pressure-(sbp-=140-or-dbp-=90)-(age-standardized-
estimate), accessed 1 May 2021).
10. Alcohol data by country (Global Health Observatory) [online database]. Geneva: World Health Organization; 2019 (https://apps.
who.int/gho/data/view.main.1800?lang=en, accessed 1 May 2021).
11. Global Burden of Disease 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries
and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389:1885–1906
(https://www.thelancet.com/action/showPdf?pii=S0140-6736%2817%2930819-X, accessed 1 May 2021).
12. Jha P, Ramasundarahettige C, Landsman V, Rostrong B, Thun M, Anderson R et al. 21st-Century Hazards of Smoking
and Benefits of Cessation in the United States. N Engl J Med. 2013;368:341–50 (https://www.nejm.org/doi/pdf/10.1056/
NEJMsa1211128?articleTools=true, accessed 1 May 2021).
13. Prevalence of current tobacco use among persons aged 15 years and older (Global Health Observatory) [online database].
Geneva: World Health Organization; 2019 (https://www.who.int/data/gho/data/indicators/indicator-details/GHO/age-
standardized-prevalence-of-current-tobacco-smoking-among-persons-aged-15-years-and-older, accessed 1 May 2021).
14. WHO global report on trends in prevalence of tobacco use 2000-2025, third edition. Geneva: World Health Organization; 2019
(https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-
edition, accessed 1 May 2021).
15. Draft guidelines on saturated fatty acid and trans-fatty acid intake for adults and children. Geneva: World Health Organization;
2018
16. Brouwer I. Effect of trans-fatty acid intake on blood lipids and lipoproteins: a systematic review and meta-regression analysis.
Geneva, World Health Organization, 2016 (https://apps.who.int/iris/bitstream/handle/10665/246109/9789241510608-eng.pdf,
accessed 1 May 2021).
18. WHO plan to eliminate industrially-produced trans-fatty acids from global food supply. Geneva, World Health Organization,
2018 (https://apps.who.int/iris/bitstream/handle/10665/334170/9789240010178-eng.pdf, accessed 1 May 2021).
19. Air pollution (Global Health Observatory) [online database]. Geneva: World Health Organization; 2019 (https://www.who.int/
data/gho/data/themes/theme-details/GHO/air-pollution, accessed 1 May 2021).
20. UN-Water Global Analysis and Assessment of Sanitation and Drinking-Water (GLAAS) 2019 report. Geneva: World Health
Organization; 2019. (https://www.who.int/publications/i/item/9789241516297, accessed 1 May 2021)
21. Global progress report on WASH in health care facilities: Fundamentals first. Geneva: World Health Organization; 2020
(https://www.who.int/publications/i/item/9789240017542, accessed 1 May 2021).
22. WHO/UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP) [website] (http://www.washdata.
org, accessed 1 May 2021).
45
Service coverage of progress and represents a heavier load to those
countries with weaker systems.
Improvements in coverage of essential health services
have been recorded in all regions and all income Achieving UHC requires multiple approaches.
groups, with the UHC service coverage index (UHC The primary health care approach and life course
SCI) increasing from a global average of 45 (of 100) approaches are critical. As a first point of entry between
in 2000 to 66 in 2017 (Fig. 4.1). Greatest progress patients and health systems, primary health care
has been in LICs, mainly driven by interventions for allows all people to benefit from basic health services
infectious diseases and, to some extent, for improved while reducing financial and geographic barriers.
reproductive, maternal, newborn and child health It is considered one of the most effective means to
(RMNCH) services. guarantee equitable progress on access to health
care. Its reinforcement at the community level is a
Globally and for many countries, however, the pace key aspect for the realization of UHC, and needs to be
of progress has slowed since 2010, and the poorest increasingly supported. Applying a life course approach
countries and those affected by conflict generally lag optimizes people’s health by addressing their needs
furthest behind. In the midst of the COVID-19 pandemic, and maximizing opportunities across all phases of life
health care systems are experiencing increased so that they can be and do what they justifiably value
resource constraints and conflicting priorities. This at all ages, always guided by principles that promote
imposes challenges for the anticipated continuity human rights and gender equality.
Source: Primary health care on the road to universal health coverage: 2019 monitoring report (1).
Fig. 4.1. Variation of universal health coverage service index (UHC SCI), 2017
12
According to the data available for 2014–2020, 83% of Inequalities in the area of RMNCH
global births were assisted by skilled birth attendants, The RMNCH composite coverage index (9,10) summarizes
including medical doctors, nurses and midwives: an the level of coverage across the spectrum of RMNCH
increase of about 30% compared to data from 2000– interventions. It is calculated as a weighted average
2006. Despite this remarkable progress, regional of eight indicators in four stages of the continuum of
inequalities remain and the COVID-19 pandemic may be care: reproductive health (demand for family planning
undermining these advances. Evidence is emerging that satisfied); maternal health (antenatal care coverage – at
access to competent and quality care during childbirth least four visits –, and birth attended by skilled health
90
80
74.9
73.4 72.6 72.6
71.0
70 66.8 67.1
64.9
61.3
60 56.8
Coverage (%)
50
40
30
20
10
Notes: Circles indicate countries – each country is represented by multiple circles (one for each subgroup). Horizontal black lines indicate the median value (middle point of estimates).
Sources: Demographic and Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS) available from the WHO Health Equity Monitor database, 2020 (11).
Fig. 4.3. RMNCH composite coverage index by multiple dimensions of inequality: latest situation, 2010–2019
2000–2009
2010–2019
2000–2009
2010–2019
2000–2009
0 10 20 30 40 50 60 70 80 90 100
Coverage (%)
Note: Circles indicate median values across countries – one circle for each subgroup.
Sources: Demographic and Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS) available from the WHO Health Equity Monitor database, 2020 (11).
Fig. 4.4. RMNCH composite coverage index by multiple dimensions of inequality: change over time, 2000–2009 and 2010–2019
personnel); child immunization (Bacillus Calmette– While the gap between the richest and poorest did
Guérin (BCG), measles and diphtheria, tetanus and not change much in relation to demand for family
pertussis (third dose ) (DTP3) immunization coverage); planning satisfied, the poorest quintile is nevertheless
and management of childhood illnesses (oral rehydration increasingly left behind. Great improvements can be
therapy for diarrhoea and care-seeking for suspected observed for skilled birth attendance, with coverage
childhood pneumonia symptoms). increasing fastest among the poorest quintile and
leading to a large reduction in economic-related
The coverage of RNMCH interventions varies substantially inequality over time (difference between the richest and
across countries, with the composite coverage index poorest quintile of 48 percentage points in 2000–2009
ranging across 71 countries from 28% in Chad to 90% compared with 21 percentage points in 2010–2019).
in Cuba (with a global median of 69%). Within countries, Coverage of DTP3 immunization also increased over
coverage also varies between population subgroups, with time and inequalities reduced, leading to very little
a common pattern of higher coverage among advantaged economic-related inequality in 2010–2019 (gap between
groups. It increases with increasing economic status and the richest and poorest quintile of 6 percentage points).
education levels and is higher in urban than rural areas.
Immunization
However, data from 33 countries shows that the During 2019, about 85% of infants worldwide (116
situation has improved over time, with overall coverage million infants) received three doses of DTP3 vaccine,
increasing and inequalities between population protecting them against three infectious diseases that
subgroups reducing in the past decade. For instance, can cause serious illness, disability or death. By 2019,
the gap between median coverage in the richest and 125 countries had reached at least 90% coverage of
the poorest population subgroups reduced from 27 DTP3 vaccine. However, an estimated 19.7 million
percentage points in 2000–2009 to 15 percentage children under the age of one year did not receive DTP3
points in 2010–2019. The pace of change of these vaccine in 2019. By the end of 2019, 85% of children had
improvements have tended to favour the disadvantaged received one dose of measles vaccine by their second
subgroups more; that is, the changes were for the most birthday and 178 countries had included a second dose
part pro-poor, pro-less educated and pro-rural. as part of routine immunization, with 71% of children
receiving two doses of measles vaccine according to
The situation varies for different component indicators national immunization schedules. Global coverage
of the composite coverage index (Fig. 4.5). Overall, levels of more recently recommended vaccines such
coverage increased and economic-related inequality as rotavirus vaccine and pneumococcal-conjugated
decreased for all indicators, albeit at varying degrees. vaccine were still under 50%. Human papillomavirus
2010–2019
Births attended by skilled health
personnel (in the two or three (55 countries)
years preceding the survey) (%)
2000–2009
2010–2019
0 10 20 30 40 50 60 70 80 90 100
Coverage (%)
Quintile 1 (poorest) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (richest)
Note: Circles indicate median values across countries – one circle for each subgroup.
Sources: Demographic and Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS) and Reproductive Health Surveys (RHS) available from the WHO Health Equity Monitor database, 2020 (11).
Fig. 4.5. RMNCH indicators by economic status: change over time, 2000–2009 and 2010–2019
vaccine was introduced in 103 countries by the end of Inequalities in the area of communicable
2019, not counting three countries where it was only diseases
partially introduced. Nearly a third of these Member
States (33) also started to vaccinate boys. Socioeconomic inequalities exist in all countries and
have important impacts on health. There are systemic
Despite encouraging progress, improvements and differences in infectious diseases between social
expansions in immunization coverage may be under groups that differ by dimensions such as economic
threat: preliminary data for the four months to April status, education, place of residence, occupation and
2020 indicate a substantial drop in DTP3 coverage for so on. Poor, more disadvantaged populations tend to
the first time in almost three decades (12). According suffer from a higher burden of communicable diseases,
to the second round of the WHO “pulse survey”’ for instance due to low knowledge of protective
of 135 countries (April 2021), three quarters of 82 behaviours, increased exposure due to living and
responding countries reported various reasons for working conditions, poor health-seeking behaviours
COVID-19 related disruptions in their immunization and barriers to accessing health services, all of which
programmes. Even when immunization services are inhibit rapid detection and treatment.
offered, people are either unable to access them
because of reluctance to leave home, transport HIV/AIDS
interruptions, economic hardships, restrictions on Overall, HIV knowledge, attitudes and practices (KAP)
movement, or fear of being exposed to COVID-19. tend to be better among the richest and most educated.
Many health workers are also unavailable to provide For instance, in over half of countries with data available
routine vaccination due to restrictions on travel or between 2010–2019, there was a gap of at least 20
redeployment to COVID response duties, as well as a percentage points between the richest and poorest for
lack of protective equipment. KAP indicators. Knowledge about HIV was also at least
20 percentage points higher among the most educated
than the least-educated (Fig. 4.6).
100
90
80
70 65.9 67.2
64.2
Percentage (%)
60
51.9
50
42.7 44.0
42.0 40.6 41.6
40
30
24.6
20.2
20 16.2
10
Notes: Circles indicate countries – each country is represented by multiple circles (one for each indicator and subgroup). Horizontal black lines indicate the median value (middle point of estimates).
Sources: Demographic and Health Surveys (DHS) and AIDS Indicator Surveys (AIS), 2010–2019 (11).
Fig. 4.6. Education-related inequalities in HIV knowledge, attitudes and practice among females and males: latest situation, 2010–2019
Nigeria 2017
Uganda 2017
Kenya 2017
Lesotho 2019
0 10 20 30 40 50 60 70 80 90 100
Percentage (%)
Quintile 1 (poorest) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (richest)
Fig. 4.7. Percentage of TB-affected households facing catastrophic costs due to TB by economic status in six countries: latest situation, 2016–2019
70
60
50
46.7
45.6
Percentage (%)
41.3 41.6
40
37.1
35.4 34.6
32.9 32.6
31.7
30
25.9
20
10
Notes: Circles indicate countries – each country is represented by multiple circles (one for each subgroup). Horizontal black lines indicate the median value (middle point of estimates).
Sources: Demographic and Health Surveys (DHS) and Malaria Indicator Surveys (MIS), 2010–2019 (11).
Fig. 4.8. Prompt care-seeking for children aged <5 years with fever by multiple dimensions of inequality in 28 countries: latest situation, 2010–2019
inequality.
80
76 2018 (n=183) 2019 (n=175)
74
73
72 71
70 70 70
70 67 67
66 66 66 66
65 65
62
63 63 63 64 63 63 63 63
61 60
59 60
60
57 56 57 55 54
53 53 52
52
50
50
40
30
20
10
0
7. Human resources
3. Zoonotic events
Point Functions
interface
Core capacities
Note: *Based on information of 146 States Parties reporting in 2018 (n=183), 2019 (n=175) and 2020 (n=164).
Source: As of 16 of April, 164 State Parties reported for SPAR 2020 IHR annual report. For the latest update see: https://extranet.who.int/e-spar.
Fig. 4.9. International Health Regulations State Parties SPAR reports, 2018 to 2020
Activities from IHR MEF are disseminated regularly on weekly updates and also available
1
at the Strategic Partnership for Health Security and Emergency Preparedness (SPH)
Portal. See: https://extranet.who.int/sph/home.
40
30
20
10
6. Surveillance
and the human–animal
7. Human resources
5. Laboratory
8. National Health
3. Zoonotic events
National IHR Focal
Point Functions
interface
Core capacities
Note: *Based on information of 146 States Parties reporting in 2018 (n=183), 2019 (n=175) and 2020 (n=164).
Source: As of 16 of April, 164 State Parties reported for SPAR 2020 IHR annual report. For the latest update see: https://extranet.who.int/e-spar.
Fig. 4.10. SPAR reports for 146 countries reporting for 2018, 2019 and 2020
and next steps. It will be important to ensure that the substantial impact on protecting more lives through
Prevent vaccination indicators continue to express the roll-out of COVID-related vaccines, to refocus
positive hard-earned gains due to COVID-related efforts on other priority vaccine-preventable diseases;
disruptions to essential health services, and to ensure and also, to address key factors of overall health
equitable roll-out of COVID vaccines. The current systems readiness to prepare for, respond to, and
pandemic offers a tangible opportunity to have a ultimately protect more lives from health emergencies.
2. Poverty and shared prosperity 2020: reversals of fortune. Washington D.C.: World Bank; 2020 (https://www.worldbank.org/en/
publication/poverty-and-shared-prosperity, accessed 1 May 2021).
3. Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020.
Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-
survey-2020.1, accessed 1 May 2021).
4. Family planning/contraception methods: Key facts. Geneva: World Health Organization; 2020 (https://www.who.int/news-
room/fact-sheets/detail/family-planning-contraception, accessed 1 May 2021).
5. Fore, H. A wake-up call: COVID-19 and its impact on children’s health and wellbeing. Lancet Glob Health. 2020;8:7. doi.
org/10.1016/S2214-109X(20)30238-2.
6. Kotlar B, Gerson E, Petrillo S, Langer A, Tiemeier H. The impact of the COVID-19 pandemic on maternal and perinatal health:
a scoping review. Reprod Health. 2021;18:10. doi.org/10.21203/rs.3.rs-96736/v1.
7. Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y et al. Early estimates of the indirect effects of the
COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet
Glob Health. 2020;8:7. doi.org/10.1016/s2214-109x(20)30229-1.
8. Global Health Estimates 2019: Global Health Estimates: Life expectancy and leading causes of death and disability. Geneva,
World Health Organization; 2020. (https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates,
accessed 1 May 2021).
9. Countdown 2008 Equity Analysis Group. Mind the gap: equity and trends in coverage of maternal, newborn, and child health
services in 54 Countdown countries. Lancet. 2008;371(9620):1259–67. doi.org/10.1016/s0140-6736(08)60560-7.
10. Wehrmeister FC, Barros AJD, Hosseinpoor AR, Boerma T, Victora CG. Measuring universal health coverage in reproductive,
maternal, newborn and child health: an update of the composite coverage index. PLoS ONE. 2020;15(4):e0232350. doi.
org/10.1371/journal.pone.0232350.
11. WHO Health Equity Monitor database [online database]. Geneva: World Health Organization; 2020 (https://www.who.int/data/
gho/health-equity, accessed 1 May 2021).
12. WHO and UNICEF warn of a decline in vaccinations during COVID-19. Geneva: World Health Organization; 2020 (https://www.
who.int/news/item/15-07-2020-who-and-unicef-warn-of-a-decline-in-vaccinations-during-covid-19, accessed 1 May 2021).
14. World Population Prospects 2019: highlights (ST/ESA/SER.A/423). New York: United Nations, Department of Economic and
Social Affairs, Population Division; 2019 (https://www.un.org/development/desa/publications/world-population-prospects-
2019-highlights.html, accessed 1 May 2021).
15. Gasper D. Needs and human rights. In: Smith R, van den Anker C (eds). The essentials of human rights. London: Hodder &
Stoughton; 2005.
16. WHO Study on global AGEing and adult health (SAGE) [online database]. Geneva: World Health Organization (https://www.
who.int/healthinfo/sage/en, accessed 1 May 2021).
17. Gender equity in the health workforce: analysis of 104 countries. Health Workforce Working Paper 1. Geneva: World Health
Organization; 2019 (https://www.who.int/hrh/resources/gender_equity-health_workforce_analysis/en/, accessed 1 May 2021).
18. State of the world’s nursing 2020: investing in education, jobs and leadership. Geneva: World Health Organization; 2019
(https://apps.who.int/iris/bitstream/handle/10665/331673/9789240003293-eng.pdf, accessed 1 May 2021).
19. National Health Workforce Accounts data portal [online database]. Geneva: World Health Organization (https://apps.who.int/
nhwaportal/, accessed 1 May 2021).
20. Investments on grants for biomedical research by funder, type of grant, health category and recipient (Global Health
Observatory) [online database]. (https://www.who.int/observatories/global-observatory-on-health-research-and-
development/monitoring/investments-on-grants-for-biomedical-research-by-funder-type-of-grant-health-category-and-
recipient, accessed 1 May 2021).
The world was already off-track to meet the SDGs and the WHO Triple Billions, and COVID-19 has
upended recent progress. Delivering on the WHO Triple Billion targets is imperative to get back on
track, be better prepared and recover equitably.
Note: Analysis does not yet account for impact of COVIS-19 on Triple Billion targets.
Source: Triple Billion dashboard https://www.who.int/data/triple-billion-dashboard (1).
Fig. 5.1. Projected shortfall in reaching WHO Triple Billion targets by 2023, compared to 2018
57
Triple Billion targets people with noncommunicable diseases and other
underlying risk factors have been reported to be
The WHO Triple Billion targets are a shared vision at higher risk of severe illness and death since the
among WHO and Member States, which help countries pandemic began in 2020 (6–7). Multisectoral action must
to accelerate the delivery of the SDGs. They aim to be strengthened at the global, regional and national
improve the health of billions of people by 2023 through levels to mitigate the impacts of COVID-19, and address
achieving: 1) One billion more people enjoying better social, behavioural, metabolic and environmental
health and well-being; 2) One billion more people determinants of health.
benefiting from universal health coverage (UHC);
3) One billion more people better protected from health UHC Billion
emergencies. These targets are aligned closely with One billion more people benefiting from universal health
the SDGs and are the foundation of the WHO Thirteenth coverage (UHC)
General Programme of Work (GPW 13), acting as both a The UHC Billion target is assessed with a set of 14
measurement tool and a policy roadmap to accelerate health service coverage (SDG 3.8.1) and financial
progress towards health related SDGs. The ongoing hardship tracer indicators (SDG 3.8.2). Between 2018
COVID-19 pandemic underscores the importance and 2023, both LICs and other countries are projected
of investing in health to have populations that are to have similar progress towards the UHC target with
healthier and are able to withstand or recover quickly 4% more of the population with UHC (1). However, the
from health risks; to have resilient health systems that percentage of population with UHC in LICs overall is
deliver to all people essential health services of good projected to be 50% in 2023, remaining low compared
quality without incurring financial hardship; and to to the projection of 66% among other countries.
have well-functioning mechanisms to efficiently and
effectively prepare for, prevent, detect and respond to At the current rate of progress, it is projected that
health emergencies. 290 million more people would be covered by health
services without experiencing financial hardship by
Healthier Population Billion 2023, compared to the 2018 baseline value, leaving
One billion more people enjoying better health and well-being a gap of 710 million until the UHC Billion is reached
The Healthier Population Billion target aims for one (1). This projection does not account for the impact of
billion more people to live in better health by 2023 COVID-19. Given reported disruptions in health services
by encouraging healthier behaviours, lifestyles and and global economic contraction due to the pandemic,
environments. Progress towards this target is measured progress towards the UHC Billion is very likely under
using the Healthier Population Index, which consists of threat, and urgent investment is necessary to maintain
17 tracers from the GPW 13 outcome indicators mainly the progress (8,9).
derived from the SDGs. These indicators cover clean air,
safe water, sanitation and roads, tobacco and alcohol Health Emergencies Billion
use, obesity, domestic violence, child nutrition and child One billion more people better protected from health
development, trans-fats, and mental health (2). emergencies
The Health Emergencies Billion target is based on
The current projected number of people living healthier SDG 3 and accounts for the need to prepare for,
lives by 2023 is about 900 million more than the 2018 prevent, detect and respond to health emergencies. It is
baseline value, still 100 million short of the one billion measured through the Health Emergencies Protection
target (1). Economic development affects progress Index (HEPI) that comprises three component indicators
towards the target across countries. Just 2% more of – Prepare, Prevent, Detect and Respond – representing
the population in LICs is projected to live a healthier life the key elements of WHO health emergencies activities.
by 2023, compared to 12% more among other countries Prior to the onset of COVID-19, early estimates showed
and 11% more globally. However, the majority of global that the world was on track to achieve one billion
progress occurs in just a few countries. If the current people better protected from health emergencies by
trend continues without intentional intervention, there 2023 with a positive trend across all three component
is risk of deepening inequalities between LICs and indicators. Although the full impact of the COVID-19
other countries. pandemic is yet to be determined, latest estimates
that include observed data from 2020 suggest that
The impact of the COVID-19 pandemic is not reflected the current trajectory will result in 920 million people
in this projection but will be accounted for in future better protected from health emergencies by 2023 –
work. The pandemic may have reversed some of the just 80 million short of the target (1). In LICs, 23% more
progress and worsened existing health inequalities, of the population are projected to be protected from
with increases in reported substance and alcohol use, health emergencies from 2018 to 2023, compared to
domestic violence and mental illness (3–5). Moreover, 10% among other countries.
+3.5
percentage
points
+3.8
percentage
points
62.9% 66.4%
45.9% 49.7%
Fig. 5.2. Increase in proportion of population projected to have universal health coverage by 2023 in comparison to 2018
The ongoing COVID-19 pandemic suggests that the regarding health, in order to inform equity-oriented
world was not prepared for health emergencies of such policies, programmes and practices that ensure that
a scale. Further monitoring and analysis are required to disadvantaged or hard-to-reach populations are not
determine the longer-term consequences of COVID-19 for left behind. This relies on the collection, analysis and
the attainment of the Health Emergencies billion target. reporting of health data disaggregated by inequality
dimensions, such as sex, age, economic status,
However, investments driven by the response to education, place of residence, ethnicity and other
COVID-19, and particularly those related to country context-specific population subgroups. In this light,
preparedness, disease surveillance and COVID-19 health information systems are the foundation for
vaccination roll-out, may be leveraged to accelerate monitoring health inequality.
progress towards achieving the target of 1 billion people
better protected from health emergencies. Global data availability on health inequality
A WHO global assessment found that only 51% of the 133
participating countries included data disaggregation
Monitoring health inequality: an essential in their published national health statistical reports
step to achieve health equity (ranging from 63% of HICs to 46–50% of countries in
other income groups) (Fig. 5.3) (10). Household surveys
“Leaving no one behind” is the overarching refrain of the are one of the main sources of data for assessing
SDGs. The 2030 Agenda for Sustainable Development health inequality. Of the 673 conducted in these
recognizes that high and rising inequalities, both countries between 2013 and 2018, 91% collected data
within countries and between countries, are not only disaggregated by sex, 83% by age, and only 74% by
an impediment to growth and human development, education, 70% by urban–rural place of residence and
but are also a violation of shared norms, values and 58% by wealth.
fairness.
Data disaggregation continues to be lacking in many
Relying solely on national level data to monitor countries and inequality data are often not being made
health may lead to biased conclusions and some accessible to the decision-makers who need them.
subpopulations being overlooked. Inequality monitoring Investment in robust health information systems is vital
is the process of generating evidence on how various to ensure that health service access and uptake, and
subpopulations within a country are performing ultimately health outcomes, are equitable.
0 10 20 30 40 50 60 70 80 90 100
0 10 20 30 40 50 60 70 80 90 100
Source: SCORE for health data technical package: global report on health data systems and capacity, 2020 (10).
Fig. 5.3. Availability and reporting of disaggregated health data in 133 countries, 2013–2018
Availability of disaggregated data for GPW 13 Building capacity for monitoring inequality
outcome indicators Disaggregated data enable policy-makers to identify
Out of the 46 outcome indicators defined by WHO GPW populations that are vulnerable to being left behind, and
13 impact measurement, 38 can be disaggregated by direct resources and design programmes accordingly.
nature. Based on data that were recently published The availability of high-quality disaggregated data
(survey data conducted within the past 10 years and continues to be a challenge in many countries,
estimates from latest year(s) available), and comparable hindering the monitoring of health inequalities both
across countries, only 22 of the 38 indicators have data within and between countries. This requires great
disaggregated by at least one dimension of inequality efforts to enhance country health information systems
(i.e. age, economic status, education level, place of that collect data to produce disaggregated data by
residence or sex) available in the public domain. multiple inequality dimensions through various data
sources including civil registration and vital statistics
Of the 22 GPW 13 outcome indicators, six had data (CRVS), population-based surveys, routine health
disaggregated by age, eight by economic status, facility data and administrative data.
eight by level of education, 11 by place of residence
(urban–rural) and 17 by sex (Annex 4, Table 1). Sex- Countries’ capacity to analyse and report health
disaggregated data are available for the largest number inequality data also needs to be strengthened. WHO
of countries in general, largely because these are based has developed a package of tools and resources to
on data that are estimated or modelled by organizations support countries for developing inequality monitoring
including WHO. Population-based household surveys capacities, including a step-by-step manual (11), a
are the main data source for data disaggregated by handbook (12), statistical codes to facilitate the
economic status, education and place of residence. calculation of disaggregated estimates from household
However, the frequency and timeliness of this data vary survey data (13), the Health Equity Monitor database
considerably across countries. Of the eight outcome (one of the largest databases of disaggregated health
indicators with disaggregation by economic status or data), and the Health Equity Assessment Toolkit (HEAT
education, data are only available for 64 to 93 countries and HEAT Plus) (14), an interactive software application
for at least one year between 2010 and 2019. that enables countries to assess inequalities at national
and subnational levels.
Data disaggregation is also not available for many of
the indicators used to calculate progress against the
Triple Billion targets (Annex 4, Table 2).
Lower-middle income 8
Upper-middle income 35
High income 78
Global 33
0 10 20 30 40 50 60 70 80 90
Percentage (%)
Source: SCORE for health data technical package: global report on health data systems and capacity, 2020 (10).
Fig. 5.4. Percentage of health surveys that are fully funded by government, by World Bank income group, 2013–2018
Population-based surveys are one of the essential A well-functioning civil registration and vital statistics
tools to measure population health and health- (CRVS) system is vital as accurate birth and death
related trends. However, many countries rely heavily registration provide essential data for service planning
on external support for implementing health surveys. and resource allocation. SCORE data showed that 44%
SCORE results indicated that only 8% of the surveys of the countries have only poor capacity or no capacity at
in LMICs and 3% in LICs were fully funded by the all to fully register the births, deaths and report causes
respective national government (Fig. 5.4). This would of death (Fig. 5.5). In the African Region, less than half
very likely cause data disruption in tracking health- of the births and only 10% of deaths were registered
related SDGs and other health priorities when external annually. Causes of death were reported for only 8% of
support is not available or insufficient. deaths registered in LICs. These findings were echoed
96 98 98
100
Births Deaths 91 91
90
82
78
80
72
69
70
62 61
60 55
Percentage (%)
50 44
40
30
20
10
10
0
European Region
Source: SCORE for health data technical package: global report on health data systems and capacity, 2020 (10).
SYNTHESIZING HEALTH SERVICE DATA The COVID-19 pandemic exposed the weakness of
existing health information systems. Every country
Health service data can be generated through routine health facility deserves a strong health information system that
and community reporting systems, health facility assessments and
health resource data including on health financing and the health can inform policies to save lives and allow people to
workforce. These systems should be integrated and interoperable to live a healthier life without the burden of excessive
ensure synergized monitoring, analysis and management of health
services to support patient care, facility management and health
health care costs. Countries need to increase their
sector planning to improve primary health care and UHC. The WHO investments in such systems in order to build strong
Harmonized facility and community data toolkit and related digital and robust health information systems that can prevent
packages – such as the District Health Information Software 2 –
provide reliable and actionable data to improve the access to quality of the next pandemic and stride towards the health-
health care (25). related SDGs and Triple Billion targets.
2. Thirteenth General Programme of Work (GPW 13) methods for impact measurement. Geneva: World Health Organization;
2020 (https://www.who.int/publications/m/item/thirteenth-general-programme-of-work-(gpw13)-methods-for-impact-
measurement, accessed 1 May 2021).
3. Domestic violence during Covid-19: evidence from a systematic review and meta-analysis. Journal of Criminal Justice.
2021;74:101806 (https://www.sciencedirect.com/science/article/pii/S004723522100026X, accessed 1 May 2021).
4. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55–
64. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413844/pdf/main.pdf, accessed 1 May 2021).
5. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open.
2020;3(9):e2022942. (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770975, accessed 1 May 2021).
6. Smoking and COVID-19: Scientific Brief. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/
handle/10665/332895/WHO-2019-nCoV-Sci_Brief-Smoking-2020.2-eng.pdf?sequence=1&isAllowed=y, accessed 1 May 2021).
7. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-
analysis. Diabetes Obes Metab. 2020;22:1915–1924. (https://dom-pubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/
dom.14124, accessed 1 May 2021).
8. Second round of the national pulse survey on continuity of essential health services during the COVID-19 pandemic. Geneva:
World Health Organization; 2021 (https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS-continuity-survey-2021.1,
accessed 1 May 2021).
9. Monitoring global poverty. In: Poverty and shared prosperity 2020: reversals of fortune. Washington D.C.: World Bank; 2020
(https://openknowledge.worldbank.org/bitstream/handle/10986/34496/9781464816024_Ch1.pdf, accessed 1 May 2021).
10. SCORE for health data technical package: Global report on health data systems and capacity, 2020. Geneva: World Health
Organization; 2021 (https://www.who.int/publications/i/item/global-report-on-health-data-systems-and-capacity-2020,
accessed 1 May 2021).
11. National health inequality monitoring: a step-by-step manual. Geneva: World Health Organization; 2017 (https://www.who.int/
gender-equity-rights/knowledge/national-health-inequality-monitoring/en/, accessed 1 May 2021).
12. Handbook on health inequality monitoring with a special focus on low- and middle-income countries. Geneva: World Health
Organization; 2013 (https://www.who.int/docs/default-source/gho-documents/health-equity/handbook-on-health-inequality-
monitoring/handbook-on-health-inequality-monitoring.pdf, accessed 1 May 2021).
13. Statistical codes to calculate disaggregated estimates using household surveys. Geneva: World Health Organization; 2017
(http://www.who.int/gho/health_equity/statistical_codes/, accessed 1 May 2021).
14. Hosseinpoor AR, Nambiar D, Schlotheuber A, Ross Z. Health Equity Assessment Toolkit (HEAT): software for exploring and
comparing health inequalities in countries. BMC Med Res Methodol. 2016;16:141.
15. Hosseinpoor AH, Nambiar D, Tawilah J, Schlotheuber A, Briot B, Bateman et al. (2018) Capacity building for health inequality
monitoring in Indonesia: enhancing the equity orientation of country health information systems. Glob Health Action.
2018;11(suppl1):7-12 doi.10.1080/16549716.2017.1419739.
16. State of health inequality: Indonesia. Geneva: World Health Organization; 2017 (https://www.who.int/gho/health_equity/
report_2017_indonesia/en/, accessed 1 May 2021).
17. Innov8 approach for reviewing national health programmes to leave no one behind: Technical handbook. Geneva: World
Health Organization; 2016 (https://www.who.int/life-course/partners/innov8/innov8-technical-handbook/en/, accessed 1 May
2021).
18. SCORE for Health Data Technical Package: essential interventions. Geneva: World Health Organization; 2020 (https://apps.
who.int/iris/handle/10665/334005, accessed 1 May 2021).
19. World Health Survey Plus. Geneva: World Health Organization; 2020 (https://www.who.int/data/data-collection-tools/world-
health-survey-plus, accessed 1 May 2021).
20. Civil Registration and Vital Statistics Strategic Implementation Plan 2021-2025. Geneva: World Health Organization; 2021.
21. Revealing the toll of COVID-19: a technical package for rapid mortality surveillance and epidemic response. Geneva: World
Health Organization; 2020 (https://www.who.int/publications/i/item/revealing-the-toll-of-covid-19, accessed 1 May 2021).
22. International guidelines for certification and classification (coding) of COVID-19 as cause of death. Geneva: World Health
Organization; 2020 (https://www.who.int/classifications/icd/Guidelines_Cause_of_Death_COVID-19.pdf, accessed 1 May
2021).
23. Global COVID-19 weekly mortality data entry platform. Geneva: World Health Organization; 2020 (https://covidmortality-who.
hub.arcgis.com/, accessed 1 May 2021).
24. Technical Advisory Group on COVID-19 mortality assessment. Geneva: World Health Organization; 2021 (https://www.who.int/
data/technical-advisory-group/covid-19--mortality-assessment/membership, accessed 1 May 2021).
25. WHO Health Data Toolkit. Oslo: DHIS2 (https://dhis2.org/who/, accessed 1 May 2021).
Explanatory notes
Unless otherwise noted, the statistics shown below represent official World Health Organization (WHO) statistics
for selected health-related Sustainable Development Goal (SDG) indicators and selected Thirteenth General
Programme of Work (GPW 13) indicators, based on evidence available in early 2021. They have been compiled
primarily from publications and databases produced and maintained by WHO or by United Nations (UN) groups
of which WHO is a member. Unless otherwise noted, all statistics presented here are available in Annex 2. Owing
to limited space, indicators are often referred to using SDG targets, along with a shorter indicator name (Annex
2 has a full summary of indicator names and relevant references).
Comparable estimates are subject to considerable uncertainty, especially for countries where the availability and
quality of the underlying primary data are limited (1). Uncertainty intervals and other details on the indicators and
statistics presented here can be found at the WHO Global Health Observatory1.
Reference
1. World Health Statistics 2018: Monitoring health for the SDGs. Geneva: World Health Organization; 2018 (https://www.who.int/
gho/publications/world_health_statistics/2018/en/, accessed 20 April 2021).
The Global Health Observatory is a WHO online portal that provides access to data and analyses for monitoring the global health situation (available at https://www.who.int/gho/en/).
1
Innovating to generate evidence for policy with limited data – understanding and
guiding health system functionality
Overall health system performance index
Countries are making efforts to attain essential health gains in the context of
changing social, economic, environmental, political and cultural situations. To
achieve this, health sectors are grappling with providing services in constantly
shifting environments, where disease, economic and environmental shocks occur
frequently. As a result, determining where and what to focus on is complex, with
countries required to make varying investments to overcome their most immediate
challenges and ensure effective, efficient and equitable achievement of specific
health-related goals. Determining and meeting the information needs of this
process, and adjusting to changing and unique country needs in a manner that
ensures appropriate evidence available, is an equally complex challenge.
The WHO Regional Office for Africa is focusing on use of functional indices
constructed from multiple related indicators to generate this essential information,
focusing on understanding ongoing contexts and where effort needs to be
concentrated (1,2). The approach determines and assesses the level of functionality
of systems in the region, as important predictors of health outcomes. Functionality
is based on understanding relative capacities to ensure access to the quality
essential services demanded by a given population, in a manner resilient to
shocks and similar events. Based on indices for various functional capacities, Overall System Functionality
succinct guidance is available to countries on where efforts need to be placed <40
to continue momentum towards their health goals. Emerging evidence on the 40.1-45
45.1-50
relative status of different functional capacities is both valid and sensitive to 50.1-55
country specificities, even in contexts of limited data availability, and the average 55.1-60
60.1-65
of the four combined indices in the areas of access, quality, demand and resilience 65.1-60
>70
shows a high correlation with the current status of health outcomes (r=0.778, Not applicable
The system provides countries with the evidence to guide where focused
investments are needed across the health system to attain UHC and other health
outcomes given current contexts. The evidence is specific for overall functionality
Cabo Verde Comoros Mauritius Sao Tome and Principe Seychelles
and in relation to the status of contributing capacities. Relevant capacities include:
ensuring better access (overcoming physical, financial or cultural barriers); The designations employed and the presentation of the material in this publication do not imply the expression of
strengthening quality of care (improving user experiences, care processes and any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of
Source: Report on the performance of health systems in the WHO African Region (1).
its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps
effectiveness of outcomes); demand for services (improving healthy actions and represent approximate border lines for which there may not yet be full agreement. © WHO 2021. All rights reserved.
health-seeking behaviours); and resilience to shocks. Each country can therefore Fig. A1.2. Relative functionality of health systems across countries of the
focus its health systems development by focusing on addressing the most essential WHO African Region, 2015–2020
capacity gaps.
90
80
70
Overall system functionality, 2015–2020
60
50
Low income
Lower middle income
40 Upper middle income
High income
30
20
Note: UHC service coverage index does not include
the service capacity and access components. Income
groups are according to World Bank Income Groups
(July 2020).
10
Sources: Report on the performance of health
systems in the WHO African Region (1) and Primary
health care on the road to universal health coverage:
0 2019 Monitoring report (3).
0 10 20 30 40 50 60 70 80 90
UHC service coverage index, 2017
Fig. A1.1. Functionality index correlation with UHC service coverage index in countries of the WHO African Region, by income group
Hepatitis B prevalenceᵍ
Unintentional poisoning
Tuberculosis incidenceᵉ
MCV2 immunizationᵐ
Alcohol consumptionⁱ
New HIV infectionsᵈ
DTP3 immunizationˡ
PCV3 immunizationˡ
Malaria incidenceᶠ
mortality rate..
HPV vaccineⁿ
Member State 2017 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2017 2016 2016 2019 2018 2019 2019 2019 2019
Algeria 112 23 16 0.05 61 0.0 0.08 13.9 2.5 0.6 20.9 78 49.7 1.9 0.7 18.8 91 77 91
Angola 241 75 28 0.84 351 235.2 4.57 22.2 6.1 7.8 26.1 40 118.5 48.8 2.0 57 45 53
Benin 397 90 31 0.31 55 406.7 2.87 22.6 7.8 2.2 26.8 40 205.0 59.7 2.6 7.2 76 73
Botswana 144 42 18 4.78 253 0.2 0.18 27.0 16.1 6.6 26.4 61 101.3 11.8 1.8 23.7 95 76 92 47
Burkina Faso 320 88 26 0.14 47 386.7 1.66 23.9 7.5 11.0 31.0 40 206.2 49.6 3.1 16.0 91 71 91
Burundi 548 56 21 0.17 107 296.0 1.35 25.0 6.2 7.5 35.5 42 179.9 65.4 3.2 12.6 93 80 93
Cabo Verde 58 15 9 0.19 46 0.0 0.26 17.4 12.9 6.4 26.8 69 99.5 4.1 0.4 96 91
Cameroon 529 75 26 0.69 179 243.1 1.75 23.9 9.0 5.5 30.2 46 208.1 45.2 2.6 9.3 67 67
Central African Republic 829 110 40 1.10 540 345.0 3.75 36.0 12.3 1.7 37.7 33 211.9 82.1 2.8 47 47
Chad 1140 114 33 0.34 142 202.1 10.79 22.7 6.4 1.3 32.4 28 280.1 101.0 3.5 11.8 50
Comoros 273 63 30 <0.01 35 20.7 1.16 20.6 5.4 1.1 26.6 52 172.4 50.7 2.4 19.5 91
Congo 378 48 19 1.55 373 230.8 2.56 22.6 6.5 9.2 29.7 39 130.7 38.7 1.3 16.1 79 9 68
Cote d'Ivoire 617 0.51 137 300.6 21.7 8.9 3.0 24.1 47 269.1 47.2 2.5 13.0 84 84
Democratic
Democratic Republic
Republic of theofCongo
the .. 473 85 27 0.22 320 325.8 3.28 24.0 6.7 1.1 34.9 41 163.9 59.8 2.0 57 58
Equatorial Guinea 301 82 29 4.06 181 237.1 6.07 22.1 7.9 6.9 27.2 45 177.7 22.3 1.6 53
Eritrea 480 40 18 0.11 86 57.3 1.02 26.8 10.9 2.1 37.9 38 173.7 45.6 3.3 7.2 95 88 95
Eswatini 437 49 18 4.90 363 0.7 35.2 29.4 8.8 33.5 63 137.0 27.9 3.3 10.7 90 75 87
Ethiopia 401 51 28 0.16 140 34.3 1.59 17.1 5.4 2.2 28.2 39 144.4 43.7 3.3 4.6 69 41 63 84
Gabon 252 42 20 0.74 521 211.9 2.12 21.3 8.4 8.1 23.9 49 76.0 20.6 1.3 70
Gambia 597 52 27 1.06 158 50.5 1.60 21.1 4.8 3.4 29.6 44 237.0 29.7 1.8 14.4 88 61 87
Ghana 308 46 23 0.70 144 161.5 2.13 22.5 6.6 2.8 25.7 47 203.8 18.8 1.7 3.7 97 83 97
Guinea 576 99 30 0.39 176 296.9 6.07 24.9 7.0 1.1 29.7 37 243.3 44.6 2.3 47
Guinea-Bissau 667 78 35 1.15 361 86.9 2.11 24.9 7.0 5.5 32.2 40 214.7 35.3 2.3 84 84
Kenya 342 43 21 0.92 267 57.0 0.40 21.0 6.1 2.1 28.3 55 78.1 51.2 2.4 11.8 92 45 92
Lesotho 544 86 43 6.43 654 1.22 42.7 72.4 5.1 31.9 48 177.6 44.4 5.2 29.7 87 82 87
Liberia 661 85 32 0.46 308 366.6 4.66 17.8 4.4 5.4 38.9 39 170.2 41.5 1.7 8.4 74 13 74
Madagascar 335 51 20 0.23 233 76.1 2.13 26.0 5.5 2.0 29.2 28 159.6 30.2 2.1 28.9 79 79
Malawi 349 42 20 1.94 146 207.7 1.39 22.6 5.4 4.1 33.4 46 115.0 28.3 1.7 12.8 95 75 95
Mali 562 94 32 52 333.7 4.62 22.3 4.1 1.3 22.7 38 209.1 70.7 2.9 12.0 77 4 74
Mauritania 766 73 32 89 43.4 3.35 16.1 3.1 0.0 25.6 41 169.5 38.6 1.5 81 77
Mauritius 61 16 10 0.57 12 0.41 23.2 9.5 4.8 12.2 63 38.3 0.6 0.8 26.9 96 99 97 80
Mozambique 289 74 29 4.68 361 308.4 0.59 30.6 13.6 2.7 30.0 46 110.0 27.6 3.7 14.4 88 85 80
Namibia 195 42 19 3.10 486 2.8 0.36 22.6 9.7 3.1 34.8 62 145.0 18.3 1.9 17.9 87 56 57
Niger 509 80 24 0.06 84 343.2 3.44 21.0 5.3 0.5 25.5 37 251.8 70.8 3.3 8.6 81 58 81
Nigeria 917 117 36 0.52 219 303.3 2.94 16.9 3.5 6.2 20.7 42 307.4 68.6 3.3 4.8 57 9 57
Rwanda 248 34 16 0.44 57 366.1 0.49 20.2 5.6 8.0 29.4 57 121.4 19.3 1.7 13.3 98 92 98 94
Sao Tome and Principe 130 30 14 114 11.4 1.31 21.0 1.5 5.8 27.9 55 162.4 11.4 0.7 5.4 95 81 95
Senegal 315 45 22 0.09 117 50.5 0.93 19.5 6.0 0.7 23.5 45 160.7 23.9 1.9 9.1 93 78 92 25
Seychelles 53 14 9 16 0.09 21.1 8.1 8.8 11.3 71 49.3 0.2 0.5 21.1 99 99 92 68
Sierra Leone 1120 109 31 0.65 295 334.8 1.98 23.5 6.7 5.3 33.0 39 324.1 81.3 2.8 19.8 95 72 94
South Africa 119 34 11 3.98 615 0.5 3.10 24.1 23.5 9.5 22.2 69 86.7 13.7 1.7 31.4 77 54 76 56
South Sudan 1150 96 39 1.50 227 272.0 13.03 16.8 3.8 36.7 31 165.1 63.3 2.3 49
Togo 396 67 25 0.59 37 225.0 3.27 23.9 8.8 2.7 28.7 43 249.6 41.6 1.9 7.6 84 67 83
Uganda 375 46 20 1.38 200 262.7 0.96 21.2 4.6 12.5 29.4 45 155.7 31.6 1.7 9.8 93 92 64
United Republic of Tanzania 524 50 20 1.46 237 111.2 17.4 4.3 12.0 31.1 43 139.0 38.4 2.0 13.3 89 72 83 49
Zambia 213 62 23 3.17 333 147.7 1.32 24.6 7.3 4.5 20.5 53 127.2 34.9 2.6 14.7 88 66 89
Zimbabwe 458 55 26 2.81 199 67.9 2.74 28.4 14.1 4.5 41.2 54 133.0 24.6 3.5 13.9 90 75 90 67
ᵃ Comparable estimates refer to country values of the same reference year, which may be adjusted or modelled to allow comparisons between countries and are produced for countries with underlying
primary data and, in some cases, for those without. Refer to Annex 2 for the full set of SDG 3 indicators. Shading from blue to orange represents low to high for mortality, incidence and prevalence indicators;
and from high to low for immunization coverage and service index indicators. Each indicator is graphed on an individual scale.
ᵇ per 100 000 live births ᵉ per 100 000 population ʰ betwe en ages 30-69 (%) ᵏ age-standardized, among adults 18+ (%) ⁿ among 15 year-old girls (%)
ᶜ per 1000 live births ᶠ per 1000 population at risk ⁱ litres of pure alcohol per capita ≥15 years ˡ among 1-year-olds (%)
ᵈ per 1000 uninfected population ᵍ among children under 5 years (%) ʲ age-standardized, per 100 00 population ᵐ by the nationally recommended age (%)
The Region of the Americas experienced a steady decline in tuberculosis (TB) from first decade of the century (corresponding to a 2.9% annual average reduction in
1990 to 2015, cutting its prevalence and mortality by half over that period. It was absolute between-country inequality) has been reversed (averaging a 2.6% annual
the first region in the world to meet the Millennium Development Goal (MDG) target increase from 2011 onwards). The corresponding relative inequality, as measured
for halting the spread of TB.1 However, progress in closing gaps in the prevention, by the concentration index (CIx), showed a slightly better prospect, with a steady
detection and reporting of incident TB cases, multidrug-resistant TB (MDR-TB) 1% annual average reduction in between-country relative inequality in the period
and TB/HIV coinfection has been slow, and the disease remains a serious public observed (Fig. A1.3c). This change in CIx equates to a reduction from 81% to 76%
health problem, posing a critical challenge to meeting the SDG 3.3.2 target (5). in the TB incidence burden among the poorest half of countries in the Americas
from 2000 to 2019, respectively.
In 2019, the regional TB incidence rate (all forms, both sexes) was 28.6 per
100 000 population [95% CI: 26.6 to 30.7], up from 27.5 per 100 000 population The observed deceleration of the regional efforts to reduce TB incidence in the past
[25.5 to 29.5] in 2015, representing an annual average increase of almost 1%. five years, along with its sizeable income-related inequalities across countries, will
Despite an apparent 2018–19 stabilization, this unwanted trend contrasts with the no doubt be amplified by the multidimensional impacts of the COVID-19 pandemic
one observed from 2000 to 2015, during which a steady –1.9% annual average in the region. Attaining SDG 3.3.2 will demand, therefore, truly stepped-up efforts
reduction was observed (Fig. A1.3a). with an explicit focus on inequality, including territories and populations living
under conditions of social and health vulnerability. To enhance accountability
Income-related inequalities in TB incidence between countries in the Region of for the 2030 Agenda for Sustainable Development’s overarching pledge that
the Americas continue to be extremely high. The extra TB burden associated with no one will be left behind, the Region of the Americas is implementing a health
this social gradient, as measured by the slope index of inequality (SII), went from inequality monitoring system for all its SDG 3 related indicators,2 informing the
–99.5 excess TB incident cases per 100 000 population (between the richest and adoption of equity-sensitive targets, policies and interventions. This approach is
poorest countries) in 2000 to –77.0 in 2010 and back to –99.6 in 2019 (Fig. A1.3b). critical for a region with extreme wealth-related inequality, and especially for the
This means that the favourable downward trend (i.e. towards zero) observed in the post-COVID-19 scenario.
1
Unless otherwise noted the data found here are from the Global tuberculosis report
2020. Geneva: World Health Organization; 2020 (https://www.who.int/teams/global- 2
For information regarding PAHO’s SDG 3 related health inequality monitoring, please visit:
tuberculosis-programme/tb-reports/global-tuberculosis-report-2020) (4). https://www.paho.org/ods3.
a)
40
TB incidence rate per
100 000 population
35
30
25
20
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
b)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
0
Absolute inequality: slope index of inequality (SII)
Increasing -25
inequality -50
favouring the
richest -75
countries -100
-125
c)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
0
Increasing Relative inequality: concentration index (CIx)
inequality -10
favouring the -20
richest
-30
countries
-40
-50
Notes: The slope index of inequality (SII) represents an estimate of the difference in TB incidence rates between the richest and the poorest countries, while taking into consideration the other countries in the region. The
Concentration Index (CIx) indicates the extent to which TB incidence is concentrated among the richest or the poorest countries. In the lower two panels, SII and CIx negative values account for negative inequality (i.e. TB incidence
disproportionately concentrated among the most socially disadvantaged (i.e. poorest) countries: the closer to zero (0), the lower the inequality).3
Sources: Global tuberculosis report 2020 (4); Gross domestic product per capita 2000–2019 estimates (6).
Fig. A1.3. Regional trends (a) and cross-country income-related inequalities (b and c) in the incidence of tuberculosis (SDG 3.3.2) in the Region of the
Americas, 2000–2019
Cross-country inequalities in TB incidence (all forms, both sexes) were measured across the social hierarchy defined by the gross domestic product per capita (in 2018 constant,
3
international dollars). For information regarding the calculation of the SII and the CIx as summary measures of absolute and relative inequality, please refer to the WHO’s Handbook for
health inequality monitoring https://www.who.int/gho/health_equity/handbook/en/).
Hepatitis B prevalenceᵍ
Unintentional poisoning
Tuberculosis incidenceᵉ
MCV2 immunizationᵐ
Alcohol consumptionⁱ
New HIV infectionsᵈ
DTP3 immunizationˡ
PCV3 immunizationˡ
Malaria incidenceᶠ
mortality rate..
HPV vaccineⁿ
Member State 2017 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2017 2016 2016 2019 2018 2019 2019 2019 2019
Antigua and Barbuda 42 7 4 0.0 0.19 17.5 0.4 9 .4 0.0 73 29.9 0.1 0.7 95 95
Argentina 39 9 6 0.13 29 0.0 0.01 15.7 8.4 9.5 14.1 76 26.6 0.4 0.4 21.8 86 89 88 59
Bahamas 70 13 7 15 0.16 19.9 3.5 4.8 7.7 75 19.9 0.1 0.2 10.9 86 82 86 9
Barbados 27 13 8 0.18 0.0 0.18 16.0 0.6 10.4 8.2 77 31.1 0.2 0.7 8.7 90 77 93 29
Belize 36 12 8 27 0.0 0.60 16.5 7.1 6.4 22.6 64 68.6 1.0 0.4 98 95 63
Bolivia (PlurinationalState
Bolivia (Plurinational Stateof).. 155 26 15 0.08 106 2.4 0.14 17.9 6.2 3.9 21.1 68 63.7 5.6 0.6 75 44 75 70
Brazil 60 14 8 0.23 46 4.2 0.03 15.5 6.9 7.3 16.0 79 29.9 1.0 0.1 16.5 73 54 84 69
Canada 10 5 3 5.5 0.34 9.6 11.8 8.8 5.3 89 7.0 0.4 0.3 17.5 91 87 81 83
Chile 13 7 5 0.27 18 0.03 10.0 9.0 8.9 14.9 70 25.3 0.2 0.4 44.7 96 91 95 82
Colombia 83 14 7 0.25 35 10.7 0.15 9.7 3.9 5.5 15.4 76 37.0 0.8 0.1 7.9 92 88 94 39
Costa Rica 27 9 6 0.19 10.0 0.1 0.02 9.5 8.1 4.1 14.8 77 23.3 0.9 0.1 9.8 95 93 95 39
Cuba 36 5 2 0.14 6.5 0.03 16.6 14.5 6.3 8.9 83 49.5 1.0 0.2 27.1 99 99
Dominica 35 28 16 7.2 99 92
Dominican Republic 95 28 19 0.27 42 0.3 0.10 19.1 4.9 6.7 64.6 74 43.0 2.2 0.4 9.4 89 60 70 7
Ecuador 59 14 7 0.14 46 3.6 0.09 11.0 7.6 3.3 20.1 77 24.5 0.6 0.3 85 76 83 54
El Salvador 46 13 7 0.14 58 0.0 0.02 10.7 6.1 4.1 20.9 76 41.9 2.0 0.2 12.7 81 87 82
Grenada 25 17 11 3.1 0.12 23.3 0.7 9.0 8.0 72 45.3 0.3 0.1 92 82 41
Guatemala 95 25 12 0.07 26 0.2 0.03 16.5 5.9 1.6 22.9 55 73.8 6.3 1.6 85 78 88 24
Guyana 169 29 19 0.42 79 33.7 0.40 29.2 40.3 5.3 22.3 72 107.8 3.6 0.1 12.2 99 92 98 13
Haiti 480 63 25 0.52 170 1.4 1.04 31.3 9.6 3.0 18.8 49 184.3 23.8 1.4 8.3 51 41 42
Honduras 65 17 9 0.11 31 0.1 0.03 18.7 2.1 3.9 16.1 65 60.7 3.6 0.5 87 85 87 59
Jamaica 80 14 10 0.58 3.2 0.55 16.9 2.4 4.2 15.1 65 25.4 0.6 0.1 11.0 96 92 9
Mexico 33 14 9 23 0.2 0.03 15.6 5.3 5.0 12.8 76 36.7 1.1 0.4 13.9 82 73 86 95
Nicaragua 98 17 10 0.06 43 5.9 0.09 15.3 4.3 5.1 16.9 73 55.7 2.2 0.3 98 99 98
Panama 52 15 9 37 0.4 0.07 10.7 2.9 7.8 13.9 79 25.8 1.9 0.1 6.9 88 97 96 73
Paraguay 84 19 11 0.16 46 0.0 0.42 16.0 6.0 7.0 22.0 69 57.5 1.5 0.2 12.8 86 83 89 61
Peru 88 13 6 0.10 119 3.6 0.06 9.7 2.8 6.8 13.6 77 63.9 1.3 0.4 9.6 88 66 80 76
Saint Kitts and Nevis 15 10 1.5 6.3 96 98
Saint Lucia 117 22 13 3.8 0.22 17.7 7.9 9.6 29.8 68 30.0 0.6 0.1 92 75 46
SaintVincent
Saint Vincent
andand
thethe Grena..
Grenadines 68 15 9 4.2 0.15 20.7 1.0 7.2 7.4 71 47.6 1.3 0.0 97 99 10
Suriname 120 18 11 0.45 29 1.1 0.07 22.7 25.4 7.4 15.3 71 56.7 2.0 0.3 77 58 38
Trinidad and Tobago 67 18 12 0.07 18 0.19 17.1 8.7 6.5 9.3 74 38.6 0.1 0.1 93 92 93 9
United States of America 19 6 4 3.0 0.01 13.6 16.1 10.0 12.7 84 13.3 0.2 0.5 25.1 94 95 92 39
Uruguay 17 7 4 35 0.15 16.5 21.2 6.9 14.8 80 17.5 0.4 0.5 21.8 94 99 95 38
Venezuela
Venezuela (Bolivarian
(Bolivarian Repu..
Republic of) 125 24 15 0.19 45 32.8 0.15 14.8 2.1 3.6 39.0 74 34.6 1.4 0.2 64 13
ᵃ Comparable estimates refer to country values of the same reference year, which may be adjusted or modelled to allow comparisons between countries and are produced for countries with underlying
primary data and, in some cases, for those without. Refer to Annex 2 for the full set of SDG 3 indicators. Shading from blue to orange represents low to high for mortality, incidence and prevalence indicators;
and from high to low for immunization coverage and service index indicators. Each indicator is graphed on an individual scale.
ᵇ per 100 000 live births ᵉ per 100 000 population ʰ betwe en ages 30-69 (%) ᵏ age-standardized, among adults 18+ (%) ⁿ among 15 year-old girls (%)
ᶜ per 1000 live births ᶠ per 1000 population at risk ⁱ litres of pure alcohol per capita ≥15 years ˡ among 1-year-olds (%)
ᵈ per 1000 uninfected population ᵍ among children under 5 years (%) ʲ age-standardized, per 100 00 population ᵐ by the nationally recommended age (%)
Maintaining high quality essential health services during the COVID-19 crisis
and recovery
is to strengthen emergency risk management for seriously constrained without Frontline service 69%
sustainable development. Committed to building a improvement in the quality of health
Children prescribed
better, healthier future in the region, WHO is working care
Health care associated antibiotics for common
Vacancy rate Doctors 19%
Poor-quality health care remains common, especially More is better Frontline service
many dimensions, all of which suffer from severe Injection Medical devices
20 35
data limitations in low- and middle-income countries. 0 11 9
31
A regional fit-for-service dashboard of quality of National Non- National Non- National Non- National Non- 1.33 Outpatient visit/ 57% of indicators are
health care indicators has been developed to address hospital hospital hospital hospital person/year monitored and reported
various dimensions of effective services, and cleaner Basic service Limited service No service
Bangladesh 173 24 19 31
Bhutan 183 10 17 28
India 145 14 22 34
Indonesia 177 9 12 24
Maldives 53 6 5 8
Myanmar 250 14 22 45
Nepal 186 17 20 31
Sri Lanka 36 6 4 7
Thailand 37 6 5 9
Timor-Leste 142 13 20 44
Hepatitis B prevalenceᵍ
Unintentional poisoning
Tuberculosis incidenceᵉ
MCV2 immunizationᵐ
Alcohol consumptionⁱ
New HIV infectionsᵈ
DTP3 immunizationˡ
PCV3 immunizationˡ
Malaria incidenceᶠ
mortality rate..
HPV vaccineⁿ
Member State 2017 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2017 2016 2016 2019 2018 2019 2019 2019 2019
Bangladesh 173 31 19 221 1.2 0.51 18.9 3.7 0.0 15.3 48 149.0 11.9 0.3 39.1 98 95 97
Bhutan 183 28 17 165 <0.1 0.14 18.5 4.6 0.2 16.2 62 124.5 3.9 0.2 97 92 26 73
Democratic People's 89 17 10 513 0.2 0.20 23.9 9.4 4.2 24.2 71 207.2 1.4 1.4 18.8 97 98
Republic of Korea
India 145 34 22 193 4.3 0.16 21.9 12.7 5.6 15.6 55 184.3 18.6 0.3 27.0 91 84 15
Indonesia 177 24 12 312 2.4 1.30 24.8 2.4 0.2 11.3 57 112.4 7.1 0.3 37.9 85 71 3 1
Myanmar 250 45 22 0.19 322 2.3 1.11 24.9 2.9 2.1 20.4 61 156.4 12.6 1.3 45.5 90 80 90
Nepal 186 31 20 0.03 238 0.1 0.16 21.5 9.0 0.6 16.3 48 193.8 19.8 1.7 31.9 93 76 83
Sri Lanka 36 7 4 <0.01 64 0.0 0.34 13.2 14.0 2.9 19.7 66 79.8 1.2 0.4 22.9 99 99 82
Thailand 37 9 5 0.08 150 0.3 0.27 13.7 8.8 8.5 32.2 80 61.5 3.5 0.2 22.8 97 87 66
Timor-Leste 142 44 20 0.15 498 0.0 0.72 19.9 3.7 0.5 11.9 52 139.8 9.9 0.4 38.2 83 80
ᵃ Comparable estimates refer to country values of the same reference year, which may be adjusted or modelled to allow comparisons between countries and are produced for countries with underlying
primary data and, in some cases, for those without. Refer to Annex 2 for the full set of SDG 3 indicators. Shading from blue to orange represents low to high for mortality, incidence and prevalence indicators;
and from high to low for immunization coverage and service index indicators. Each indicator is graphed on an individual scale.
ᵇ per 100 000 live births ᵉ per 100 000 population ʰ betwe en ages 30-69 (%) ᵏ age-standardized, among adults 18+ (%) ⁿ among 15 year-old girls (%)
ᶜ per 1000 live births ᶠ per 1000 population at risk ⁱ litres of pure alcohol per capita ≥15 years ˡ among 1-year-olds (%)
ᵈ per 1000 uninfected population ᵍ among children under 5 years (%) ʲ age-standardized, per 100 00 population ᵐ by the nationally recommended age (%)
How countries are using equity-sensitive data to build back more healthy
and equitable societies
Over the past year, the impacts of COVID-19 have set back the mission of levelling policies aimed at supporting those most negatively impacted. Data disaggregated
up health and closing inequities in health and well-being in countries around as part of the Welsh Index of Multiple Deprivation show that 1.6 times more Welsh
the world. The pandemic has disproportionately impacted already vulnerable residents in the most deprived quintile reported a worsening of their financial
communities and may have widened pre-existing health and socioeconomic situation due to the impacts of COVID-19 compared to those in the least deprived
inequities (Fig. A1.5). These include inequities in physical and mental health, and quintile (Fig. A1.6) (12). The financial impact of COVID-19 has additionally affected
in the essential conditions needed for good health and well-being, such as access gender and age inequities, since women and young people were more likely to
to and quality of health care services, income security and social protection, living work in a sector that was shut down (18% of women compared to 14% of men,
and neighbourhood conditions, opportunities for social and human capital building, and 27% of young people compared to 12% of the general workforce).
and decent employment and working conditions.
Recognizing that these newly emerging inequities compound baseline inequities
In the WHO European Region, collection of data disaggregated by demographic that existed prior to COVID-19, the United Kingdom and Welsh Governments have
and socioeconomic status during the pandemic has made it possible to monitor implemented an extensive support framework to address the loss of income to
and assess its impacts on inequities. Using a four-step approach, policy-makers individuals and businesses. This support has protected more than 500 000 jobs
can use this data to identify and prioritize policies and investments for recovery in Wales through job retention and self-employed schemes, and over 40 000
that mitigate the most pressing equity gaps, both in health and in the essential businesses in Wales through more than £1.4 billion in loans.
conditions needed for good health and well-being. The steps comprise: 1) assessing
the pre-COVID trends or baseline status of inequities between socioeconomic Identifying directly comparable data since the onset of the COVID-19 pandemic
groups, using disaggregated indicators of health and the essential conditions can be a challenge in many countries. In the absence of directly comparable data,
for health; 2) identifying pathways of health, social and economic impact from drawing from different data sources can still provide meaningful comparisons
COVID-19 and its containment measures; 3) mapping these impacts to relevant and crucial insights about the impact of COVID-19 and its containment measures
disaggregated indicators to assess changes in inequities over the period of the on inequities.
pandemic; 4) identifying and prioritizing policy actions that reduce the most severe
impacts on inequities from the assessment. Combining the assessments of baseline status with COVID-19 impacts, this
INSECURITY IN THE 5 ESSENTIAL CONDITIONS IS HARMFUL TO HEALTH
strategy provides quantitative evidence supporting the need for both short-term
For example, equity-sensitive data from Wales prior to and since the COVID-19 emergency income support as well as longer-term wage and social protection
pandemic on income security – one of the essential conditions for health – has policies to close these inequities, to enable all people in society to meet their
allowed monitoring of existing and newly emerging inequities, helping to inform basic needs for a healthy life irrespective of demographic or socioeconomic status.
Insecure and inadequate conditions include:
Inadequate access to Income insecurity and Poor quality, unsafe or Poor quality education, and Job insecurity, poor working
good quality, affordable inadequate social unaffordable housing, fuel, lack of trust, belonging and conditions and long-term
health services protection food, and neighbourhoods political participation unemployment
Fig. A1.5. Socioeconomic inequities that contribute to inequities in health and well-being
These lead to risks to health
Survey respondents who reported being in a worse financial situation as a result of the
coronavirus restrictions, by Welsh Index of Multiple Deprivation fifth, percentage,
Wales, Welsh residents 18+, 15 June to 25 July 2020 (survey weeks 11 – 16)
1 - Most deprived 33.7 The WHO European Health Equity Status Report Initiative
2 25.9
3 24.8
4 24.8
Source: Welsh COVID-19 National Public Engagement Survey, Public Health Wales
Source: Placing health equity at the heart of the COVID-19 sustainable response and recovery: Building prosperous lives for all in Wales (12).
Fig. A1.6. Proportion of Welsh residents (18+) reporting being in a worse financial situation as
a result of COVID-19 restrictions, by Welsh Index of Multiple Deprivation quintiles, 15 June to
25 July 2020
Hepatitis B prevalenceᶠ
DTP3 immunizationᵏ
PCV3 immunizationᵏ
MCV2 immunizationˡ
New HIV infectionsᵈ
mortality rateᵉ
HPV vaccineᵐ
index
rateᵉ
rateⁱ
Member State 2017 2019 2019 2019 2019 2019 2019 2019 2019 2019 2017 2016 2016 2019 2018 2019 2019 2019 2019
Albania 15 10 8 0.03 16 0.29 11.4 4.3 6.8 11.7 59 68.0 0.2 0.3 29.2 99 96 96
Andorra 3 1 7.5 12.3 33.8 99 95 96 64
Armenia 26 12 6 0.05 26 0.06 19.9 3.3 4.7 20.0 69 54.8 0.2 0.7 26.7 92 96 92 7
Austria 5 3 2 6.2 0.16 10.4 14.6 11.9 4.9 79 15.3 0.1 0.2 29.1 85 84
Azerbaijan 26 20 11 0.06 60 0.06 27.2 4.1 1.0 6.7 65 63.9 1.1 0.9 19.6 94 97 95
Belarus 2 3 1 0.20 29 0.29 23.8 21.2 11.0 7.6 76 60.7 0.1 3.3 26.6 98 98
Belgium 5 3 2 8.9 0.09 10.6 18.3 10.8 5.8 84 15.7 0.3 0.4 25.0 98 85 94 67
Bosnia and Herzegovina 10 6 4 27 0.63 18.7 10.9 7.8 13.5 61 79.8 0.1 0.4 38.3 73 76
Bulgaria 10 7 3 0.04 21 0.09 24.2 9.7 12.5 9.2 66 61.8 0.1 0.5 38.9 92 87 88 4
Croatia 8 5 3 0.02 8.0 0.12 16.1 16.4 8.7 7.9 71 35.5 0.1 0.4 36.6 94 95
Cyprus 6 2 1 5.3 0.34 8.2 3.6 10.8 5.8 78 20.1 0.3 0.3 36.7 96 88 81 64
Czechia 3 3 2 4.9 0.13 14.3 12.2 14.3 5.9 76 29.6 0.2 0.4 31.5 97 84
Denmark 4 4 3 5.0 0.68 10.8 10.7 10.1 3.7 81 13.2 0.3 0.1 18.6 97 90 97 62
Estonia 9 2 1 13 0.29 14.9 14.9 10.8 4.5 75 25.0 <0.1 0.6 30.5 91 90 45
Finland 3 2 1 4.7 0.81 9.6 15.3 10.7 3.9 78 7.2 <0.1 0.4 19.7 91 93 89 60
France 8 4 3 8.7 0.15 10.6 13.8 12.2 5.1 78 9.7 0.3 0.3 34.6 96 83 92 24
Georgia 25 10 5 74 0.06 24.9 9.2 9.5 12.4 66 101.8 0.2 0.6 29.7 94 97 84 11
Germany 7 4 2 5.8 0.21 12.1 12.3 12.8 3.8 83 16.0 0.6 0.3 28.0 93 93 84 43
Greece 3 4 2 4.3 0.14 12.5 5.1 10.5 8.3 75 27.6 <0.1 0.2 39.1 99 83 96
Hungary 12 4 2 6.3 0.90 22.1 16.6 11.1 7.7 74 38.8 0.2 0.5 30.6 99 99 99 78
Iceland 4 2 1 4.4 0.15 8.7 11.9 9.2 2.0 84 8.7 0.1 1.0 13.8 91 95 90 93
Ireland 5 3 2 5.8 0.04 9.7 9.6 12.7 3.1 76 11.9 0.1 0.3 23.6 94 86 69
Israel 3 4 2 2.9 0.05 8.8 5.3 4.4 3.9 82 15.4 0.2 0.0 25.5 98 96 95 52
Italy 2 3 2 0.04 7.1 0.33 9.0 6.7 8.0 5.3 82 15.0 0.1 0.3 23.4 95 88 92 40
Kazakhstan 10 10 5 0.20 68 0.15 22.4 17.6 5.0 12.7 76 62.7 0.4 1.9 24.4 97 98 89
Kyrgyzstan 60 18 12 0.14 110 0.15 20.3 7.4 4.9 12.7 70 110.7 0.8 0.9 27.9 95 98 96
Latvia 19 4 2 0.19 26 0.27 21.6 20.1 13.2 8.1 71 41.3 <0.1 1.2 36.7 99 96 84 54
Lithuania 8 4 2 0.09 42 0.05 19.3 26.1 12.8 8.1 73 34.0 0.1 1.7 27.1 92 93 79 66
Luxembourg 5 3 1 9.0 0.06 9.7 11.3 12.4 4.1 83 11.6 <0.1 0.2 21.7 99 90 96 14
Malta 6 7 5 14 0.20 10.5 6.1 8.3 4.1 82 20.2 <0.1 0.1 25.1 98 95 81
Monaco 3 2 0.0 99 79
Montenegro 6 2 1 0.05 15 0.67 22.3 21.0 12.2 7.6 68 78.6 <0.1 0.6 86 86
Netherlands 5 4 3 0.02 5.0 0.08 10.3 11.8 9.7 4.0 86 13.7 0.2 0.1 23.4 94 90 93 53
North Macedonia 7 6 4 12 22.7 9.4 6.4 5.1 72 82.2 0.1 0.5 92 94 40
Norway 2 2 1 3.3 0.02 8.7 11.8 7.1 2.1 87 8.6 0.2 0.3 18.4 97 95 95 91
Poland 2 4 3 15 0.01 17.0 11.3 11.9 9.4 75 37.9 0.1 0.5 26.0 95 92 60
Portugal 8 4 2 19 0.02 11.0 11.5 12.1 8.2 82 9.8 0.2 0.3 27.9 99 96 98 81
Republic of Moldova 19 14 11 0.23 80 0.20 24.1 14.7 12.9 7.3 69 78.3 0.1 5.5 25.3 91 95 80 31
Romania 19 7 3 0.04 66 0.29 21.0 9.7 12.3 10.3 74 59.3 0.4 1.9 25.5 88 76 88
Russian Federation 17 6 3 50 0.55 24.2 25.1 10.5 12.0 75 49.4 0.1 3.8 28.3 97 97 85
San Marino 2 1 0.0 88 79 76 50
Serbia 12 5 3 0.02 14 0.04 22.0 11.4 8.9 7.5 65 62.5 0.7 0.3 40.6 97 91 93
Slovakia 5 6 3 4.5 0.31 15.5 12.1 11.1 6.1 77 33.5 <0.1 0.5 32.3 97 98 96
Slovenia 7 2 1 5.4 1.12 11.4 19.8 12.1 5.1 79 22.6 <0.1 0.2 22.7 95 94 65 59
Spain 4 3 2 0.06 9.3 0.13 9.6 7.7 12.7 3.9 83 9.9 0.2 0.4 27.9 96 94 95 79
Sweden 4 3 1 5.5 0.13 8.4 14.7 9.0 3.1 86 7.2 0.2 0.2 28.8 98 95 97 80
Switzerland 5 4 3 0.03 5.4 0.16 7.9 14.5 11.2 2.2 83 10.1 0.1 0.2 25.1 96 90 84 59
Tajikistan 17 34 15 0.17 83 0.18 28.3 4.3 0.9 15.7 68 129.3 2.7 0.4 97 97
Turkey 17 10 5 16 0.11 15.6 2.4 1.8 6.7 74 46.6 0.3 0.4 29.3 99 88 97
Turkmenistan 7 42 24 45 0.07 27.7 5.7 3.1 13.5 70 79.3 4.0 0.6 99 99 99
Ukraine 19 8 5 0.28 77 0.25 25.5 21.6 8.3 10.2 68 70.7 0.3 2.5 25.5 80 92
United Kingdom 7 4 3 8.0 0.41 10.3 7.9 11.4 3.2 87 13.8 0.2 0.3 19.2 93 87 91 82
Uzbekistan 29 17 10 0.13 67 0.16 25.3 8.0 2.6 11.7 73 81.1 0.4 0.8 12.3 96 99 99
ᵃ Comparable estimates refer to country values of the same reference year, which may be adjusted or modelled to allow comparisons between countries and are produced for countries with underlying
primary data and, in some cases, for those without. Malaria incidence is not included in the this graph because all countries in this region are certified malaria free, or considered to have eliminated malaria.
Refer to Annex 2 for the full set of SDG 3 indicators. Shading from blue to orange represents low to high for mortality, incidence and prevalence indicators; and from high to low for immunization coverage and
service index indicators. Each indicator is graphed on an individual scale.
ᵇ per 100 000 l ive births ᵉ per 100 000 population ʰ litres of pure alcohol per capita ≥15 years ᵏ among 1-year-olds (%)
ᶜ per 1000 live births ᶠ among children under 5 years (%) ⁱ age-standardized, per 100 000 population ˡ by the nationally recommended age (%)
ᵈ per 1000 uninfected population ᵍ between ages 30-69 (%) ʲ age-standardized, among adults 18+ (%) ᵐ among 15 year-old girls (%)
The Lebanese Republic began interventions to improve civil registration and of all causes of death to be done in individual hospitals in addition to using the
vital statistics (CRVS) systems in the 1990s, with several initiatives involving the Analysing mortality levels and causes-of-death (ANACoD) tool for assessment
Ministry of Interior and Municipalities (the authority mandated by law to issue death of data quality and automatic coding and IRIS to facilitate accurate selection of
certificates) and the Ministry of Public Health (MoPH). WHO has been supporting underlying cause of death.
the MoPH to enhance its CRVS system to generate timely and reliable data on
birth and deaths, including causes of death. This is important because 15 out of 17 In 2019, the number of recorded deaths was 18 544, of which 70% were due
SDG targets require vital registration data for measurement of indicators. Current to noncommunicable diseases, 14% to communicable, maternal, perinatal and
efforts are also focusing on supporting statistical capacity-building in line with the nutritional conditions, 6% to external causes of injury and 10% to ill-defined
WHO Thirteenth General Programme of Work (GPW 13) goal of better supporting conditions (Fig A1.7) (13).
countries to strengthen information systems for health at all levels and the use of
data for evidence-based decision-making. The death registration system that the MoPH is implementing covers more than
80% of registered deaths according to national sources (13). Efforts are being made
A first review of death certificates took place in 1999 as part of the Burden to address the remaining gaps and increase reporting to include the remaining
of disease study and preparatory work for health sector reforms. The review 20%, believed to have occurred outside health facilities. In collaboration with
showed: most death certificates were incomplete in some way (e.g. address, the Order of Physicians, a doctor in each district will be contracted to notify the
year of birth and/or underlying cause of death); cardiac arrest was the immediate underlying cause of death on all deaths occurring outside health facilities.
cause of death in the majority of cases; and reporting forms were not unified.
Lebanon conducted a CRVS assessment in 2013, and its recommendations led To improve quality of cause of death data, ongoing training workshops have also
to implementation of activities aimed at building national capacities in adaptation been conducted for doctors from all hospitals in collaboration with WHO and the
and use of global standardized death certificate, training of physicians and medical Order of Physicians.
staff in identifying and reporting cause of death, as well as using electronic
approaches to automating death registration, selecting the underlying cause of During the COVID-19 pandemic, investments in the cause of death registration
death and improving data quality. system were highly effective and timely in facilitating and supporting the
surveillance system for COVID-19-related deaths. The system contributes to better
Building on those previous efforts, recent initiatives included development of a understanding and monitoring of the pandemic situation in Lebanon.
national hospital mortality system (HMS) in 2016 covering 150 hospitals (more than
90% of functioning hospitals). This consists of death notification and registration Collaborative initiatives between MoPH and WHO for system improvement are
of basic demographic information for deaths that occur among nationals and aimed at scaling up system coverage, reporting of non-national mortality rates
non-nationals in hospital settings. Such reports are submitted, compiled, cleaned by age and cause of death, responding to data needs for monitoring of epidemic
and utilized at the central MoPH level. diseases through integration with surveillance systems and regular data updates,
in addition to data quality improvement and feedback at the national, regional and
After almost 17 years of incomplete reporting of cause of death data – with global levels. The country is planning a phased implementation of the International
the last report published in 2000 without reliable medically certified causes of classification of diseases (ICD-11) as part of a broad agenda to enhance the
death – Lebanon produced cause of death data from 2017–2019, disaggregated functionality of the national health information system in line with latest standards
by age and sex. One of the major related achievements was the development and guidelines.
of an electronic death registration system through a collaboration between the
MoPH and hospitals. The comprehensive and decentralized system allows coding
75+
55–74
35–54
25–34
Age group
15–24
5–14
1–4
<1
0 10 20 30 40 50 60 70 80 90 100
Percent of total
Source: Based on data reported by the Ministry of Public Health Lebanon to the WHO mortality database (13).
Hepatitis B prevalenceᵍ
Unintentional poisoning
Tuberculosis incidenceᵉ
MCV2 immunizationᵐ
Alcohol consumptionⁱ
New HIV infectionsᵈ
DTP3 immunizationˡ
PCV3 immunizationˡ
Malaria incidenceᶠ
mortality rate..
HPV vaccineⁿ
Member State 2017 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2017 2016 2016 2019 2018 2019 2019 2019 2019
Afghanistan 638 60 36 0.04 189 14.5 0.39 35.3 4.1 <0.1 15.9 37 211.1 13.9 1.0 66 39 65
Bahrain 14 7 3 12 0.03 16.1 8.9 1.1 5.2 77 40.1 <0.1 0.3 25.1 99 99 97
Djibouti 248 57 31 0.14 234 67.7 0.26 22.0 9.6 0.4 23.5 47 159.0 31.3 2.5 85 81 85
Egypt 37 20 11 0.05 12 0.0 0.20 28.0 3.0 0.1 10.1 68 108.9 2.0 0.2 21.4 95 94
Iran (Islamic Republic of) 16 14 9 0.05 13 0.0 0.05 14.8 5.2 1.0 21.5 72 50.9 1.0 1.0 14.0 99 98
Iraq 79 26 15 41 0.0 0.29 23.5 3.6 0.4 27.3 61 75.1 3.0 0.2 22.2 84 86 37
Jordan 46 16 9 5.5 0.56 15.3 1.6 0.5 17.0 76 51.2 0.6 0.5 89 96
Kuwait 12 8 5 22 0.03 11.9 2.9 0.0 15.4 76 103.8 <0.1 0.4 22.1 91 94 91
Lebanon 29 7 4 0.03 13 0.07 19.9 2.8 1.5 16.4 73 51.4 0.8 0.6 42.6 83 63 82
Libya 72 12 6 0.07 59 0.43 18.6 4.5 <0.1 21.3 64 71.9 0.6 0.8 73 72 73
Morocco 70 21 14 0.02 97 0.0 0.16 24.1 7.2 0.5 17.0 70 49.1 1.9 0.7 14.7 99 99 98
Oman 19 11 5 0.04 8.5 0.0 0.13 21.5 4.9 0.9 10.6 69 53.9 <0.1 0.9 9.6 99 99 99
Pakistan 140 67 41 0.12 263 3.3 0.91 29.4 8.9 0.3 13.0 45 173.6 19.6 1.6 20.0 75 71 75
Qatar 9 7 3 35 0.05 10.7 5.8 1.5 7.3 68 47.4 <0.1 0.3 14.0 98 95 98
Saudi Arabia 17 7 4 9.9 <0.1 0.00 20.9 6.0 0.0 35.9 74 83.7 0.1 0.8 16.6 96 96 96
Somalia 829 117 37 0.03 258 49.1 6.32 30.4 7.9 0.0 27.4 25 212.8 86.6 4.9 42
Sudan 295 58 27 0.08 67 55.4 1.66 22.8 3.8 26.8 44 184.9 17.3 1.7 93 74 93
Syrian Arab Republic 31 22 11 <0.01 19 0.0 0.69 22.1 1.9 0.2 14.9 60 75.2 3.7 0.6 54 54
Tunisia 43 17 12 0.05 35 0.12 15.7 3.3 2.0 16.5 70 56.1 1.0 0.7 26.0 92 93
United Arab Emirates 3 7 4 1.0 0.0 0.02 18.5 6.4 3.8 8.9 76 54.7 <0.1 0.4 18.2 99 99 99 27
Yemen 164 58 27 0.04 48 46.4 1.76 27.6 5.8 <0.1 29.4 42 194.2 10.2 1.8 20.9 73 46 72
ᵃ Comparable estimates refer to country values of the same reference year, which may be adjusted or modelled to allow comparisons between countries and are produced for countries with underlying
primary data and, in some cases, for those without. Refer to Annex 2 for the full set of SDG 3 indicators. Shading from blue to orange represents low to high for mortality, incidence and prevalence indicators;
and from high to low for immunization coverage and service index indicators. Each indicator is graphed on an individual scale.
ᵇ per 100 000 live births ᵉ per 100 000 population ʰ betwe en ages 30-69 (%) ᵏ age-standardized, among adults 18+ (%) ⁿ among 15 year-old girls (%)
ᶜ per 1000 live births ᶠ per 1000 population at risk ⁱ litres of pure alcohol per capita ≥15 years ˡ among 1-year-olds (%)
ᵈ per 1000 uninfected population ᵍ among children under 5 years (%) ʲ age-standardized, per 100 00 population ᵐ by the nationally recommended age (%)
The Western Pacific Region vision for managing future health challenges is laid its fourth meeting in August 2020, recommended that WHO should accelerate its
out in For the Future: towards the healthiest and safest region. Grounded in support to countries on data collection, reporting and analysis. This should also
an operational shift towards driving and measuring country impact, the vision include equity-focused analysis of disaggregated data to support monitoring and
contextualizes the SDGs and GPW 13 to the Western Pacific Region. Over the past policy decision-making on regional UHC enhancements for reaching the unreached.
few decades, Member States have made significant investments in improving their
strategic health information systems, reorienting them progressively from simply Currently, WPRO has combined data from multiple COVID-19 surveillance sources
measuring inputs and processes to documenting results. The ongoing challenge for rapid and concrete COVID-19 responses. A multi-source COVID-19 dashboard
remains that systems lack cohesive measurement frameworks and struggle with has been developed for a broader set of users for aiding COVID-19 responses in
maximizing data use for strategic dialogue and decision-making. countries (Fig. A1.8). Meanwhile, a comprehensive data analysis approach has
also been adopted in health-related SDG monitoring in the region. The ongoing
The complexities of the COVID-19 pandemic have highlighted the pre-existing regional country-focused SDG analysis is integrating health information from
demands for new data analytic approaches. Flexible measurement frameworks multiple sources with estimates generated within countries, as well as at the global
that can efficiently generate and integrate data across sources and sectors are or regional levels, to strategically link different health areas and programmes in
needed to accurately measure population impact and to inform the pursuit of a cohesive measurement framework and to draw a systematic picture of country
national goals. The Universal Health Coverage Technical Advisory Group, during progress for policy decision-making.
Fig. A1.8. Multi-source COVID-19 surveillance dashboard for Western Pacific Region
Hepatitis B prevalenceᵍ
Unintentional poisoning
Tuberculosis incidenceᵉ
MCV2 immunizationᵐ
Alcohol consumptionⁱ
New HIV infectionsᵈ
DTP3 immunizationˡ
PCV3 immunizationˡ
Malaria incidenceᶠ
mortality rate..
HPV vaccineⁿ
Member State 2017 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2017 2016 2016 2019 2018 2019 2019 2019 2019
Australia 6 4 2 0.03 6.9 0.13 8.6 12.5 10.4 4.9 87 8.4 0.1 0.1 16.2 95 94 96 79
Brunei Darussalam 31 11 6 64 0.10 18.5 2.7 0.5 7.5 81 13.3 <0.1 0.0 15.5 99 98 90
Cambodia 160 27 14 0.05 287 12.0 0.19 22.5 4.9 7.8 19.6 60 149.8 6.5 0.5 21.8 92 82 89
China 29 8 4 58 0.0 0.22 15.9 8.1 6.0 17.4 79 112.7 0.6 1.8 24.7 99 98
Fiji 34 26 11 0.14 66 0.13 37.7 9.0 3.7 13.5 64 99.0 2.9 0.3 26.7 99 94 99 56
Japan 5 2 1 13 0.96 8.3 15.3 10.1 3.6 83 11.9 0.2 0.2 21.9 98 93 97 0
Kiribati 92 51 22 436 1.57 50.8 28.3 2.3 1.9 41 140.2 16.7 2.6 52.0 97 91 97
Lao People's Democratic 185 46 22 0.11 155 2.8 0.68 26.8 5.4 12.1 17.9 51 188.5 11.3 0.6 37.8 68 57 56
Lao People’s Democratic Republic
Republic
Malaysia 29 9 5 0.20 92 0.0 0.06 18.4 5.7 0.9 22.5 73 47.4 0.4 0.7 21.8 98 87 85
New Zealand 9 5 3 0.03 7.5 0.77 10.3 11.0 10.7 9.6 87 7.2 0.1 0.2 14.8 92 90 91 67
Palau 17 9 38 23.7 97 88 74 67
Papua New Guinea 145 45 22 0.38 432 156.4 1.36 36.0 2.9 2.1 12.6 40 152.0 16.3 1.4 35 20 35
Philippines 121 27 13 0.14 554 0.7 0.38 24.5 2.2 7.0 12.0 61 185.2 4.2 0.2 24.3 65 40 43 0
Republic of Korea 11 3 2 59 0.1 0.09 7.3 28.6 8.5 8.6 86 20.5 1.8 0.2 22.0 98 96 98 52
Samoa 43 15 8 11 0.34 31.2 12.6 2.8 13.0 58 85.0 1.5 0.4 28.9 58 44
Singapore 8 3 1 0.03 41 0.13 9.5 11.2 2.0 2.1 86 25.9 0.1 0.0 16.5 96 84 82 0
Solomon Islands 104 20 8 66 247.9 0.87 39.2 14.7 1.7 16.5 47 137.0 6.2 2.3 37.9 94 54 94
Tonga 52 17 7 11 0.89 24.8 3.8 0.4 33.0 58 73.3 1.4 1.1 30.2 99 99
Vanuatu 72 26 11 41 3.5 2.25 39.7 18.0 2.1 14.9 48 135.6 10.4 0.7 24.1 90
Viet Nam 43 20 10 0.05 176 0.1 0.64 21.2 7.5 7.9 30.6 75 64.5 1.6 0.9 89 92
ᵃ Comparable estimates refer to country values of the same reference year, which may be adjusted or modelled to allow comparisons between countries and are produced for countries with underlying
primary data and, in some cases, for those without. Refer to Annex 2 for the full set of SDG 3 indicators. Shading from blue to orange represents low to high for mortality, incidence and prevalence indicators;
and from high to low for immunization coverage and service index indicators. Each indicator is graphed on an individual scale.
ᵇ per 100 000 live births ᵉ per 100 000 population ʰ betwe en ages 30-69 (%) ᵏ age-standardized, among adults 18+ (%) ⁿ among 15 year-old girls (%)
ᶜ per 1000 live births ᶠ per 1000 population at risk ⁱ litres of pure alcohol per capita ≥15 years ˡ among 1-year-olds (%) ..
ᵈ per 1000 uninfected population ᵍ among children under 5 years (%) ʲ age-standardized, per 100 00 population
2. Karamagi HC, Tumusiime P, Titi-Ofei R, Droti B, Kipruto H, Nabyonga-Orem J et al. Towards universal health coverage in
the WHO African Region: assessing health system functionality, incorporating lessons from COVID-19. BMJ Global Health.
2021;6:e004618. doi:10.1136/bmjgh-2020-004618.
3. Primary health care on the road to universal health coverage: 2019 Monitoring report. Geneva: World Health Organization;
2019 (https://www.who.int/healthinfo/universal_health_coverage/report/2019/en/, accessed 30 April 2021).
4. Global tuberculosis report 2020. Geneva: World Health Organization; 2020 (https://www.who.int/teams/global-tuberculosis-
programme/tb-reports/global-tuberculosis-report-2020, accessed 30 April 2021).
5. Health in the Americas+, 2017 Edition. Summary: Regional outlook and country profiles. Washington DC: Pan American
Health Organization; 2017 (https://iris.paho.org/handle/10665.2/34321, accessed 30 April 2021).
6. Gross domestic product per capita 2000–2019 estimates. Seattle: Institute for Health Metrics and Evaluation; 2020 (http://
ghdx.healthdata.org/, accessed 30 April 2021).
7. World population prospects 2019. New York: United Nations Department of Economic and Social Affairs; 2019 (https://
population.un.org/wpp/, accessed 30 April 2021).
8. Monitoring progress on universal health coverage and the health-related Sustainable Development Goals in the WHO South-
East Asia Region: 2020 update. New Delhi: World Health Organization Regional Office for South-East Asia; 2020 (https://apps.
who.int/iris/handle/10665/334213, accessed 30 April 2021).
9. Maternal mortality: Levels and trends 2000 to 2017. Geneva: World Health Organization; 2019 (https://www.who.int/
reproductivehealth/publications/maternal-mortality-2000-2017/en/, accessed 30 April 2021)
10. Maternal, Newborn, Child and Adolescent Health and Ageing data portal [online database]. Geneva: World Health
Organization; 2021 (https://www.who.int/data/mncah, accessed 30 April 2021).
11. Levels and trends in child mortality 2019. New York: United Nations Children’s Fund/United Nations Inter-agency Group for
Child Mortality Estimation; 2019 (https://www.unicef.org/reports/levels-and-trends-child-mortality-report-2019, accessed 30
April 2021).
12. Placing health equity at the heart of the COVID-19 sustainable response and recovery: Building prosperous lives for all
in Wales. Cardiff: Welsh Health Equity Status Report initiative (WHESRi)/ Public Health Wales NHS Trust; 2021 (https://
phwwhocc.co.uk/resources/welsh-health-equity-status-report-whesri/, accessed 30 April 2021).
13. Based on data reported by Ministry of Public Health Lebanon to the WHO mortality database as of 20 March 2021 (https://
www.who.int/data/data-collection-tools/who-mortality-database, accessed 30 April 2021).
14. COVID-19 Situation in WHO - Western Pacific Region [online database]. Manila: World Health Organization Regional Office for
the Western Pacific; 2021 (https://experience.arcgis.com/experience/e1a2a65fe0ef4b5ea621b232c23618d5; accessed 30 April
2021).
15. For the future: towards the healthiest and safest Region: a vision for the WHO work with Member States and partners in the
Western Pacific. Manila: WHO regional office for the Western Pacific; 2020 (https://iris.wpro.who.int/handle/10665.1/14476,
accessed April 30 2021).
Explanatory notes
The statistics shown below represent official (WHO) statistics for selected health-related Sustainable Development
Goal (SDG) indicators and selected Thirteenth General Programme of Work (GPW 13) indicators, based on evidence
available in early 2021. In addition, summary measures of health, such as (healthy) life expectancy and total
population, are included to provide a general indication of the current situation.
These statistics have been compiled primarily from publications and databases produced and maintained by WHO,
or United Nations (UN) groups of which WHO is a member. Some statistics have been derived from data produced
and maintained by other international organizations and in each instance the source of the data series is provided.
The type of data used for each data series (comparable estimate or primary data) is also provided (1). Comparable
estimates are subject to considerable uncertainty, especially for countries where the availability and quality of
the underlying primary data are limited. Uncertainty intervals and other details on the indicators and statistics
presented here can be found at the WHO Global Health Observatory.1
Although every effort has been made to maximize the comparability of statistics across countries and over time,
data series based on primary data may differ in terms of the definitions, data collection methods, population
coverage and estimation methods used. For indicators with a reference period expressed as a range, country
values refer to the latest available year in the range unless otherwise noted; the accompanying footnotes provide
more details. In some cases, as SDG indicator definitions are being refined and baseline data are being collected,
proxy indicators have been presented in this annex; where this is the case, proxy indicators have been clearly
indicated as such through accompanying footnotes.
Unless otherwise stated, the WHO regional and global aggregates for rates and ratios are presented as weighted
averages when relevant, whereas for absolute numbers they are the sums. Aggregates are shown only if data are
available for at least 50% of the population (or other denominator) within an indicated group. For indicators with
a reference period expressed as a range, aggregates are for the reference period shown in the corresponding
table column heading above the WHO regional values. Some WHO regional and global aggregates may include
country estimates that are not individually reported.
Changes in the values shown for indicators reported in previous editions of the World Health Statistics Series
should not be assumed to accurately reflect underlying trends. This applies to all data types (comparable estimates
and primary data) and all reporting levels (country, regional and global). The data presented here may also differ
from, and should not be regarded as, the official national statistics of individual WHO Member States.
Reference
1. World Health Statistics 2018: Monitoring health for the SDGs. Geneva: World Health Organization; 2018 (https://www.who.int/
gho/publications/world_health_statistics/2018/en/, accessed 1 May 2021).
1
The Global Health Observatory (GHO) is a WHO online portal that provides access to data and analyses for monitoring the global health situation (available at https://www.who.int/gho/en/).
ANNEX 2
Part 1 Maternal
PA R T 1
mortality
ratiod (per
100 000 live
Total populationa (000s) Life expectancy at birthb,c (years) Healthy life expectancy at birthb,c (years) births)
Data type Comparable estimates Comparable estimates Comparable estimates Comparable
estimates
Male Female Both sexes Male Female Both sexes Male Female Both sexes
Member State 2019 2019 2019 2017
Afghanistan 19 530 18 512 38 042 63.3 63.2 63.2 54.7 53.2 53.9 638
Albania 1 467 1 414 2 881 76.3 79.9 78.0 68.0 70.3 69.1 15
Algeria 21 750 21 303 43 053 76.2 78.1 77.1 66.7 66.1 66.4 112
Andorra – – 77 – – – – – – –
Angola 15 745 16 081 31 825 60.7 65.5 63.1 53.6 56.2 54.8 241
Antigua and Barbuda 47 50 97 74.9 78.0 76.5 66.2 67.7 67.0 42
Argentina 21 841 22 939 44 781 73.5 79.5 76.6 65.4 68.8 67.1 39
Armenia 1 391 1 566 2 958 72.5 79.2 76.0 64.9 69.1 67.1 26
Australia 12 551 12 652 25 203 81.3 84.8 83.0 70.2 71.7 70.9 6
Austria 4 409 4 546 8 955 79.4 83.8 81.6 69.9 71.9 70.9 5
Azerbaijan 5 016 5 032 10 048 68.8 74.1 71.4 62.1 65.2 63.6 26
Bahamas 189 200 389 69.9 76.6 73.2 62.3 66.5 64.4 70
Bahrain 1 055 586 1 641 75.0 77.0 75.8 66.0 65.5 65.9 14
Bangladesh 82 474 80 572 163 046 73.0 75.6 74.3 64.2 64.4 64.3 173
Barbados 139 148 287 74.3 77.7 76.0 66.2 67.7 67.0 27
Belarus 4 400 5 052 9 452 69.7 79.6 74.8 62.3 69.4 66.0 2
Belgium 5 711 5 828 11 539 79.3 83.5 81.4 69.8 71.3 70.6 5
Belize 194 196 390 71.4 77.8 74.4 63.5 67.3 65.3 36
Benin 5 891 5 910 11 801 61.2 65.7 63.4 54.5 56.6 55.5 397
Bhutan 405 358 763 72.0 74.4 73.1 63.2 63.5 63.4 183
Bolivia (Plurinational State of) 5 780 5 733 11 513 71.1 73.1 72.1 63.2 63.3 63.3 155
Bosnia and Herzegovina 1 617 1 684 3 301 74.4 79.1 76.8 65.7 68.7 67.2 10
Botswana 1 114 1 190 2 304 58.9 65.5 62.2 51.9 55.8 53.9 144
Brazil 103 733 107 316 211 050 72.4 79.4 75.9 63.4 67.4 65.4 60
Brunei Darussalam 225 208 433 73.4 75.4 74.3 65.2 66.1 65.6 31
Bulgaria 3 400 3 600 7 000 71.6 78.6 75.1 63.9 68.7 66.3 10
Burkina Faso 10 148 10 174 20 321 60.1 65.2 62.7 53.4 56.3 54.9 320
Burundi 5 719 5 812 11 531 61.5 66.1 63.8 54.0 57.2 55.6 548
Cabo Verde 276 274 550 69.9 77.9 74.0 62.2 67.2 64.8 58
Cambodia 8 047 8 439 16 487 67.2 72.7 70.1 59.8 63.0 61.5 160
Cameroon 12 940 12 936 25 876 60.3 64.5 62.4 53.5 55.6 54.5 529
Canada 18 564 18 848 37 411 80.4 84.1 82.2 70.5 72.0 71.3 10
Central African Republic 2 352 2 393 4 745 50.2 56.3 53.1 44.5 48.4 46.4 829
Chad 7 961 7 986 15 947 58.0 61.3 59.6 51.3 52.8 52.0 1140
Chile 9 342 9 610 18 952 78.1 83.2 80.7 69.0 71.1 70.0 13
China 739 350 702 510 1 441 860 74.7 80.5 77.4 67.2 70.0 68.5 29
Colombia 24 713 25 626 50 339 76.7 81.9 79.3 67.4 70.5 69.0 83
Comoros 429 422 851 65.9 68.9 67.4 58.3 59.6 58.9 273
Congo 2 687 2 693 5 381 63.8 65.6 64.7 56.4 56.1 56.2 378
Cook Islands – – 18 – – – – – – –
Costa Rica 2 523 2 525 5 048 78.3 83.4 80.8 68.6 71.3 70.0 27
Côte d'Ivoire 12 974 12 742 25 717 60.5 65.8 62.9 53.4 56.5 54.8 617
Croatia 1 990 2 140 4 130 75.5 81.6 78.6 66.7 70.5 68.6 8
Cuba 5 628 5 706 11 333 75.4 80.3 77.8 66.6 69.2 67.8 36
Cyprus 599 599 1 199 81.1 85.1 83.1 71.8 73.0 72.4 6
Czechia 5 261 5 429 10 689 76.3 81.9 79.1 67.0 70.6 68.8 3
Democratic People's Republic of Korea 12 553 13 113 25 666 69.3 75.7 72.6 63.3 66.6 65.0 89
Democratic Republic of the Congo 43 319 43 471 86 791 60.0 64.8 62.4 52.8 55.4 54.1 473
Denmark 2 870 2 902 5 772 79.6 83.0 81.3 70.7 71.4 71.0 4
Djibouti 512 462 974 64.1 67.8 65.8 57.2 58.9 58.0 248
Dominica – – 72 – – – – – – –
Dominican Republic 5 366 5 373 10 739 69.8 76.2 72.8 62.1 66.1 64.0 95
Ecuador 8 690 8 683 17 374 76.4 80.5 78.4 67.7 69.3 68.5 59
Egypt 50 723 49 665 100 388 69.6 74.1 71.8 62.3 63.7 63.0 37
El Salvador 3 023 3 430 6 454 70.6 79.1 75.0 61.6 67.8 64.9 46
PA R T 1
of births Under-five Neonatal infectionsg Tuberculosis incidencei prevalence of people
attended by mortality ratef mortality ratef (per 1000 incidenceh (per 1000 among requiring
skilled health (per 1000 live (per 1000 live uninfected (per 100 000 population at children under interventions
personnele (%) births) births) population) population) risk) 5 yearsj (%) against NTDsk
Primary data Comparable Comparable Comparable Comparable Comparable Comparable Primary data
estimates estimates estimates estimates estimates estimates
2011–2020 2019 2019 2019 2019 2018 2019 2019 Member State
59 60 36 0.04 189 14.5 0.39 16 222 053 Afghanistan
100 10 8 0.03 16 – 0.29 0 Albania
99 23 16 0.05 61 0.0 0.08 10 339 Algeria
100 ai 3 1 – 7.5 – – 0 Andorra
50 75 28 0.84 351 235.2 4.57 15 362 008 Angola
100 ai 7 4 – 0.0 – 0.19 1 223 Antigua and Barbuda
100 9 6 0.13 29 0.0 0.01 160 777 Argentina
100 ai 12 6 0.05 26 0.0 0.06 17 Armenia
97 aj 4 2 0.03 6.9 – 0.13 13 700 Australia
98 aj 3 2 – 6.2 – 0.16 29 Austria
99 ai 20 11 0.06 60 0.0 0.06 686 000 Azerbaijan
99 ai 13 7 – 15 – 0.16 27 Bahamas
100 ai 7 3 – 12 – 0.03 5 Bahrain
59 31 19 – 221 1.2 0.51 56 339 394 Bangladesh
99 ai 13 8 0.18 0.0 – 0.18 44 Barbados
100 3 1 0.20 29 – 0.29 0 Belarus
– 3 2 – 8.9 – 0.09 22 Belgium
94 ai 12 8 – 27 0.0 0.60 13 317 Belize
78 90 31 0.31 55 406.7 2.87 6 070 676 Benin
96 ai 28 17 – 165 <0.1 0.14 229 846 Bhutan
81 ai 26 15 0.08 106 2.4 0.14 190 910 Bolivia (Plurinational State of)
100 6 4 – 27 – 0.63 0 Bosnia and Herzegovina
100 aj 42 18 4.78 253 0.2 0.18 238 203 Botswana
99 aj 14 8 0.23 46 4.2 0.03 9 560 959 Brazil
100 ai 11 6 – 64 – 0.10 0 Brunei Darussalam
100 7 3 0.04 21 – 0.09 193 Bulgaria
80 88 26 0.14 47 386.7 1.66 3 652 080 Burkina Faso
85 56 21 0.17 107 296.0 1.35 3 418 124 Burundi
97 ai 15 9 0.19 46 0.0 0.26 137 073 Cabo Verde
89 ai 27 14 0.05 287 12.0 0.19 5 068 956 Cambodia
69 ai 75 26 0.69 179 243.1 1.75 16 891 418 Cameroon
98 aj 5 3 – 5.5 – 0.34 0 Canada
40 ai 110 40 1.10 540 345.0 3.75 4 442 825 Central African Republic
24 ai 114 33 0.34 142 202.1 10.79 6 270 047 Chad
100 7 5 0.27 18 – 0.03 33 Chile
100 ai 8 4 – 58 0.0 0.22 22 841 China
99 14 7 0.25 35 10.7 0.15 3 186 736 Colombia
82 63 30 <0.01 35 20.7 1.16 788 813 Comoros
91 48 19 1.55 373 230.8 2.56 1 407 153 Congo
– 8 4 – 13 – – 0 Cook Islands
99 9 6 0.19 10 0.1 0.02 10 011 Costa Rica
74 – – 0.51 137 300.6 – 21 713 670 Côte d'Ivoire
100 5 3 0.02 8.0 – 0.12 1 Croatia
100 5 2 0.14 6.5 – 0.03 3 445 Cuba
99 aj 2 1 – 5.3 – 0.34 0 Cyprus
100 aj 3 2 – 4.9 – 0.13 0 Czechia
100 17 10 – 513 0.2 0.20 5 418 928 Democratic People's Republic of Korea
85 85 27 0.22 320 325.8 3.28 53 320 501 Democratic Republic of the Congo
95 aj 4 3 – 5.0 – 0.68 0 Denmark
87 ai 57 31 0.14 234 67.7 0.26 110 561 Djibouti
100 ai 35 28 – 16 – – 1 066 Dominica
100 aj 28 19 0.27 42 0.3 0.10 2 749 409 Dominican Republic
96 14 7 0.14 46 3.6 0.09 9 608 Ecuador
92 20 11 0.05 12 0.0 0.20 6 894 411 Egypt
100 13 7 0.14 58 0.0 0.02 1 443 743 El Salvador
ANNEX 2
Part 1 Maternal
PA R T 1
mortality
ratiod (per
100 000 live
Total populationa (000s) Life expectancy at birthb,c (years) Healthy life expectancy at birthb,c (years) births)
Data type Comparable estimates Comparable estimates Comparable estimates Comparable
estimates
Male Female Both sexes Male Female Both sexes Male Female Both sexes
Member State 2019 2019 2019 2017
Equatorial Guinea 754 602 1 356 60.9 63.6 62.2 53.4 54.1 53.9 301
Eritrea 1 753 1 744 3 497 61.3 67.1 64.1 53.9 57.7 55.7 480
Estonia 627 699 1 326 74.7 82.6 78.9 66.4 71.7 69.2 9
Eswatini 563 585 1 148 53.4 63.2 57.7 47.1 53.8 50.1 437
Ethiopia 56 069 56 010 112 079 66.9 70.5 68.7 59.0 60.8 59.9 401
Fiji 451 439 890 65.9 70.3 68.0 58.5 60.7 59.6 34
Finland 2 727 2 805 5 532 79.2 84.0 81.6 69.9 72.0 71.0 3
France 31 524 33 605 65 130 79.8 85.1 82.5 71.1 73.1 72.1 8
Gabon 1 106 1 066 2 173 63.6 69.7 66.5 56.0 59.3 57.6 252
Gambia 1 164 1 183 2 348 63.4 67.7 65.5 56.4 57.7 57.0 597
Georgia 1 906 2 091 3 997 68.8 77.8 73.3 61.4 67.9 64.7 25
Germany 41 249 42 268 83 517 78.7 84.8 81.7 69.7 72.1 70.9 7
Ghana 15 416 15 002 30 418 63.7 69.2 66.3 56.5 59.6 58.0 308
Greece 5 141 5 333 10 473 78.6 83.6 81.1 69.9 71.9 70.9 3
Grenada 56 56 112 70.6 75.3 72.9 62.6 65.4 63.9 25
Guatemala 8 660 8 922 17 581 69.0 75.0 72.0 60.5 64.1 62.3 95
Guinea 6 166 6 605 12 771 59.5 62.3 61.0 52.9 53.7 53.3 576
Guinea–Bissau 939 982 1 921 57.4 63.0 60.2 51.1 54.1 52.6 667
Guyana 393 390 783 62.5 69.4 65.7 55.1 59.7 57.2 169
Haiti 5 558 5 705 11 263 63.3 64.8 64.1 55.9 55.8 55.8 480
Honduras 4 869 4 877 9 746 70.7 73.2 71.9 62.7 63.3 63.0 65
Hungary 4 608 5 076 9 685 73.1 79.6 76.4 65.0 69.3 67.2 12
Iceland 170 169 339 80.8 83.9 82.3 71.7 72.3 72.0 4
India 710 130 656 288 1366 418 69.5 72.2 70.8 60.3 60.4 60.3 145
Indonesia 136 270 134 356 270 626 69.4 73.3 71.3 61.9 63.8 62.8 177
Iran (Islamic Republic of) 41 890 41 024 82 914 75.7 79.1 77.3 66.0 66.5 66.3 16
Iraq 19 892 19 418 39 310 69.9 75.0 72.4 61.6 63.7 62.7 79
Ireland 2 422 2 460 4 882 80.2 83.5 81.8 70.7 71.4 71.1 5
Israel 4 237 4 282 8 519 80.8 84.4 82.6 72.0 72.7 72.4 3
Italy 29 461 31 089 60 550 80.9 84.9 83.0 71.2 72.6 71.9 2
Jamaica 1 464 1 485 2 948 74.4 77.7 76.0 65.9 67.3 66.6 80
Japan 61 950 64 910 126 860 81.5 86.9 84.3 72.6 75.5 74.1 5
Jordan 5 113 4 988 10 102 77.0 78.8 77.9 68.1 67.2 67.6 46
Kazakhstan 9 000 9 552 18 551 70.0 77.6 74.0 62.4 67.4 65.0 10
Kenya 26 122 26 452 52 574 63.7 68.4 66.1 56.4 58.9 57.7 342
Kiribati 58 60 118 56.1 62.8 59.4 50.5 54.9 52.6 92
Kuwait 2 563 1 644 4 207 79.3 83.9 81.0 69.5 71.1 70.1 12
Kyrgyzstan 3 174 3 242 6 416 70.7 77.3 74.2 63.6 67.7 65.8 60
Lao People's Democratic Republic 3 599 3 570 7 169 66.2 70.9 68.5 59.2 61.9 60.5 185
Latvia 878 1 029 1 907 70.6 79.8 75.4 62.9 69.3 66.2 19
Lebanon 3 449 3 406 6 856 74.0 79.2 76.4 65.1 67.0 66.0 29
Lesotho 1 048 1 077 2 125 47.7 54.2 50.7 42.3 46.4 44.2 544
Liberia 2 481 2 456 4 937 63.2 65.0 64.1 54.9 55.0 54.9 661
Libya 3 423 3 355 6 777 74.2 77.3 75.8 64.9 65.5 65.2 72
Lithuania 1 276 1 483 2 760 71.2 80.4 76.0 63.4 69.7 66.7 8
Luxembourg 311 305 616 80.6 84.2 82.4 71.1 72.0 71.6 5
Madagascar 13 453 13 516 26 969 64.1 66.6 65.3 56.9 57.7 57.3 335
Malawi 9 185 9 443 18 629 62.3 68.9 65.6 55.1 59.0 57.1 349
Malaysia 16 423 15 527 31 950 72.6 77.1 74.7 64.5 66.9 65.7 29
Maldives 336 195 531 78.6 80.8 79.6 69.7 70.0 70.0 53
Mali 9 845 9 813 19 658 62.2 63.4 62.8 54.8 54.5 54.6 562
Malta 221 220 440 79.9 83.8 81.9 70.9 71.9 71.5 6
Marshall Islands – – 59 – – – – – – –
Mauritania 2 272 2 254 4 526 68.1 68.7 68.4 60.2 59.4 59.8 766
Mauritius 627 643 1 270 71.0 77.3 74.1 62.0 65.9 63.9 61
PA R T 1
of births Under-five Neonatal infectionsg Tuberculosis incidencei prevalence of people
attended by mortality ratef mortality ratef (per 1000 incidenceh (per 1000 among requiring
skilled health (per 1000 live (per 1000 live uninfected (per 100 000 population at children under interventions
personnele (%) births) births) population) population) risk) 5 yearsj (%) against NTDsk
Primary data Comparable Comparable Comparable Comparable Comparable Comparable Primary data
estimates estimates estimates estimates estimates estimates
2011–2020 2019 2019 2019 2019 2018 2019 2019 Member State
68 ai 82 29 4.06 181 237.1 6.07 429 326 Equatorial Guinea
– 40 18 0.11 86 57.3 1.02 427 112 Eritrea
100 2 1 – 13 – 0.29 0 Estonia
88 49 18 4.90 363 0.7 – 406 184 Eswatini
50 51 28 0.16 140 34.3 1.59 76 238 251 Ethiopia
100 ai 26 11 0.14 66 – 0.13 919 387 Fiji
100 aj 2 1 – 4.7 – 0.81 8 Finland
98 aj 4 3 – 8.7 – 0.15 55 France
89 ai 42 20 0.74 521 211.9 2.12 937 923 Gabon
84 52 27 1.06 158 50.5 1.60 168 211 Gambia
100 10 5 – 74 0.0 0.06 48 Georgia
99 aj 4 2 – 5.8 – 0.21 113 Germany
79 46 23 0.70 144 161.5 2.13 17 220 101 Ghana
100 ai 4 2 – 4.3 – 0.14 0 Greece
100 ai 17 11 – 3.1 – 0.12 106 Grenada
70 ai 25 12 0.07 26 0.2 0.03 4 957 871 Guatemala
55 ai 99 30 0.39 176 296.9 6.07 7 480 197 Guinea
54 78 35 1.15 361 86.9 2.11 1 232 549 Guinea–Bissau
96 ai 29 19 0.42 79 33.7 0.40 685 176 Guyana
42 63 25 0.52 170 1.4 1.04 5 921 717 Haiti
74 aj 17 9 0.11 31 0.1 0.03 2 214 843 Honduras
100 ai 4 2 – 6.3 – 0.90 0 Hungary
98 aj 2 1 – 4.4 – 0.15 0 Iceland
81 ai 34ak 22ak – 193 4.3 0.16 733 660 997 India
95 24 12 – 312 2.4 1.30 98 728 063 Indonesia
99 ai 14 9 0.05 13 0.0 0.05 8 251 Iran (Islamic Republic of)
96 26 15 – 41 0.0 0.29 2 170 486 Iraq
100 aj 3 2 – 5.8 – 0.04 0 Ireland
– 4 2 – 2.9 – 0.05 0 Israel
100 aj 3 2 0.04 7.1 – 0.33 1 Italy
100 14 10 0.58 3.2 – 0.55 7 560 Jamaica
100 aj 2 1 – 13 – 0.96 8 Japan
100 16 9 – 5.5 – 0.56 70 Jordan
100 aj 10 5 0.20 68 0.0 0.15 55 Kazakhstan
70 43 21 0.92 267 57.0 0.40 8 321 398 Kenya
92 ai 51 22 – 436 – 1.57 122 769 Kiribati
100 aj 8 5 – 22 – 0.03 0 Kuwait
100 18 12 0.14 110 0.0 0.15 2 169 854 Kyrgyzstan
64 46 22 0.11 155 2.8 0.68 2 256 885 Lao People's Democratic Republic
100 aj 4 2 0.19 26 – 0.27 5 Latvia
– 7 4 0.03 13 – 0.07 2 Lebanon
87 86 43 6.43 654 – 1.22 382 336 Lesotho
84 ai 85 32 0.46 308 366.6 4.66 3 175 460 Liberia
100 ai 12 6 0.07 59 – 0.43 6 774 Libya
100 ai 4 2 0.09 42 – 0.05 51 Lithuania
– 3 1 – 9.0 – 0.06 1 Luxembourg
46 ai 51 20 0.23 233 76.1 2.13 21 125 732 Madagascar
90 ai 42 20 1.94 146 207.7 1.39 12 393 153 Malawi
100 ai 9 5 0.20 92 0.0 0.06 127 602 Malaysia
100 8 5 – 36 – 0.21 5 013 Maldives
67 94 32 – 52 333.7 4.62 7 735 946 Mali
100 aj 7 5 – 14 – 0.20 1 Malta
92 32 15 – 483 – – 19 594 Marshall Islands
69 73 32 – 89 43.4 3.35 826 827 Mauritania
100 16 10 0.57 12 – 0.41 0 Mauritius
ANNEX 2
Part 1 Maternal
PA R T 1
mortality
ratiod (per
100 000 live
Total populationa (000s) Life expectancy at birthb,c (years) Healthy life expectancy at birthb,c (years) births)
Data type Comparable estimates Comparable estimates Comparable estimates Comparable
estimates
Male Female Both sexes Male Female Both sexes Male Female Both sexes
Member State 2019 2019 2019 2017
Mexico 62 403 65 172 127 576 73.1 78.9 76.0 64.3 67.2 65.8 33
Micronesia (Federated States of) 58 56 114 60.3 66.0 63.0 54.4 57.8 56.0 88
Monaco – – 39 – – – – – – –
Mongolia 1 590 1 635 3 225 63.8 72.8 68.1 57.1 63.8 60.3 45
Montenegro 311 317 628 73.2 78.7 75.9 65.2 68.7 67.0 6
Morocco 18 093 18 379 36 472 71.7 74.3 73.0 63.7 63.7 63.7 70
Mozambique 14 746 15 620 30 366 54.5 61.7 58.1 47.9 52.8 50.4 289
Myanmar 26 045 28 001 54 045 65.9 72.2 69.1 58.8 62.8 60.9 250
Namibia 1 209 1 286 2 495 60.6 68.4 64.6 53.4 58.6 56.1 195
Nauru – – 11 – – – – – – –
Nepal 13 047 15 562 28 609 68.9 72.7 70.9 60.6 62.1 61.3 186
Netherlands 8 515 8 582 17 097 80.4 83.1 81.8 71.3 71.5 71.4 5
New Zealand 2 351 2 432 4 783 80.4 83.5 82.0 69.6 70.8 70.2 9
Nicaragua 3 226 3 320 6 546 72.1 77.9 75.0 63.7 67.2 65.5 98
Niger 11 714 11 596 23 311 62.1 64.6 63.3 55.3 55.8 55.5 509
Nigeria 101 832 99 132 200 964 61.2 64.1 62.6 53.9 54.9 54.4 917
Niue – – 2 – – – – – – –
North Macedonia 1 042 1 041 2 083 72.8 76.9 74.8 65.1 67.3 66.1 7
Norway 2 717 2 662 5 379 81.1 84.1 82.6 71.0 71.6 71.4 2
Oman 3 284 1 691 4 975 73.0 75.3 73.9 64.5 64.5 64.7 19
Pakistan 111 448 105 118 216 565 64.6 66.7 65.6 56.9 56.8 56.9 140
Palau – – 18 – – – – – – –
Panama 2 126 2 120 4 246 76.6 82.1 79.3 67.4 70.0 68.7 52
Papua New Guinea 4 480 4 296 8 776 63.4 67.4 65.3 56.2 58.1 57.1 145
Paraguay 3 581 3 464 7 045 73.1 78.8 75.8 64.5 67.3 65.8 84
Peru 16 148 16 362 32 510 78.5 81.3 79.9 69.2 69.8 69.5 88
Philippines 54 316 53 801 108 117 67.4 73.6 70.4 60.1 63.9 62.0 121
Poland 18 361 19 527 37 888 74.5 81.9 78.3 65.9 71.3 68.7 2
Portugal 4 837 5 390 10 226 78.6 84.4 81.6 69.6 72.2 71.0 8
Qatar 2 134 699 2 832 78.0 76.6 77.2 68.1 65.1 67.1 9
Republic of Korea 25 649 25 576 51 225 80.3 86.1 83.3 71.3 74.7 73.1 11
Republic of Moldova 1 938 2 105 4 043 69.3 77.1 73.3 61.9 67.1 64.5 19
Romania 9 418 9 946 19 365 72.0 79.3 75.6 64.3 69.4 66.8 19
Russian Federation 67 603 78 269 145 872 68.2 78.0 73.2 60.7 67.5 64.2 17
Rwanda 6 206 6 421 12 627 66.9 71.2 69.1 59.0 61.4 60.2 248
Saint Kitts and Nevis – – 53 – – – – – – –
Saint Lucia 90 93 183 71.3 77.7 74.3 63.0 66.6 64.7 117
Saint Vincent and the Grenadines 56 54 111 71.3 75.3 73.2 62.9 65.1 64.0 68
Samoa 102 95 197 69.2 71.8 70.5 61.8 62.5 62.1 43
San Marino – – 34 – – – – – – –
Sao Tome and Principe 108 107 215 68.8 72.0 70.4 60.9 62.2 61.6 130
Saudi Arabia 19 784 14 485 34 269 73.1 76.1 74.3 63.8 64.4 64.0 17
Senegal 7 946 8 350 16 296 66.8 70.1 68.6 58.8 59.9 59.4 315
Serbia 4 297 4 475 8 772 73.5 78.3 75.9 65.4 68.4 66.9 12
Seychelles 50 48 98 70.0 77.1 73.3 61.9 66.4 64.0 53
Sierra Leone 3 898 3 915 7 813 59.6 61.9 60.8 52.5 53.3 52.9 1120
Singapore 3 038 2 766 5 804 81.0 85.5 83.2 72.4 74.7 73.6 8
Slovakia 2 657 2 800 5 457 74.8 81.4 78.2 66.2 70.8 68.5 5
Slovenia 1 035 1 044 2 079 78.6 84.1 81.3 69.0 72.5 70.7 7
Solomon Islands 341 329 670 62.9 67.9 65.2 56.5 59.1 57.8 104
Somalia 7 700 7 743 15 443 54.0 59.2 56.5 48.3 51.3 49.7 829
South Africa 28 859 29 699 58 558 62.2 68.3 65.3 54.6 57.7 56.2 119
South Sudan 5 537 5 526 11 062 60.8 64.8 62.8 52.9 54.5 53.7 1150
Spain 22 961 23 776 46 737 80.7 85.7 83.2 71.3 72.9 72.1 4
Sri Lanka 10 233 11 090 21 324 73.8 79.8 76.9 65.1 69.0 67.0 36
PA R T 1
of births Under-five Neonatal infectionsg Tuberculosis incidencei prevalence of people
attended by mortality ratef mortality ratef (per 1000 incidenceh (per 1000 among requiring
skilled health (per 1000 live (per 1000 live uninfected (per 100 000 population at children under interventions
personnele (%) births) births) population) population) risk) 5 yearsj (%) against NTDsk
Primary data Comparable Comparable Comparable Comparable Comparable Comparable Primary data
estimates estimates estimates estimates estimates estimates
2011–2020 2019 2019 2019 2019 2018 2019 2019 Member State
97 14 9 – 23 0.2 0.03 19 900 177 Mexico
– 29 16 – 100 – 0.40 70 736 Micronesia (Federated States of)
– 3 2 – 0.0 – – 0 Monaco
99 ai 16 8 0.01 428 – 0.47 0 Mongolia
99 2 1 0.05 15 – 0.67 0 Montenegro
87 21 14 0.02 97 0.0 0.16 5 576 Morocco
73 74 29 4.68 361 308.4 0.59 21 517 399 Mozambique
60 ai 45 22 0.19 322 2.3 1.11 23 748 613 Myanmar
88 42 19 3.10 486 2.8 0.36 1 094 020 Namibia
– 31 20 – 182 – – 10 774 Nauru
77 ai 31 20 0.03 238 0.1 0.16 14 118 850 Nepal
– 4 3 0.02 5.0 – 0.08 0 Netherlands
96 aj 5 3 0.03 7.5 – 0.77 6 New Zealand
96 ai 17 10 0.06 43 5.9 0.09 1 611 101 Nicaragua
39 aj 80 24 0.06 84 343.2 3.44 14 046 246 Niger
43 ai 117 36 0.52 219 303.3 2.94 134 545 208 Nigeria
100 ai 23 13 – 0.0 – – 0 Niue
100 6 4 – 12 – – 0 North Macedonia
99 aj 2 1 – 3.3 – 0.02 3 Norway
99 11 5 0.04 8.5 0.0 0.13 80 Oman
71 ai 67 41 0.12 263 3.3 0.91 25 234 450 Pakistan
100 17 9 – 38 – – 3 Palau
93 15 9 – 37 0.4 0.07 51 175 Panama
56 ai 45 22 0.38 432 156.4 1.36 6 982 087 Papua New Guinea
98 aj 19 11 0.16 46 0.0 0.42 1 974 836 Paraguay
94 13 6 0.10 119 3.6 0.06 342 185 Peru
84 27 13 0.14 554 0.7 0.38 47 496 283 Philippines
100 4 3 – 15 – 0.01 46 Poland
100 4 2 – 19 – 0.02 11 Portugal
100 7 3 – 35 – 0.05 22 Qatar
100 aj 3 2 – 59 0.1 0.09 4 Republic of Korea
100 14 11 0.23 80 – 0.20 0 Republic of Moldova
95 7 3 0.04 66 – 0.29 0 Romania
100 ai 6 3 – 50 – 0.55 1 Russian Federation
94 ai 34 16 0.44 57 366.1 0.49 5 015 979 Rwanda
100 aj 15 10 – 1.5 – – 46 Saint Kitts and Nevis
100 ai 22 13 – 3.8 – 0.22 26 Saint Lucia
99 ai 15 9 – 4.2 – 0.15 702 Saint Vincent and the Grenadines
89 15 8 – 11 – 0.34 191 219 Samoa
– 2 1 – 0.0 – – 0 San Marino
97 30 14 – 114 11.4 1.31 201 114 Sao Tome and Principe
99 ai 7 4 – 9.9 <0.1 0.00 1 113 Saudi Arabia
75 45 22 0.09 117 50.5 0.93 8 815 619 Senegal
100 5 3 0.02 14 – 0.04 0 Serbia
99 ai 14 9 – 16 – 0.09 0 Seychelles
87 109 31 0.65 295 334.8 1.98 6 910 107 Sierra Leone
100 ai 3 1 0.03 41 – 0.13 15 998 Singapore
98 6 3 – 4.5 – 0.31 11 Slovakia
100 aj 2 1 – 5.4 – 1.12 1 Slovenia
86 ai 20 8 – 66 247.9 0.87 493 611 Solomon Islands
32 ai 117 37 0.03 258 49.1 6.32 2 286 299 Somalia
97 34 11 3.98 615 0.5 3.10 18 807 465 South Africa
– 96 39 1.50 227 272.0 13.03 8 472 338 South Sudan
100 3 2 0.06 9.3 – 0.13 7 Spain
100 7 4 <0.01 64 0.0 0.34 106 353 Sri Lanka
ANNEX 2
Part 1 Maternal
PA R T 1
mortality
ratiod (per
100 000 live
Total populationa (000s) Life expectancy at birthb,c (years) Healthy life expectancy at birthb,c (years) births)
Data type Comparable estimates Comparable estimates Comparable estimates Comparable
estimates
Male Female Both sexes Male Female Both sexes Male Female Both sexes
Member State 2019 2019 2019 2017
Sudan 21 388 21 425 42 813 67.6 70.8 69.1 59.6 60.3 59.9 295
Suriname 292 289 581 68.5 74.6 71.5 60.7 64.2 62.4 120
Sweden 5 026 5 011 10 036 80.8 84.0 82.4 71.7 72.1 71.9 4
Switzerland 4 261 4 331 8 591 81.8 85.1 83.4 72.2 72.8 72.5 5
Syrian Arab Republic 8 555 8 516 17 070 71.2 74.3 72.7 62.5 63.3 62.9 31
Tajikistan 4 698 4 623 9 321 67.6 71.5 69.5 60.9 63.2 62.0 17
Thailand 33 905 35 721 69 626 74.4 81.0 77.7 65.9 70.6 68.3 37
Timor-Leste 654 640 1 293 67.9 71.4 69.6 59.8 62.0 60.9 142
Togo 4 021 4 062 8 082 61.5 67.2 64.3 54.7 57.8 56.2 396
Tonga 52 52 104 69.8 75.6 72.6 62.7 65.5 64.0 52
Trinidad and Tobago 689 706 1 395 72.5 79.9 76.1 64.0 68.6 66.2 67
Tunisia 5 798 5 897 11 695 74.9 79.2 77.0 66.1 67.7 66.9 43
Turkey 41 174 42 256 83 430 76.4 80.7 78.6 67.8 69.0 68.4 17
Turkmenistan 2 926 3 016 5 942 66.5 73.0 69.7 59.9 64.3 62.1 7
Tuvalu – – 12 – – – – – – –
Uganda 21 807 22 462 44 270 63.2 70.1 66.7 56.0 60.4 58.2 375
Ukraine 20 379 23 615 43 994 68.0 77.8 73.0 60.6 67.8 64.3 19
United Arab Emirates 6 767 3 004 9 771 75.1 78.4 76.1 65.8 66.2 66.0 3
United Kingdom 33 351 34 179 67 530 79.8 83.0 81.4 69.6 70.6 70.1 7
United Republic of Tanzania 28 981 29 025 58 005 65.4 69.3 67.3 57.6 59.3 58.5 524
United States of America 162 826 166 239 329 065 76.3 80.7 78.5 65.2 67.0 66.1 19
Uruguay 1 672 1 790 3 462 73.5 80.6 77.1 65.4 69.5 67.5 17
Uzbekistan 16 450 16 532 32 982 70.8 75.2 73.0 63.5 65.8 64.7 29
Vanuatu 152 148 300 62.7 68.3 65.3 56.4 59.4 57.8 72
Venezuela (Bolivarian Republic of) 14 045 14 471 28 516 69.9 78.2 73.9 61.9 67.1 64.4 125
Viet Nam 48 151 48 311 96 462 69.6 78.1 73.7 62.4 68.3 65.3 43
Yemen 14 692 14 470 29 162 64.4 68.9 66.6 56.9 58.2 57.5 164
Zambia 8 843 9 018 17 861 59.5 65.4 62.5 52.5 56.3 54.4 213
Zimbabwe 6 983 7 662 14 645 57.5 63.6 60.7 51.2 54.8 53.1 458
Global 3 870 732 3 805 840 7 676 965 70.8 75.9 73.3 62.5 64.9 63.7 211
PA R T 1
of births Under-five Neonatal infectionsg Tuberculosis incidencei prevalence of people
attended by mortality ratef mortality ratef (per 1000 incidenceh (per 1000 among requiring
skilled health (per 1000 live (per 1000 live uninfected (per 100 000 population at children under interventions
personnele (%) births) births) population) population) risk) 5 yearsj (%) against NTDsk
Primary data Comparable Comparable Comparable Comparable Comparable Comparable Primary data
estimates estimates estimates estimates estimates estimates
2011–2020 2019 2019 2019 2019 2018 2019 2019 Member State
78 ai 58 27 0.08 67 55.4 1.66 12 015 065 Sudan
98 ai 18 11 0.45 29 1.1 0.07 241 Suriname
– 3 1 – 5.5 – 0.13 28 Sweden
– 4 3 0.03 5.4 – 0.16 0 Switzerland
– 22 11 <0.01 19 0.0 0.69 2 440 286 Syrian Arab Republic
95 34 15 0.17 83 0.0 0.18 3 161 746 Tajikistan
99 ai 9 5 0.08 150 0.3 0.27 129 102 Thailand
57 ai 44 20 0.15 498 0.0 0.72 1 327 038 Timor-Leste
69 ai 67 25 0.59 37 225.0 3.27 4 311 460 Togo
98 ai 17 7 – 11 – 0.89 37 131 Tonga
100 ai 18 12 0.07 18 – 0.19 442 Trinidad and Tobago
100 17 12 0.05 35 – 0.12 7 085 Tunisia
99 aj 10 5 – 16 0.0 0.11 0 Turkey
100 ai 42 24 – 45 0.0 0.07 105 Turkmenistan
– 24 16 – 296 – – 11 500 Tuvalu
74 46 20 1.38 200 262.7 0.96 24 639 995 Uganda
100 ai 8 5 0.28 77 – 0.25 0 Ukraine
100 ai 7 4 – 1.0 0.0 0.02 55 United Arab Emirates
– 4 3 – 8.0 – 0.41 5 United Kingdom
64 ai 50 20 1.46 237 111.2 – 27 086 592 United Republic of Tanzania
99 6 4 – 3.0 – 0.01 1 158 United States of America
100 ai 7 4 – 35 – 0.15 13 Uruguay
100 ai 17 10 0.13 67 0.0 0.16 405 951 Uzbekistan
89 ai 26 11 – 41 3.5 2.25 291 481 Vanuatu
99 ai 24 15 0.19 45 32.8 0.15 8 062 142 Venezuela (Bolivarian Republic of)
94 20 10 0.05 176 0.1 0.64 7 368 702 Viet Nam
45 ai 58 27 0.04 48 46.4 1.76 10 471 813 Yemen
80 ai 62al 23al 3.17 333 147.7 1.32 12 032 435 Zambia
86 55 26 2.81 199 67.9 2.74 10 660 813 Zimbabwe
2014–2020 2019 2019 2019 2019 2019 2019 2019 WHO region
65 74 27 0.94 226 225.2 2.53 590 380 426 African Region
96 13 7 0.17 29 6.4 0.07 63 062 825 Region of the Americas
81 32 20 0.08 217 3.9 0.38 933 812 197 South-East Asia Region
99 8 4 0.21 26 0.0 0.26 6 424 369 European Region
81 46 25 0.07 114 10.4 0.84 77 874 457 Eastern Mediterranean Region
98 11 6 0.06 93 2.3 0.30 71 521 277 Western Pacific Region
PA R T 2
– – 118.5 48.8 2.0 – Angola
– – 29.9 0.1 0.7 – Antigua and Barbuda
– – 26.6 0.4 0.4 21.8 Argentina
16.1 4.9 54.8 0.2 0.7 26.7an Armenia
– – 8.4 0.1 0.1 16.2 Australia
– – 15.3 0.1 0.2 29.1an Austria
– – 63.9 1.1 0.9 19.6an Azerbaijan
2.7 0.2 19.9 0.1 0.2 10.9an Bahamas
– – 40.1 <0.1 0.3 25.1 Bahrain
24.7 9.5 149.0 11.9 0.3 39.1 Bangladesh
16.4 3.8 31.1 0.2 0.7 8.7 Barbados
9.2 0.7 60.7 0.1 3.3 26.6an Belarus
– – 15.7 0.3 0.4 25.0an Belgium
– – 68.6 1.0 0.4 – Belize
10.9 5.4 205.0 59.7 2.6 7.2 Benin
1.8 0.4 124.5 3.9 0.2 – Bhutan
6.0 1.1 63.7 5.6 0.6 – Bolivia (Plurinational State of)
8.2 1.4 79.8 0.1 0.4 38.3an Bosnia and Herzegovina
– – 101.3 11.8 1.8 23.7 Botswana
– – 29.9 1.0 0.1 16.5 Brazil
– – 13.3 <0.1 0.0 15.5an Brunei Darussalam
– – 61.8 0.1 0.5 38.9an Bulgaria
3.1 0.4 206.2 49.6 3.1 16.0 Burkina Faso
3.3 0.4 179.9 65.4 3.2 12.6 Burundi
– – 99.5 4.1 0.4 – Cabo Verde
15.3 5.2 149.8 6.5 0.5 21.8 Cambodia
10.8 3.0 208.1 45.2 2.6 9.3 Cameroon
– – 7.0 0.4 0.3 17.5 Canada
– – 211.9 82.1 2.8 – Central African Republic
– – 280.1 101.0 3.5 11.8 Chad
14.6 2.1 25.3 0.2 0.4 44.7an Chile
19.7 5.4 112.7 0.6 1.8 24.7 China
8.2 2.2 37.0 0.8 0.1 7.9an Colombia
8.8 1.6 172.4 50.7 2.4 19.5 Comoros
4.6 0.7 130.7 38.7 1.3 16.1 Congo
– – – – – 26.6an Cook Islands
9.8 1.7 23.3 0.9 0.1 9.8an Costa Rica
12.4 3.4 269.1 47.2 2.5 13.0 Côte d’Ivoire
– – 35.5 0.1 0.4 36.6an Croatia
– – 49.5 1.0 0.2 27.1an Cuba
– – 20.1 0.3 0.3 36.7an Cyprus
– – 29.6 0.2 0.4 31.5an Czechia
– – 207.2 1.4 1.4 18.8an Democratic People’s Republic of Korea
4.8 0.6 163.9 59.8 2.0 – Democratic Republic of the Congo
– – 13.2 0.3 0.1 18.6an Denmark
– – 159.0 31.3 2.5 – Djibouti
– – – – – – Dominica
– – 43.0 2.2 0.4 9.4an Dominican Republic
10.3 2.4 24.5 0.6 0.3 – Ecuador
26.2 3.9 108.9 2.0 0.2 21.4 Egypt
1.7 0.3 41.9 2.0 0.2 12.7 El Salvador
PA R T 2
4.9 1.4 144.4 43.7 3.3 4.6 Ethiopia
– – 99.0 2.9 0.3 26.7an Fiji
– – 7.2 <0.1 0.4 19.7an Finland
– – 9.7 0.3 0.3 34.6an France
– – 76.0 20.6 1.3 – Gabon
0.2 <0.1 237.0 29.7 1.8 14.4 Gambia
29.2 9.0 101.8 0.2 0.6 29.7an Georgia
– – 16.0 0.6 0.3 28.0an Germany
1.1 0.1 203.8 18.8 1.7 3.7 Ghana
16.9 1.6 27.6 <0.1 0.2 39.1an Greece
– – 45.3 0.3 0.1 – Grenada
1.4 <0.1 73.8 6.3 1.6 – Guatemala
7.0 1.3 243.3 44.6 2.3 – Guinea
– – 214.7 35.3 2.3 – Guinea–Bissau
– – 107.8 3.6 0.1 12.2an Guyana
11.5 4.0 184.3 23.8 1.4 8.3an Haiti
– – 60.7 3.6 0.5 – Honduras
– – 38.8 0.2 0.5 30.6an Hungary
– – 8.7 0.1 1.0 13.8an Iceland
17.3 3.9 184.3 18.6 0.3 27.0 India
2.7 0.5 112.4 7.1 0.3 37.9 Indonesia
15.8 3.8 50.9 1.0 1.0 14.0 Iran (Islamic Republic of)
3.3 0.4 75.1 3.0 0.2 22.2 Iraq
– – 11.9 0.1 0.3 23.6an Ireland
6.7 1.0 15.4 0.2 0.0 25.5an Israel
– – 15.0 0.1 0.3 23.4an Italy
– – 25.4 0.6 0.1 11.0 Jamaica
4.4 0.6 11.9 0.2 0.2 21.9an Japan
– – 51.2 0.6 0.5 – Jordan
2.6 0.1 62.7 0.4 1.9 24.4an Kazakhstan
5.4 1.5 78.1 51.2 2.4 11.8 Kenya
– – 140.2 16.7 2.6 52.0an Kiribati
– – 103.8 <0.1 0.4 22.1 Kuwait
3.5 0.7 110.7 0.8 0.9 27.9 Kyrgyzstan
– – 188.5 11.3 0.6 37.8 Lao People’s Democratic Republic
– – 41.3 <0.1 1.2 36.7an Latvia
– – 51.4 0.8 0.6 42.6 Lebanon
– – 177.6 44.4 5.2 29.7 Lesotho
– – 170.2 41.5 1.7 8.4 Liberia
– – 71.9 0.6 0.8 – Libya
– – 34.0 0.1 1.7 27.1an Lithuania
– – 11.6 <0.1 0.2 21.7an Luxembourg
– – 159.6 30.2 2.1 28.9 Madagascar
4.2 0.9 115.0 28.3 1.7 12.8 Malawi
2.0 0.2 47.4 0.4 0.7 21.8an Malaysia
10.3 4.1 25.6 0.3 0.0 – Maldives
6.5 1.1 209.1 70.7 2.9 12.0 Mali
– – 20.2 <0.1 0.1 25.1an Malta
– – – – – – Marshall Islands
11.7 3.0 169.5 38.6 1.5 – Mauritania
8.9 1.8 38.3 0.6 0.8 26.9 Mauritius
1.6 0.2 36.7 1.1 0.4 13.9an Mexico
PA R T 2
– – 49.1 1.9 0.7 14.7 Morocco
1.6 0.4 110.0 27.6 3.7 14.4 Mozambique
14.4 2.8 156.4 12.6 1.3 45.5 Myanmar
– – 145.0 18.3 1.9 17.9 Namibia
– – – – – 52.1 Nauru
10.7 2.4 193.8 19.8 1.7 31.9 Nepal
– – 13.7 0.2 0.1 23.4an Netherlands
– – 7.2 0.1 0.2 14.8an New Zealand
14.8 3.0 55.7 2.2 0.3 – Nicaragua
6.6 1.9 251.8 70.8 3.3 8.6 Niger
15.1 4.1 307.4 68.6 3.3 4.8 Nigeria
– – – – – – Niue
– – 82.2 0.1 0.5 – North Macedonia
– – 8.6 0.2 0.3 18.4an Norway
– – 53.9 <0.1 0.9 9.6 Oman
4.5 0.5 173.6 19.6 1.6 20.0 Pakistan
– – – – – 23.7 Palau
– – 25.8 1.9 0.1 6.9 Panama
– – 152.0 16.3 1.4 – Papua New Guinea
7.1 1.9 57.5 1.5 0.2 12.8an Paraguay
9.2 1.3 63.9 1.3 0.4 9.6an Peru
6.3 1.4 185.2 4.2 0.2 24.3an Philippines
14.1 1.3 37.9 0.1 0.5 26.0an Poland
– – 9.8 0.2 0.3 27.9an Portugal
– – 47.4 <0.1 0.3 14.0 Qatar
21.8 3.9 20.5 1.8 0.2 22.0an Republic of Korea
18.7 3.6 78.3 0.1 5.5 25.3an Republic of Moldova
13.4 2.2 59.3 0.4 1.9 25.5an Romania
4.9 0.6 49.4 0.1 3.8 28.3an Russian Federation
1.2 0.1 121.4 19.3 1.7 13.3 Rwanda
– – – – – – Saint Kitts and Nevis
– – 30.0 0.6 0.1 – Saint Lucia
– – 47.6 1.3 0.0 – Saint Vincent and the Grenadines
– – 85.0 1.5 0.4 28.9an Samoa
– – – – – – San Marino
– – 162.4 11.4 0.7 5.4 Sao Tome and Principe
– – 83.7 0.1 0.8 16.6 Saudi Arabia
3.3 0.2 160.7 23.9 1.9 9.1 Senegal
8.1 0.5 62.5 0.7 0.3 40.6an Serbia
3.5 1.6 49.3 0.2 0.5 21.1 Seychelles
54.2 22.2 324.1 81.3 2.8 19.8 Sierra Leone
9.0 1.5 25.9 0.1 0.0 16.5an Singapore
– – 33.5 <0.1 0.5 32.3an Slovakia
2.9 0.3 22.6 <0.1 0.2 22.7an Slovenia
– – 137.0 6.2 2.3 37.9an Solomon Islands
– – 212.8 86.6 4.9 – Somalia
– – 86.7 13.7 1.7 31.4 South Africa
– – 165.1 63.3 2.3 – South Sudan
– – 9.9 0.2 0.4 27.9an Spain
5.4 0.9 79.8 1.2 0.4 22.9 Sri Lanka
– – 184.9 17.3 1.7 – Sudan
4.9 1.4 56.7 2.0 0.3 – Suriname
PA R T 2
2.2 0.4 61.5 3.5 0.2 22.8 Thailand
2.9 0.5 139.8 9.9 0.4 38.2 Timor-Leste
– – 249.6 41.6 1.9 7.6 Togo
– – 73.3 1.4 1.1 30.2an Tonga
3.9 1.9 38.6 0.1 0.1 – Trinidad and Tobago
18.4 2.7 56.1 1.0 0.7 26.0 Tunisia
3.2 0.4 46.6 0.3 0.4 29.3an Turkey
– – 79.3 4.0 0.6 – Turkmenistan
– – – – – 48.7 Tuvalu
15.3 3.8 155.7 31.6 1.7 9.8 Uganda
7.8 0.9 70.7 0.3 2.5 25.5an Ukraine
– – 54.7 <0.1 0.4 18.2 United Arab Emirates
1.6 0.5 13.8 0.2 0.3 19.2an United Kingdom
3.8 1.2 139.0 38.4 2.0 13.3 United Republic of Tanzania
4.8 0.8 13.3 0.2 0.5 25.1 United States of America
– – 17.5 0.4 0.5 21.8an Uruguay
– – 81.1 0.4 0.8 12.3an Uzbekistan
– – 135.6 10.4 0.7 24.1 Vanuatu
– – 34.6 1.4 0.2 – Venezuela (Bolivarian Republic of)
9.4 1.9 64.5 1.6 0.9 – Viet Nam
15.8 4.2 194.2 10.2 1.8 20.9 Yemen
– – 127.2 34.9 2.6 14.7 Zambia
– – 133.0 24.6 3.5 13.9 Zimbabwe
Data type Comparable Comparable Comparable Comparable Primary data Primary data Primary data Primary data Primary data
estimates estimates estimates estimates
Member State 2019 2019 2019 2019 2019 2011–2019 2011–2019 2010–2019 2010–2019
Afghanistan 66 39 65 – 6.90 – 2.8 4.5 0.7
Albania 99 96 96 – 2.21 – 16.5 50.9 10.3
Algeria 91 77 91 – 0.02 – 17.2 15.5 3.7
Andorra 99 95 96 64aq – – 33.3 40.1 8.2
Angola 57 45 53 – 1.35 – 2.1 4.1 –
Antigua and Barbuda 95 95 – – 0.03 – 27.7 90.8 0.4
Argentina 86 89 88 59 0.06 – 39.9 26.0 15.3
Armenia 92 96 92 7 1.89 – 44.0 43.7 5.6
Australia 95 94 96 79 – – 37.6 132.4 6.0
Austria 85 84 – – – – 52.1 70.9 5.7
Azerbaijan 94 97 95 – 0.40 – 34.5 64.3 2.7
Bahamas 86 82 86 9ar – – 19.4 45.7 2.6
PA R T 3
Primary data Primary data Primary data Primary data Comparable Comparable Primary data Comparable
estimates estimates estimates
2010–2019 2020 2019 2019 2018 2020 2011–2020 2020 Member State
0.3 47 – – 1.8 35.1 5.1ao,ap 3.9 Afghanistan
10.8 73 – – 9.7 9.6 1.6 14.6 Albania
4.5 68 – – 10.7 9.3 2.7 12.9 Algeria
10.1 41 – – 18.6 – – – Andorra
– 65 – – 5.4 37.7 4.9 3.5 Angola
– – – – 11.7 – – – Antigua and Barbuda
– 64 42 19 15.2 7.8 1.6 12.9 Argentina
0.5 84 – – 5.3 9.1 4.4 10.8 Armenia
8.9 92 18 13 17.9 2.1 – 18.5 Australia
7.1 67 5 9 15.5 – – – Austria
2.0 86 – – 2.8 16.3 3.2ap 9.4 Azerbaijan
5.6 65 – – 15.9 – – – Bahamas
PA R T 3
1.6 – 40 54 7.2 5.1 – 6.4 Bahrain
1.8 70 – 93 3.0 30.2 9.8 2.1 Bangladesh
– – – – 9.9 6.6 6.8 11.4 Barbados
3.6 – – – 10.6 3.9 – 6.8 Belarus
19.4 81 – – 15.0 2.3 0.4ap,au 5.1 Belgium
6.8 48 – – 12.5 13.3 1.8 8.0 Belize
0.3 35 – – 3.0 31.3 5.0 2.2 Benin
0.6 71 21 57 7.6 22.4 – 5.2 Bhutan
2.2 58 – – 12.1 12.7 2.0 8.8 Bolivia (Plurinational State of)
1.3 – 11 20 15.1 9.1 2.3 12.8 Bosnia and Herzegovina
2.1 43 – – 14.3 22.8 – 11.0 Botswana
6.8 92 21 28 10.3 6.1 – 7.3 Brazil
1.7 – 12 17 7.1 12.7 – 9.3 Brunei Darussalam
8.4 – – – 11.6 6.4 6.3av 5.7 Bulgaria
0.2 51 – – 8.8 25.5 8.1ao 2.6 Burkina Faso
– 53 – – 8.5 57.6 4.8ao 3.1 Burundi
0.1 52 – – 10.4 9.7 – – Cabo Verde
0.3 48 – 71 5.2 29.9 9.7 2.1 Cambodia
0.1 50 – – 1.1 27.2 4.3 9.6 Cameroon
11.7 100 – – 19.5 – – 11.8 Canada
– 32 – – 4.2 40.1 5.2ao,aw 2.6 Central African Republic
– 39 – – 5.2 35.0 13.9 3.4 Chad
5.3 76 – – 18.3 1.6 0.3 9.8 Chile
3.2 94 – – 8.9 4.7 1.9 8.3 China
– 75 – – 19.6 11.5 1.6ao 5.8 Colombia
0.2 41 – – 2.6 22.6 11.2 9.6 Comoros
0.1 37 – – 3.5 18.0 8.2 5.1 Congo
0.6 59 – – 7.8 – – – Cook Islands
7.3 77 – – 27.8 8.6 1.8 8.1 Costa Rica
0.4 44 – – 5.1 17.8 6.1 2.8 Côte d'Ivoire
7.2 78 25 16 12.3 – – – Croatia
– – – – 15.2 7.0 2.0 10.0 Cuba
6.5 67 100 20 6.6 – – – Cyprus
6.9 – 13 15 15.5 2.5 – 6.6 Czechia
4.0 70 – – – 18.2 2.5 1.9 Democratic People's Republic of Korea
0.1 52 – – 4.5 40.8 6.4 4.2 Democratic Republic of the Congo
5.4 – – – 16.6 – – – Denmark
2.3 31 – – 4.3 34.0 21.5 7.2 Djibouti
– – – – 7.0 – – – Dominica
1.2 60 – – 15.4 5.9 2.4 7.6 Dominican Republic
0.4 70 – – 11.4 23.1 3.7 9.8 Ecuador
Data type Comparable Comparable Comparable Comparable Primary data Primary data Primary data Primary data Primary data
estimates estimates estimates estimates
Member State 2019 2019 2019 2019 2019 2011–2019 2011–2019 2010–2019 2010–2019
Egypt 95 94 – – 0.10 – 7.5 19.3 2.0
El Salvador 81 87 82 – 0.44 – 28.7 18.3 8.7
Equatorial Guinea 53 – – – 0.84 – 4.0 5.0 –
Eritrea 95 88 95 – 7.16 – – 14.4 –
Estonia 91 90 – 45at – – 34.6 66.3 9.7
Eswatini 90 75 87 – 11.97 – 1.0 41.4 0.1
Ethiopia 69 41 63 84 3.46 – 0.8 7.1 0.2
Fiji 99 94 99 56 4.97 – 8.6 39.6 1.2
Finland 91 93 89 60ax – – 46.4 13.1 8.1
France 96 83 92 24at – – 65.3 114.7 6.7
Gabon 70 – – – 2.26 – 6.8 29.5 0.2
Gambia 88 61 87 – 14.55 – 1.1 6.1 0.1
PA R T 3
Primary data Primary data Primary data Primary data Comparable Comparable Primary data Comparable
estimates estimates estimates
2010–2019 2020 2019 2019 2018 2020 2011–2020 2020 Member State
4.6 86 – 88 4.7 22.3 9.5 17.8 Egypt
6.5 100 – – 18.8 11.2 2.1 6.6 El Salvador
– 26 – – 3.2 19.7 3.1 9.3 Equatorial Guinea
– 57 – – 2.4 49.1 – 2.1 Eritrea
7.2 72 – – 12.5 1.2 1.5 5.7 Estonia
0.3 46 – – 6.0 22.6 2.0 9.7 Eswatini
0.4 67 – – 4.8 35.3 7.2 2.6 Ethiopia
1.1 – – – 7.2 7.5 – 5.2 Fiji
19.2 82 2 8 13.3 – – – Finland
10.6 – 13 9 14.8 – – – France
0.6 40 – – 9.4 14.4 3.4 7.4 Gabon
– 35 – – 4.4 16.1 5.1 2.3 Gambia
PA R T 3
0.9 59 14 57 10.3 5.7 0.6 7.6 Georgia
6.6 89 7 12 20.0 1.6 0.3au 4.1 Germany
0.2 49 – – 6.4 14.2 6.8 2.9 Ghana
10.4 60 43 22 8.5 2.2 – 13.9 Greece
6.8 – – – 7.7 – – – Grenada
– 58 – – 16.7 42.8 0.8 5.1 Guatemala
0.1 48 – – 4.1 29.4 9.2 5.7 Guinea
– 35 – – 3.0 28.0 7.8ao,ap 3.4 Guinea–Bissau
0.1 100 – – 10.7 9.0 6.4 6.6 Guyana
0.3 40 – – 4.8 20.4 3.7 3.7 Haiti
– 60 – – 10.7 19.9 1.4 5.7 Honduras
8.1 66 – – 9.9 – – – Hungary
5.4 – – – 16.6 – – – Iceland
8.8 80 61 81 3.4 30.9 17.3 1.9 India
0.8 69 40 70 8.5 31.8 10.2 11.1 Indonesia
2.9 88 39 70 21.8 6.3 – 9.4 Iran (Islamic Republic of)
3.3 74 – – 6.2 11.6 3.0 9.0 Iraq
10.9 64 15 13 20.2 – – – Ireland
9.9 – – – 12.1 – – – Israel
11.4 83 39 30 13.2 – – – Italy
0.2 87 – – 13.0 8.5 3.3 6.8 Jamaica
18.9 95 36 21 23.6 5.5 – 2.4 Japan
16.0 43 72 66 12.4 7.3 2.4 7.1 Jordan
8.1 81 – – 9.1 6.7 3.1 8.8 Kazakhstan
0.2 44 – – 8.5 19.4 4.2 4.5 Kenya
0.3 70 – – 6.0 14.9 3.5 2.4 Kiribati
4.9 84 – – 8.9 6.0 2.5ba 7.1 Kuwait
0.4 52 – – 8.4 11.4 2.0 5.8 Kyrgyzstan
2.5 43 6 50 4.4 30.2 9.0 3.0 Lao People's Democratic Republic
8.5 77 8 18 9.6 – – – Latvia
12.9 69 25 56 13.3 10.4 – 19.7 Lebanon
– 40 – – 11.6 32.1 2.1 7.2 Lesotho
– 54 – – 5.2 28.0 3.4 4.7 Liberia
6.0 59 – 58 – 43.5 10.2 25.4 Libya
12.4 85 9 13 12.7 – – – Lithuania
7.0 – 6 10 10.7 – – – Luxembourg
– 36 33 41 10.5 40.2 6.4 1.5 Madagascar
0.1 39 – – 9.8 37.0 0.6ao,bb 4.7 Malawi
3.5 86 20 27 8.5 20.9 9.7 6.1 Malaysia
3.5 47 – – 21.4 14.2 9.1 4.6 Maldives
0.1 50 3 40 5.4 25.7 9.3ao,bb 2.1 Mali
12.9 61 22 18 15.6 – – – Malta
Data type Comparable Comparable Comparable Comparable Primary data Primary data Primary data Primary data Primary data
estimates estimates estimates estimates
Member State 2019 2019 2019 2019 2019 2011–2019 2011–2019 2010–2019 2010–2019
Marshall Islands 79 64 63 24 4.82 – 4.2 33.4 1.2
Mauritania 81 – 77 – 2.74 – 1.9 9.3 0.5
Mauritius 96 99 97 80 0.45 – 25.3 35.2 2.8
Mexico 82 73 86 95 0.03 – 48.5 23.6 1.4
Micronesia (Federated States of) 78 52 73 57at 4.22 – – 21.5 –
Monaco 99 79 – – – – 75.1 201.6 10.2
Mongolia 98 98 49 – 4.85 26.7 38.5 42.1 4.1
Montenegro 86 86 – – 0.28 – 27.6 52.3 0.5
Morocco 99 99 98 – 0.40 – 7.3 13.9 1.4
Mozambique 88 85 80 – 7.70 – 0.8 4.7 0.1
Myanmar 90 80 90 – 2.24 – 7.4 10.8 0.7
Namibia 87 56 57 – 5.85 – 5.9 19.5 0.7
PA R T 3
Primary data Primary data Primary data Primary data Comparable Comparable Primary data Comparable
estimates estimates estimates
2010–2019 2020 2019 2019 2018 2020 2011–2020 2020 Member State
0.7 49 – – 12.1 32.2 3.5ao,ap 4.2 Marshall Islands
0.2 35 – – 6.1 24.2 11.5ao,ap 2.7 Mauritania
4.2 64 – – 10.0 8.7 – 7.6 Mauritius
– 83 – – 10.5 12.1 1.4ap 6.3 Mexico
– 49 – – 4.8 – – – Micronesia (Federated States of)
26.3 – – – 6.6 – – – Monaco
6.8 85 – – 7.7 7.1 0.9 10.1 Mongolia
1.9 – – – 10.6 8.1 2.2 10.2 Montenegro
2.6 75 – – 7.2 12.9 2.6 11.3 Morocco
0.1 70 10 28 5.6 37.8 4.4 6.0 Mozambique
0.8 63 56 72 3.5 25.2 6.7bb 1.5 Myanmar
2.4 61 – – 10.7 18.4 7.1 5.0 Namibia
PA R T 3
1.9 – – – 7.4 15.0 – 3.7 Nauru
1.3 39 – 73 4.6 30.4 12.0 1.8 Nepal
2.1 90 2 7 15.4 1.6 – 5.0 Netherlands
7.3 87 – – 19.3 – – – New Zealand
1.9 83 – – 18.8 14.1 2.2 7.5 Nicaragua
– 10 – – 8.4 46.7 9.8ao 1.9 Niger
1.2 54 – – 4.4 35.3 6.5 2.7 Nigeria
– – – – 5.0 – – – Niue
– – – 64 12.4 4.1 3.4 10.0 North Macedonia
8.5 94 1 6 17.4 – – – Norway
5.3 79 – 55 8.0 12.2 9.3bd 4.8 Oman
1.5 52 65 89 5.3 36.7 7.1be 3.4 Pakistan
– 64 – – 16.8 – – – Palau
2.2 79 – – 21.4 14.7 – 10.8 Panama
0.1 – – – 7.4 48.4 – 8.9 Papua New Guinea
0.3 65 – – 15.3 4.6 1.0 12.0 Paraguay
0.5 59 – – 15.3 10.8 0.4 8.0 Peru
3.3 69 51 40 6.6 28.7 5.6 4.2 Philippines
7.7 50 15 16 10.8 2.3 0.7ap,bf 6.7 Poland
9.1 82 – – 13.4 3.3 0.6bb 8.5 Portugal
8.9 92 34 49 6.3 4.6 – 13.9 Qatar
7.4 98 49 37 14.0 2.2 – 8.8 Republic of Korea
4.1 62 – – 12.0 4.9 1.9bg 4.3 Republic of Moldova
9.1 67 – – 12.7 9.7 – 6.7 Romania
0.5 100 23 58 9.8 – – – Russian Federation
0.7 73 – – 8.9 32.6 1.1 5.2 Rwanda
– 51 – – 7.4 – – – Saint Kitts and Nevis
4.4 69 – – 8.2 2.8 3.7 6.9 Saint Lucia
– – – – 10.1 – – – Saint Vincent and the Grenadines
0.7 – – – 11.0 6.8 3.1 7.1 Samoa
6.7 – – – 23.4 – – – San Marino
– 31 – – 10.8 11.8 4.1 4.0 Sao Tome and Principe
8.6 79 49 57 10.9 3.9 – 7.6 Saudi Arabia
0.1 62 – – 4.3 17.2 8.1 2.1 Senegal
8.1 71 – – 12.4 5.3 2.6 10.8 Serbia
4.7 56 – – 10.2 7.4 4.3bh 9.8 Seychelles
0.1 49 – – 7.2 26.8 5.4 4.7 Sierra Leone
5.1 92 29 29 15.3 2.8 – 4.8 Singapore
8.0 72 – – 12.7 – – – Slovakia
7.1 – – – 13.8 – – – Slovenia
1.2 47 – – 7.9 29.3 8.5 4.0 Solomon Islands
– – – – – 27.4 – 2.9 Somalia
Data type Comparable Comparable Comparable Comparable Primary data Primary data Primary data Primary data Primary data
estimates estimates estimates estimates
Member State 2019 2019 2019 2019 2019 2011–2019 2011–2019 2010–2019 2010–2019
South Africa 77 54 76 56at 1.88 – 7.9 13.1 1.1
South Sudan 49 – – – 18.90 – – – –
Spain 96 94 95 79bi – – 40.3 60.8 8.2
Sri Lanka 99 99 – 82 0.76 – 11.5 22.6 1.1
Sudan 93 74 93 – 2.81 41.0 2.6 11.5 2.1
Suriname 77 58 – 38 2.78 – 8.2 39.3 0.6
Sweden 98 95 97 80aq – – 43.3 216.7 17.9
Switzerland 96 90 84 59bj – – 43.3 178.9 5.1
Syrian Arab Republic 54 54 – – 1.88 – 12.9 15.4 7.2
Tajikistan 97 97 – – 2.89 15.0 17.2 47.5 1.6
Thailand 97 87 – 66 0.35 – 9.2 31.5 2.7
Timor-Leste 83 80 – – 15.19 – 7.7 17.6 0.1
PA R T 3
Primary data Primary data Primary data Primary data Comparable Comparable Primary data Comparable
estimates estimates estimates
2010–2019 2020 2019 2019 2018 2020 2011–2020 2020 Member State
2.7 79 21 31 13.3 23.2 3.4ap,bb 12.9 South Africa
– 36 – – 2.1 30.6 – 5.7 South Sudan
11.9 88 – – 15.2 – – – Spain
0.9 62 56 63 8.3 16.0 15.1 1.3 Sri Lanka
0.3 53 48 – 6.8 33.7 16.3ao 2.7 Sudan
0.4 59 – – 16.8 8.0 5.5 4.0 Suriname
15.7 91 2 8 18.6 – – – Sweden
6.9 – 4 10 11.0 – – – Switzerland
10.7 49 – – – 29.6 – 18.2 Syrian Arab Republic
– – – – 6.1 15.3 5.6 3.5 Tajikistan
6.3 85 12 37 15.0 12.3 7.7 9.2 Thailand
2.1 42 – – 5.4 48.8 9.9ao 2.6 Timor-Leste
PA R T 3
0.3 45 – – 4.3 23.8 5.7 2.4 Togo
0.4 65 – – 7.5 2.6 1.1 12.6 Tonga
6.6 – – – 11.0 8.7 6.4 11.0 Trinidad and Tobago
2.3 74 17 36 13.6 8.6 2.1 16.5 Tunisia
3.9 88 – – 9.3 – 1.7 – Turkey
1.7 68 – – 8.7 7.6 4.1 3.8 Turkmenistan
2.7 48 – – 13.7 9.7 – 6.4 Tuvalu
– 69 – 60 5.1 27.9 3.5 4.0 Uganda
0.3 69 – – 8.9 15.9 – 17.0 Ukraine
8.8 96 36 46 7.2 – – – United Arab Emirates
8.7 95 10 11 19.2 – – – United Kingdom
0.1 51 – – 9.4 32.0 3.5bl 5.5 United Republic of Tanzania
– 92 – – 22.5 3.2 0.1 8.8 United States of America
– 80 – – 20.2 6.5 1.4 10.3 Uruguay
0.4 55 – – 7.9 9.9 1.8ao 5.0 Uzbekistan
1.2 55 – – 7.0 28.7 4.7ao 4.9 Vanuatu
– 74 – – 3.7 10.6 – 6.7 Venezuela (Bolivarian Republic of)
3.4 72 – – 9.3 22.3 5.8 6.0 Viet Nam
1.1 49 – – – 37.2 16.4 2.7 Yemen
0.4 58 – – 7.0 32.3 4.2 5.7 Zambia
1.0 52 – – 7.6 23.0 2.9 3.6 Zimbabwe
PA R T 4
29.7 1.5 0 30.8 5.4 17.9 Bosnia and Herzegovina
20.9 16.9 0 29.6 6.3 18.9 Botswana
11.8 32.6 0 23.3 10.8 22.1 Brazil
5.8 0.7 0 18.9 14.1 14.1 Brunei Darussalam
20.8 1.2 0 28.4 10.8 25.0 Bulgaria
36.3 9.6 0 32.6 1.0 5.6 Burkina Faso
35.6 6.6 0 29.2 1.9 5.4 Burundi
31.6 13.4 0 29.5 3.1 11.8 Cabo Verde
24.9 2.1 0 26.1 3.2 3.9 Cambodia
65.4 6.4 0 24.8 2.8 11.4 Cameroon
6.7 1.6 0 13.2 12.3 29.4 Canada
51.2 21.3 0 31.2 2.2 7.5 Central African Republic
50.8 9.0 0 32.9 1.5 6.1 Chad
23.1 3.9 0 20.9 15.2 28.0 Chile
51.0 0.8 0 19.2 11.7 6.2 China
17.2 38.3 0 19.2 7.0 22.3 Colombia
18.6 7.4 0 27.9 2.8 7.8 Comoros
36.4 10.0 0 26.2 2.0 9.6 Congo
12.0 – 0 22.3 32.2 55.9 Cook Islands
16.7 12.6 0 18.7 12.3 25.7 Costa Rica
23.9 11.5 0 27.2 3.4 10.3 Côte d'Ivoire
17.6 1.1 0 32.4 10.9 24.4 Croatia
21.6 5.1 0 19.0 11.4 24.6 Cuba
17.1 1.3 0 19.8 12.2 21.8 Cyprus
15.6 0.6 0 27.9 9.7 26.0 Czechia
31.0 4.2 0 18.2 8.5 6.8 Democratic People's Republic of Korea
37.4 12.8 0 28.5 2.2 6.7 Democratic Republic of the Congo
10.3 1.1 0 20.6 7.2 19.7 Denmark
41.0 6.6 0 26.8 5.3 13.5 Djibouti
18.8 – 0 22.5 15.0 27.9 Dominica
13.3 17.8 0 21.5 15.0 27.6 Dominican Republic
15.5 7.0 0 17.9 9.4 19.9 Ecuador
PA R T 4
14.7 20.7 0 24.5 10.9 22.7 Haiti
21.5 66.9 0 21.4 9.6 21.4 Honduras
16.3 1.4 0 30.0 11.1 26.4 Hungary
5.9 1.2 0 19.7 9.9 21.9 Iceland
68.0 3.8 0 25.8 2.0 3.9 India
16.4 4.3 0 23.8 6.1 6.9 Indonesia
34.4 3.1 0 19.7 9.8 25.8 Iran (Islamic Republic of)
60.1 14.4 0 25.2 14.4 30.4 Iraq
8.7 0.8 0 19.7 9.8 25.3 Ireland
19.4 1.2 0 16.6 11.9 26.1 Israel
15.7 0.7 0 21.2 12.5 19.9 Italy
13.6 50.3 0 21.8 13.0 24.7 Jamaica
11.8 0.2 0 17.6 3.3 4.3 Japan
31.7 2.7 0 21.0 12.9 35.5 Jordan
14.5 5.1 0 27.1 6.5 21.0 Kazakhstan
25.8 5.6 0 26.7 2.3 7.1 Kenya
10.9 4.8 0 21.5 23.0 46.0 Kiribati
58.9 1.8 0 23.6 22.9 37.9 Kuwait
17.4 4.6 0 26.7 3.9 16.6 Kyrgyzstan
25.5 6.6 0 24.8 4.7 5.3 Lao People's Democratic Republic
14.4 5.0 0 29.4 7.0 23.6 Latvia
30.7 4.2 0 20.7 13.9 32.0 Lebanon
28.1 43.5 0 29.0 5.0 16.6 Lesotho
17.0 9.7 0 28.3 1.9 9.9 Liberia
41.7 2.1 0 23.7 14.6 32.5 Libya
12.3 4.8 0 29.3 6.8 26.3 Lithuania
10.4 0.5 0 21.9 8.3 22.6 Luxembourg
22.5 6.5 0 28.1 1.8 5.3 Madagascar
21.9 2.2 0 28.9 2.0 5.8 Malawi
17.3 2.7 0 22.9 12.7 15.6 Malaysia
7.7 1.9 0 24.4 7.4 8.6 Maldives
29.0 10.7 0 32.6 2.6 8.6 Mali
PA R T 4
33.0 1.5 0 28.5 9.3 22.4 North Macedonia
7.8 0.6 0 19.7 9.1 23.1 Norway
36.2 0.7 0 24.8 14.9 27.0 Oman
56.2 6.0 84 30.5 3.1 8.6 Pakistan
12.4 – 0 22.9 31.4 55.3 Palau
12.0 17.2 0 19.9 10.5 22.7 Panama
11.5 11.0 0 25.6 9.8 21.3 Papua New Guinea
11.7 8.0 0 24.6 10.5 20.3 Paraguay
29.0 9.3 0 13.7 7.8 19.7 Peru
18.7 13.7 0 22.6 4.3 6.4 Philippines
21.5 0.8 0 28.7 9.1 23.1 Poland
8.1 0.9 0 24.4 10.4 20.8 Portugal
91.7 0.5 0 22.4 19.5 35.1 Qatar
24.7 0.8 0 11.0 8.5 4.7 Republic of Korea
16.5 4.1 0 29.8 4.2 18.9 Republic of Moldova
15.4 1.3 0 30.0 8.1 22.5 Romania
14.7 7.8 0 27.2 7.1 23.1 Russian Federation
40.7 4.3 0 26.7 1.7 5.8 Rwanda
12.3 – 0 25.3 12.3 22.9 Saint Kitts and Nevis
21.2 20.2 0 27.1 8.8 19.7 Saint Lucia
21.4 29.4 0 23.3 12.4 23.7 Saint Vincent and the Grenadines
10.9 2.8 0 24.0 21.7 47.3 Samoa
13.4 – – – – – San Marino
25.2 5.6 0 25.8 3.5 12.4 Sao Tome and Principe
86.7 1.9 0 23.3 17.4 35.4 Saudi Arabia
39.7 7.6 0 30.2 1.8 8.8 Senegal
24.7 1.2 0 29.5 9.8 21.5 Serbia
18.6 14.8 0 23.5 10.8 14.0 Seychelles
20.6 7.9 0 30.3 2.5 8.7 Sierra Leone
18.3 0.3 0 14.6 6.8 6.1 Singapore
18.0 1.1 0 28.5 8.1 20.5 Slovakia
16.4 0.9 0 30.5 9.2 20.2 Slovenia
WHO region 2019 2018 2018 2017 2017 2017 2019 2019
African Region 40.4 20 33 29 20 28 2932.34 19
Region of the Americas 15.4 7 25 79 49 – 591.02 92
South-East Asia Region 46.6 17 33 – – 60 1303.35 61
European Region 18.8 6 21 92 68 – 608.65 96
Eastern Mediterranean Region 34.9 17 31 56 – 66 1859.09 74
Western Pacific Region 16.4 8 20 – 67 – 979.49 67
PA R T 4
48.7 13.9 0 27.3 1.7 5.3 Uganda
19.4 6.3 0 27.1 7.0 24.1 Ukraine
37.2 0.7 0 21.1 17.3 31.7 United Arab Emirates
10.6 1.3 0 15.2 10.2 27.8 United Kingdom
25.1 8.1 0 27.3 2.5 8.4 United Republic of Tanzania
7.6 5.8 0 12.9 21.4 36.2 United States of America
8.7 8.5 0 20.7 13.8 27.9 Uruguay
28.9 1.5 0 25.6 4.0 16.6 Uzbekistan
11.0 2.3 0 24.2 8.3 25.2 Vanuatu
16.8 63.6 0 18.6 14.1 25.6 Venezuela (Bolivarian Republic of)
30.1 1.9 0 23.4 2.6 2.1 Viet Nam
44.3 9.7 0 30.7 7.0 17.1 Yemen
23.8 6.5 0 27.1 2.9 8.1 Zambia
19.1 13.1 0 28.2 4.0 15.5 Zimbabwe
WHO African Region: Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cabo Verde, Cameroon, Central
African Republic, Chad, Comoros, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Equatorial Guinea,
Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar,
Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe,
Senegal, Seychelles, Sierra Leone, South Africa, South Sudan, Togo, Uganda, United Republic of Tanzania,
Zambia, Zimbabwe.
WHO Region of the Americas: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia (Plurinational
State of), Brazil, Canada, Chile, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador,
Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint
Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, United States of
America, Uruguay, Venezuela (Bolivarian Republic of).
WHO South-East Asia Region: Bangladesh, Bhutan, Democratic People’s Republic of Korea, India, Indonesia,
Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-Leste.
WHO European Region: Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and
Herzegovina, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece,
Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Malta, Monaco,
Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Republic of Moldova, Romania, Russian
Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan,
Ukraine, United Kingdom of Great Britain and Northern Ireland, Uzbekistan.
WHO Eastern Mediterranean Region: Afghanistan, Bahrain, Djibouti, Egypt, Iran (Islamic Republic of), Iraq, Jordan,
Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab Republic,
Tunisia, United Arab Emirates, Yemen.
WHO Western Pacific Region: Australia, Brunei Darussalam, Cambodia, China, Cook Islands, Fiji, Japan, Kiribati,
Lao People’s Democratic Republic, Malaysia, Marshall Islands, Micronesia (Federated States of), Mongolia, Nauru,
New Zealand, Niue, Palau, Papua New Guinea, Philippines, Republic of Korea, Samoa, Singapore, Solomon
Islands, Tonga, Tuvalu, Vanuatu, Viet Nam.
Disaggregated data for GPW 13 impact measurement– including outcome indicators as well as indicators used
to monitor HALE and the Triple Billion targets– were compiled from a range of data sources. These included:
• Data from publicly available datasets based on demographic and health surveys (DHS), multiple indicator
cluster surveys (MICS) and reproductive health surveys (RHS). The disaggregated data are published in the
Health Equity Monitor database, with the re-analysis done by the International Center for Equity in Health in
the Federal University of Pelotas, Brazil, a WHO Collaborating Centre for Health Equity Monitoring.
• WHO estimates from the Global Health Estimates (GHE) as well as estimates produced by WHO programmes
and published in the WHO Global Health Observatory.
• Water, sanitation and hygiene (WASH) estimates from the WHO/UNICEF Joint Monitoring Programme (JMP).
• UNICEF-WHO-World Bank Joint Malnutrition Estimates from the WHO Global Database on Child Growth and
Malnutrition.
• Data source for U5MR and NMR is UN InterAgency group on Child Mortality Estimation (UN IGME).
The availability of disaggregated data was assessed across five inequality dimensions: age, economic status,
education, place of residence and sex (Tables A4.1 and A4.2). The number of WHO Member States with
disaggregated data available was calculated by indicator and inequality dimension. Estimates from the latest
year available and survey data collected between 2010 and 2019 were used for the calculation.
* For indicators with data from surveys, a country is counted if data are available for at least one survey year between 2010–2019.
** Data disaggregated by sex for under-five mortality rate is based on estimates.
Source: HEAT Plus Data Repository, Health Equity Monitor (https://www.who.int/data/gho/health-equity/assessment_toolkit/heat-plus-data-repository, accessed 30 April 20121).
Triple Billion SDG/WHA Indicator Data Age Economic Education Place of Sex
target source status residence
(year)*
HALE Healthy life expectancy (HALE) at birth (years) Estimates 183
(2019)
Universal SDG 3.8.1 UHC service coverage index
health
coverage Antenatal care coverage – at least four visits (in the two or Surveys 94 74 95
three years preceding the survey) (%)
Children aged <5 years with pneumonia symptoms taken to Surveys 62 55 82 89
a health facility (%)
SDG 3.b.1 DTP3 immunization coverage among 1-year-olds (%) Surveys 87 69 89 90
Mean fasting plasma glucose for adults 25+ years (age- Estimates 191
standardized) (%) (2014)
Percentage of population who slept under an insecticide- Surveys 30 30 30 30
treated net (%)
WHA 66.10 Prevalence of raised blood pressure among persons aged Estimates 190
18+ years (age-standardized) (%) (2015)
Proportion of people living with HIV currently receiving Estimates 42 117
antiretroviral therapy (%) (2019)
Proportion of population using at least basic sanitation Estimates 165
services (%) (2017)
Proportion of tuberculosis cases that are treated (%)
SDG 3.7.1 Demand for family planning satisfied – use of modern Surveys 85 90 78 91
methods (%)
SDG 3.8.2 Proportion of population with >10% household Surveys 96
expenditures on health (%)
Healthier SDG 11.6.2 Annual mean concentrations of fine particulate matter
populations (PM2.5) in urban areas (µg/m3)
SDG 3.9.1 Mortality rate attributed to household and ambient air Estimates 183
pollution (per 100 000 population) (2016)
SDG 2.2.2 Overweight prevalence in children aged <5 years (%) Surveys 84 86 71 85 86
SDG 2.2.1 Stunting prevalence in children aged <5 years (%) Surveys 84 86 71 85 86
SDG 3.4.2 Suicide mortality rate (per 100 000 population) Estimates 183 183
(2016)
SDG 3.5.2 Total alcohol per capita consumption in adults aged 15+ Estimates 188
(litres of pure alcohol) (2018)
SDG 2.2.2 Wasting prevalence in children aged <5 years (%) Surveys 84 86 71 85 86
Health SDG 3.b.1 Measles immunization coverage among 1-year-olds (%) Surveys 88 69 89 90
emergencies
protection SDG 3.b.1 Polio immunization coverage among 1-year-olds (%) Surveys 88 69 89 90
* For indicators with data from surveys, a country is counted if data are available for at least one survey year between 2010–2019.
Note: Not all indicators used to monitor the Triple Billion targets are GPW 13 outcome indicators.
Source: HEAT Plus Data Repository, Health Equity Monitor (https://www.who.int/data/gho/health-equity/assessment_toolkit/heat-plus-data-repository, accessed 30 April 20121).